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A relevant quote from Sir Richard Morton, who was credited with the first English-






“Mr. Duke’s daughter in St. Mary Axe, in the year 1684 and the eighteenth year of 
her age, in the month of July fell into a total suppression of her monthly courses from 
a multitude of cares and passions of her mind but without and symptom of the green-
sickness following upon it. […] I do not remember that I did ever in all my practice 
see one that was conversant with the living so much wasted with the greatest degree 
of consumption (like a skeleton only clad with skin). […] A nervous atrophy, or 
consumption, is a wasting of the body without any remarkable fever, cough, or 
shortness of break; but it is attended with a want of appetite, and a bad digestion, 
upon which there follows a languishing weakness of nature, and a falling away of the 
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Binge-eating is characterised by the recurrent consumption of large amounts of food, 
which co-occurs with a subjective loss of control over intake. This transdiagnostic 
syndrome results in significant distress, functional impairment and comorbidity. 
However, precise characterisation of the physiological and neurobiological 
mechanisms that give rise to, or maintain, this behaviour is lacking. This thesis 
integrates observations across metabolic, neural and behavioural levels in women 
with and without eating disorders, providing novel insights into how perturbations 
across each strata interact with one another in illness and in health to shape eating 
behaviour.  
 
In Chapter 1, I review the classification of binge-eating disorders prior to 
summarising the extant literature on homeostatic and non-homeostatic mechanisms 
that influence (ab)normal eating behaviour. This introductory chapter also reviews 
current perspectives on how psychological stress influences disordered eating, 
outlining the motivation for the multimodal neuroimaging protocol detailed in Chapter 
2. Chapter 2 focuses on the specific methodology of this neuroimaging study, which 
examined the impact of acute, psychological stress on gut hormones, endocrine 
responses, and inhibitory control in women acutely ill with the binge-eating and 
purging subtype of anorexia nervosa, bulimia nervosa and matched controls. 
Chapters 3 through 5 report the results of this study.  
 
Chapter 3 focuses on findings of dissociable hormonal responses to stress in 
anorexia and bulimia nervosa, presenting novel evidence that links acute changes in 
mental state to altered gut hormone signalling in anorexia nervosa. Chapter 4 is 
dedicated to the functional magnetic resonance imaging arm of the protocol, which 
rigorously examined the impact of diagnosis and induced stress on two forms of 
response inhibition: proactive and reactive control. Chapter 5 provides insight into 
associations between peripheral metabolic markers and neural integrity of the 
cerebral cortex in patients and controls.   
 
 viii 
Finally, Chapter 6 provides a brief summary, discusses the implications of these 
findings and presents some ongoing and future research that extends this original 
work.  
 
In summary, this thesis represents, to my knowledge, the first attempt to generate a 
multi-level framework for understanding the physiological and psychological 
mechanisms of illnesses characterised by binge-eating. Findings identify important 
metabolic and neurobiological distinctions between two eating disorders with shared 
symptomatology, demonstrating the need for, and value in, integrative models of 
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Chapter 1: Introduction  
 
 
1.1 Note on the philosophy of psychiatric nosology  
 
 Eating disorders, such as anorexia nervosa (AN), bulimia nervosa (BN) and 
binge-eating disorder (BED), are complex psychiatric conditions that are 
characterised by abnormal eating behaviour that results in marked distress and/or 
dysfunction. AN and BN are further defined by disturbances in the perception or 
valuation of one’s body weight and shape (5th ed.; DSM-5; American Psychiatric 
Association, 2013), which coincides with life-threatening weight loss in AN. 
Historically, research and treatment of eating disorders, as with other mental 
illnesses, has been necessarily shaped by the diagnostic criteria used to define 
them, such as those put forth by the Diagnostic and Statistical Manual of Mental 
Disorders (DSM) and its iterations. These criteria represent the culmination of 
decades of top-down, ‘expert-driven’ classification of psychiatric illnesses via clinical 
observation (Kendler, 2009), and although medically useful, they have been subject 
to scrutiny and contention. A primary criticism has been that current criteria, which 
are based on descriptive symptoms, may fail to capture the underlying aetiology of 
mental illness. This criticism partly arose from challenges in integrating ‘bottom-up’, 
empirical findings from the fields of clinical neuroscience and genomics with the 
current diagnostic framework (Insel et al., 2010), and from observations of high rates 
of psychiatric comorbidity and transdiagnostic symptomatology amongst patient 
populations (Caspi et al., 2014; Kessler et al., 2005). Such observations call into 
question whether diagnostic categories truly map onto discrete pathophysiology at 
the deeper level.  
 
Indeed, binge-eating, or the consumption of an objectively large amount of food for 
the circumstances within a relatively short period of time while experiencing a 
subjective loss of control, represents a transdiagnostic symptom of the three primary 
eating disorders, AN, BN and BED, as defined by the DSM (American Psychiatric 
Association, 2013a). While longitudinal findings indicate ‘diagnostic crossover’ 
amongst binge-eating disorders (Eddy et al., 2008), the physiological mechanisms 
that subserve binge-eating behaviour remain poorly defined, particularly across 
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disorders and body mass index (BMI)-defined weight classes. I would argue that this 
dearth of knowledge has both hindered the development of effective treatments for 
individuals who suffer with binge-eating and upheld an untested assumption that the 
mechanisms underlying the syndrome are similar across disorders. The latter is 
particularly salient as the observation of shared symptomatology at a 
phenomenological level does not mandate shared aetiology across biological levels, 
or even levels within the psychological domain, such as cognition, attitudes or 
affective states (Eronen, 2019; Kendler, 2019). Put simply, a broadly defined 
symptom, such as binge-eating, may be underpinned by a variety of neurobiological 
mechanisms, and it is crucial that we resolve this ambiguity. 
 
Consideration of various ‘levels’ of study in psychiatry has implications for both 
nosology, as well as our understanding of the causes of mental illness. Psychiatric 
disorders are predominantly studied at psychological and biological levels, where 
both the aforementioned critiques of descriptive nosology and the emergence of 
novel methodologies have galvanised research across biological levels over the past 
three decades. The explosion of research into molecular, cellular and systems 
biology has, however, raised questions regarding how explanations across biological 
and psychological strata link to one other. Recent efforts to bridge this ‘mind-body 
divide’ have adopted various forms of ‘explanatory reductionism,’ which, in the 
broadest sense, asserts that relationships between psychological and biological 
levels are unbalanced, with lower-level (biological) explanations being considered 
more robust than higher-level (psychological) ones (Eronen, 2019; Miller, 2010; 
Mitchell, 2008). Indeed, such a position has been adopted by the National Institute of 
Mental Health’s Research Domain Criteria framework (RDoC; Cuthbert, 2014; Insel 
et al., 2010), which aims to carve diagnostic boundaries in line with biological 
evidence instead of the descriptive phenomenology implemented in the DSM and the 
International Classification of Diseases (11th ed.; ICD-11; World Health Organization, 
2004). Whilst delving into the basic biology of some medical conditions, such as 
cancer, has yielded translational clinical insights, this has unfortunately not been the 
case for psychopathology thus far (Abi-Dargham & Horga, 2016). For example, 
despite large-scale efforts, no reliable ‘biomarkers’ of mental illness have been 
discovered (Kalia & Costa E Silva, 2015). It is perhaps unsurprising that biological 
reductionism alone has been insufficient in defining psychopathology, particularly 
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given the complexity of the system it aims to explain (i.e., the human brain). 
Moreover, this complexity necessitates high-level, generalisable aetiological models 
(Eronen, 2019), and many of these existing models, such as negative cognitive 
biases in depression (Beck, 1967), have been identified at the psychological level 
and lack a credible biological substrate in the brain. As such, ‘explanatory pluralism,’ 
or the view that multiple, mutually-informative levels should be considered in the 
study of natural phenomena, arguably represents a superior approach to 
understanding the nature of psychiatric illness (Kendler, 2005). 
 
Adopting an explanatory pluralism approach for the study of eating disorders will be 
key to addressing outstanding questions regarding the aetiology of binge-eating 
behaviour and its relevance to disorder classification. It should be specified that such 
a framework should strive for ‘integrative pluralism,’ or the incorporation of divergent 
levels of analysis, as it is assumed that each level offers only a partial explanation for 
psychiatric illness (Kendler, 2005; Mitchell, 2008). Indeed, energy intake is regulated 
by a complex set of interrelated factors, spanning genetic, physiological, neural, 
cognitive and environmental domains, and any attempt to characterise the 
mechanisms of disordered eating must consider how each echelon relates to the 
overall presentation of the syndrome, particularly as there is no evidence that one 
level is superior to another. That is, rather than honing in on one aetiological 
explanation for disordered eating, we must consider there to be many (Kendler, 
2019). I argue that such an integrative approach has implications for nosology, 
whereby current diagnostic boundaries can be tested through the practice of 
epistemic iteration. This practice involves revising criteria for psychiatric disorders 
based on empirical evidence arising from the methodologies that are used to validate 
them, such as clinical description, neuroimaging, genetics and prospective studies 
(Kendler, 2009). Ultimately, epistemic iteration has the potential to slowly shift the 
field of psychiatry toward an aetiologically-based nosology, which could have 
important implications for the study and treatment of binge-eating disorders. 
 
This thesis presents findings from an integrative experimental medicine study, in 
which I examined the role of metabolic, neural, cognitive and environmental factors 
in two binge-eating disorders: bulimia nervosa and the binge-eating/purging subtype 
of anorexia nervosa. Aligning with the philosophy of integrative pluralism, this project 
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sought 1) to make observations at different levels of psychological and biological 
(dys)function and 2) to synthesise these in an effort to better understand the 
aetiology of binge-eating as a transdiagnostic syndrome.  
 
In this Chapter, I will briefly review the current definitions of binge-eating disorders 
before outlining the homeostatic mechanisms that regulate energy intake via the gut-
brain axis. I will then highlight the prominent neurocognitive models that have guided 
cognitive neuroscience research of loss-of-control eating. I will also discuss the role 
of psychological stress in the pathogenesis of binge-eating syndromes, and how this 
environmental variable may perturb both neural and metabolic signalling. Finally, I 
will outline the original work presented in the subsequent chapters of this thesis.  
 
1.2 Binge-eating as a transdiagnostic symptom 
 
In accordance with the DSM-5, individuals who suffer with binge-eating may receive 
a diagnosis of AN, BN or BED. Lifetime incidence rates of BN and BED range from 
0.28 to 2.6% and 0.85 to 3.0%, respectively, whereas AN afflicts approximately 0.8-
3.6% of the population at some point during the life course (Mustelin et al., 2016; 
Stice, Marti, et al., 2013; Udo & Grilo, 2018). Both binge-eating and its associated 
disorders disproportionately affect women and girls (Sonneville et al., 2013; Udo & 
Grilo, 2018), where sex differences are particularly prominent for AN, which has a 
male-to-female ratio of 1:8 (Zipfel et al., 2015). As with much of psychiatric illness, 
both AN and BN tend to onset during adolescence (18.5 and 19.3 years, 
respectively; Fairburn & Harrison, 2003; Favaro et al., 2009); however, on average, 
BED develops later at 23.3 years (Kessler et al., 2013). These conditions often 
present with a chronic and relapsing course, where only 31.4% of patients with AN 
and 68.2% of those with BN achieve recovery 9 years post-treatment (Eddy et al., 
2016). Importantly, the persistence of binge-eating, compensatory behaviours (e.g., 
self-induced vomiting) and psychiatric comorbidity (e.g., depression) in AN and BN 
predicts poorer prognosis at 22-year follow-up (Franko et al., 2018).  
 
Both BN and BED share key diagnostic criteria, namely the experience of ‘objective’ 
binge-eating episodes, on average, at least once per week over the preceding three 
months (American Psychiatric Association, 2013a). Whilst all binge-eating episodes 
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are characterised by a subjective loss of control over eating, ‘objective’ binge-eating 
episodes differ from ‘subjective’ ones in that the individual consumes an amount that 
is ‘definitely larger than what most individuals would eat’ within a relatively short 
amount of time (within two hours). Conversely, the contents of a subjective binge-
eating episode would be not be considered large by most individuals (e.g., a granola 
bar or a sandwich), including, in some instances, by the affected individual. 
Consensus on what is deemed ‘definitely large’ can differ across individuals and 
diagnostic groups (Wolfe et al., 2009); however, assessment tools, such as the 
Eating Disorder Examination (Cooper & Fairburn, 1987) have provided guiding 
principles on what should be considered objectively large for (young) women. For 
example, the consumption of either two full meals or three entrées within two hours 
would be considered objectively large. Although the diagnostic criterion emphasises 
the amount of food consumed, not the energy density, empirical findings suggest 
that intake in excess of 1,000 kilocalories (kcal) could be considered definitely large 
(Forney et al., 2015). Nevertheless, it should be noted that modern portion sizes 
often exceed 1,000 kcal, particularly at fast food restaurants (Dumanovsky et al., 
2009), and self-reported binge-eating episodes in BN and BED often surpass this 
threshold, ranging from 3,000 to 4,500 kcal and 1,515 to 2.963 kcal, respectively 
(Wolfe et al., 2009).  
 
Diagnostic criteria for BN and BED differ in two critical ways. First, in BN, binge-
eating episodes are followed by inappropriate compensatory, or ‘purging’, 
behaviours, such as self-induced vomiting, laxative use, dietary restriction or 
excessive exercise, aimed to counteract the effects of eating and/or concerns 
surrounding one’s weight or shape. These compensatory behaviours define the two 
diagnostic subtypes of BN: the purging subtype, where vomiting or laxative use are 
present, and the non-purging subtype, in which dietary restriction and driven 
exercise are used to compensate for binge-eating. Second, objective binge-eating 
episodes in BED must relate to marked distress, and they must be accompanied by 
at least three of the following symptoms: 1) eating much more rapidly than normal, 2) 
eating until feeling uncomfortably full, 3) eating large amounts of food when not 
feeling physically hungry, 4) eating alone due to feelings of embarrassment about 
how much one is eating and 5) feeling disgusted, depressed or very guilty following 
the episode (American Psychiatric Association, 2013a). Although these symptoms 
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are not necessary for the diagnosis of BN, those suffering with the illness often 
report similar symptoms of distress, guilt and shame (Blythin et al., 2020), which are 
posited to partly maintain the binge-purge cycle (De Young et al., 2013).  
 
The cycle of binge-eating and compensatory behaviours, though almost ubiquitously 
associated with BN, is also observed in the binge-eating and/or purging subtype of 
AN. Within the DSM-5, AN may be diagnosed when restriction of energy intake 
results in significantly low body weight, or that which is less than minimally normal ‘in 
the context of age, sex, developmental trajectory and physical health’, for at least 
three months (American Psychiatric Association, 2013a). For children and 
adolescents, significantly low body weight would be evident amongst individuals 
weighing <87% of their ideal body weight (American Psychiatric Association, 2013a). 
In adults, a BMI <18.5 kg/m2 would be considered less than minimally normal 
according to the World Health Organization; however, BMI cut-offs have been shown 
to range from 17 – 18.5 kg/m2 in both research and clinical practice (T. A. Brown et 
al., 2014). Affected individuals must also report disturbances in the perception or 
experience of their weight or shape. Finally, they must experience either an intense 
fear of weight gain or suffer with behaviours that prevent weight gain despite being 
significantly underweight. The latter criterion has implications for the two diagnostic 
subtypes of AN, a restrictive subtype (AN-R) and a binge-eating and/or purging 
subtype (AN-BP), where each subtype reflects the primary behaviour that either 
facilitates or maintains weight loss. AN-BP is perhaps less specific than AN-R, as 
this subtype describes the ‘regular engagement’ in binge-eating episodes only, 
purging episodes only or both binge-eating and purging behaviours. Therefore, for 
many individuals, the primary nosological distinction between AN-BP and BN is the 
weight criterion.  
 
As I have reviewed, binge-eating represents a serious, transdiagnostic syndrome, 
and binge-eating disorders are primarily differentiated by recurrent compensatory 
behaviours and BMI status. However, the presence of purging behaviours and/or 
underweight may change over time, and prospective studies have associated a high 
degree of diagnostic crossover with binge-eating. Approximately one third of women 
with AN will receive a diagnosis of BN at some point in their lifetime (Eddy et al., 
2008), whereas women with BN are less likely to crossover to AN (Tozzi et al., 
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2005). Flux between AN and BED has not been reported (Castellini et al., 2011; 
Fichter & Quadflieg, 2007). Moreover, approximately 50% of women diagnosed with 
AN will develop binge-eating over the course of their illness while remaining 
significantly underweight (Castellini et al., 2011; Eddy et al., 2008). A recent 
prospective study of BED indicated that, approximately 1.5 years after initial 
diagnosis, 25% of patients received a diagnosis of BED at follow-up, and 16% were 
diagnosed with another eating disorder (Welch et al., 2016). Risk for crossover may 
reflect both personality and family characteristics (Tozzi et al., 2005), as well as 
whether binge-eating precedes or follows initial dieting attempts (Hilbert et al., 2014). 
Alternatively, the poor temporal stability of specific diagnoses could be indicative of a 
shared aetiology (Milos et al., 2005), which, as I have discussed, may relate to both 
biological and psychological levels. A history of crossover may indicate a poorer 
prognosis, as patients with BED and a history of either BN or AN show reduced 
treatment response to cognitive behavioural therapy (CBT) and increased binge-
eating episodes one year following treatment completion (Utzinger et al., 2015). 
Therefore, a more detailed characterisation of the mechanisms that subserve binge-
eating behaviour across diagnostic boundaries will be central to efforts to augment 
existing treatments.  
 
1.3 Homeostatic control of energy intake: Integrating central and peripheral 
metabolic signalling  
 
Our current understanding of the neural regulators of food intake and energy 
homeostasis has emerged from collaborative, interdisciplinary research across the 
fields of neuroscience, psychology, genetics and metabolic science. At the outset, it 
is important to acknowledge that these efforts have identified dynamic crosstalk 
between the brain and peripheral physiological mechanisms that, together, protect 
against prolonged energy deprivation. Moreover, within the central nervous system, 
interplay between regions underpinning both homeostatic processes (e.g., arousal, 
energy expenditure, thermoregulation) and higher-order cognition (e.g., motivation, 
decision-making, motor control) is central to coordinating and maintaining normative 
energy intake. This section will briefly review homeostatic neural and physiological 
mechanisms of food intake, as well as findings of altered gut hormones and 
metabolites in binge-eating disorders. Prominent neurocognitive models of binge-
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eating behaviour, which largely focus on neural circuits that subserve reward 
processing and self-regulation, will be discussed in Section 1.4.  
 
Homeostatic regulation of energy intake and expenditure by the brain hinges upon 
metabolic signalling from the periphery that communicates either a negative or 
positive energy balance. The hypothalamus and brainstem nuclei (e.g., the nucleus 
of the solitary tract and area postrema) play a central role in homeostatic control of 
food intake and arousal, receiving input from both afferent sensory neurones in the 
gastrointestinal tract and from circulating peptides. The hypothalamus is comprised 
of distinct nuclei, of which a set are critically involved in eating behaviour. Ablation of 
the ventromedial nucleus leads to hyperphagia, obesity and reduced water intake in 
rodents (Hetherington & Ranson, 1940; Stevenson, 1949). Conversely, ablation of 
the lateral hypothalamic area (LHA) reduces feeding and drinking, leading to 
eventual death (Anand & Brobeck, 1951). Although the lateral and ventromedial 
hypothalamic nuclei continue to be recognised as ‘feeding’ and ‘satiety’ centres of 
the brain, respectively, subsequent research suggests this framework to be overly 
simplistic (Elmquist et al., 1999). Specifically, the identification of the paraventricular 
(PVN) and arcuate (ARC) hypothalamic nuclei revealed complex inter-regional 
modulation of hunger and satiety, which is mediated by neural peptides that are 
secreted both locally (e.g., neuropeptide Y) and peripherally from enteroendocrine 
cells (e.g., ghrelin) and white adipose tissue (leptin). 
 
1.3.1 Leptin signalling in the central nervous system 
 
Circulating levels of the adipocyte-derived satiety hormone, leptin, rise in response to 
a positive energy balance, initiating the cascade of satiety sensing within the 
hypothalamus (Coll et al., 2007). Leptin crosses the blood-brain barrier at the median 
eminence, a highly vascularised, circumventricular organ, and it binds directly to 
leptin receptors within overlying nuclei, the ARC, the dorsomedial hypothalamus and 
the ventromedial hypothalamus (Figure 1.1A). These nuclei innervate the PVN, as 
well as the LHA (Flier & Maratos-Flier, 1998). The ARC contains two distinct 
populations of melanocortin neurones: those expressing pro-opiomelanocortin 
(POMC) receptors and neuropeptide Y/agouti-related peptide (NPY/AgRP)-
expressing neurones, which have opposing effects on food intake and energy 
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expenditure (Toda et al., 2017). Agonism of POMC-expressing neurones decreases 
feeding while increasing energy expenditure, whereas NPY release has potent 
orexigenic effects that co-occur with reduced energy expenditure. Leptin rapidly 
inhibits ARC NPY/AgRP neurones; however, it stimulates the release of 
antagonising melanocyte stimulating hormone (α-MSH) from POMC neurones, which 
project to the PVN, LHA and brainstem (Coll et al., 2007; Flier & Maratos-Flier, 
1998).  
 
However, the neurones that mediate ARC projections to the LHA remained unknown 
until findings from molecular genetics implicated the central melanocortin system in 
energy homeostasis. Agouti-related peptide was shown to act as a natural 
antagonist on melanocortin receptors, including the melanocortin 4 receptor (MC4R), 
where inhibition resulted in obesity (see Spiegelman & Flier, 1996). Similarly, a loss 
of function MC4R mutation was found to cause obesity in both rodents (Huszar et al., 
1997) and humans (Yeo et al., 1998). As α-MSH has been shown to agonise MC4R-
expressing neurons that innervate the LHA, leptin-induced signalling via POMC 




Figure 1.1 Control of food intake via hypothalamic signalling and the gut-brain axis. A) 
Schematic of the hypothalamic leptin-melanocortin pathway. Leptin binds directly to POMC 
and AgRP neurones in the ARC, which project to MC4R-expressing neurones in the LHA and 
PVN. For simplicity, DMN and VMN inputs to the PVN have not been illustrated; however, 
neurones that express steroidogenic factor 1 (SF-1) are thought to mediate leptin signalling 
from the VMN (Dhillon et al., 2006). B) Overview of peripheral hormones that regulate satiety 
via the gut-brain axis. AgRP = Agouti-related protein/neuropeptide Y, ARC = arcuate nucleus, 
CCK = cholecystokinin, DHA = dorsal hypothalamic area, DMN = dorsomedial nucleus, LHA 
= lateral hypothalamic area, ME = median eminence, POMC = pro-opiomelanocortin, PFA = 
parafornicular nucleus, PYY = peptide tyrosine tyrosine, VMN = ventromedial nucleus  
 
Given its central role in maintaining energy homeostasis despite transient changes in 
feeding, leptin is often conceptualised as a marker of long-term energy balance. 
Indeed, preclinical studies suggest that, along with its role as a negative feedback 
signal, leptin serves as a ‘starvation signal’ in response to extended fasting and 
waning fat stores in rodents (Ahima et al., 1996). Although leptin levels increase 
postprandially (Dallongeville et al., 1998), they remain relatively stable in a 24-hour 
period. As such, gastrointestinal peptides are the primary short-term regulators of 
appetite in response to gastric distension, nutrient sensing and blood glucose levels 
(Figure 1.1B). The majority of these peptides, such as peptide tyrosine tyrosine 
(PYY), glucagon-like peptide-1 (GLP-1) and cholecystokinin (CCK), induce satiety 
and will be reviewed in Section 1.3.3. However, as the growth hormone 
secretagogue, ghrelin, provides the principal orexigenic signal from the periphery, 
counteracting leptin’s hypothalamic effects, I will provide an overview of its 
corresponding neural mechanisms.  
 
1.3.2 Ghrelin signalling and vagal afferents  
 
Synthesised by closed-type enteroendocrine cells in the gastric mucosa, ghrelin is 
28-amino acid peptide involved in growth hormone secretion and hunger signalling 
(Kojima et al., 1999). Ghrelin levels increase during periods of fasting and decline 
post-prandially. Findings from both rodent and human studies have identified a high 
density of ghrelin cells in the stomach (Dass et al., 2003), where cell density 
decreases substantially from the duodenum to the colon (Sakata & Sakai, 2010). 
The peptide has a unique molecular structure that is modified by the enzyme, ghrelin 
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O-acyl transferase (GOAT), yielding two distinct forms: acyl ghrelin, which has been 
modified with medium chain fatty acids, and des-acyl ghrelin, which lacks the fatty 
acid chain modification. Ghrelin must be acylated in order to bind to its receptor, 
growth hormone secretagogue receptor (GHSR) 1a, which is highly expressed in the 
central nervous system (e.g., pituitary gland, ARC). As such, acyl ghrelin is often 
referred to as the bioactive form of the peptide. However, mounting evidence 
indicates biological activity of des-acyl ghrelin that is independent of GHSR 
mechanisms, such as orexin-expressing neurons in the lateral hypothalamic area 
(Toshinai et al., 2006). 
 
Stomach-derived ghrelin exerts its effects on hypothalamic function via two primary 
mechanisms (see Figure 1.2). First, circulating acyl ghrelin in blood may enter the 
central nervous system either through the median eminence or by crossing the 
blood-brain barrier (BBB). Ghrelin has high affinity for ARC NPY/ArGP neurones in 
rodents, which co-express GHSRs (Willesen et al., 1999), and binding induces 
orexigenic effects via projections to the LHA. Second, several lines of evidence 
suggest that acyl ghrelin affects hypothalamic function, in part, through vagal nerve 
afferents. Originating in the medulla oblongata, the vagus nerve facilitates 
parasympathetic control of the heart, lungs and alimentary tract, and the bilateral 
branches of the subdiaphragmatic vagus innervate the antero-superior surface of the 
stomach (Norgren & Smith, 1988). Only 10-20% of vagal fibres are efferent, whereas 
80-90% are afferent fibres that relay visceral sensory information via 
chemoreceptors, mechanoreceptors or tension receptors. The cell bodies of these 
vagal sensory neurons form, along with somatic neurones, the nodose ganglion, and 
afferent axons terminate in the nucleus of the solitary tract (Norgren & Smith, 1988). 
In turn, the nucleus of the solitary tract targets both the ARC of the hypothalamus 
and the parabrachial nucleus (M. S. King, 2006). 
 
Vagotomy abolishes ghrelin-induced feeding and growth hormone secretion in 
rodents (Asakawa et al., 2001; Date et al., 2002), and ghrelin infusion fails to 
stimulate appetite in patients who underwent vagotomy during gastric surgery (Le 
Roux et al., 2005). The presence of GHSR1a on axon terminals of the vagus nerve 
in rodents has provided further evidence of vagal-mediated ghrelin signalling to the 
brain (Date et al., 2002). Interestingly, Date et al. (2002) also found that doses of 
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acyl ghrelin required to stimulate feeding and growth hormone secretion reduced the 
firing rate of vagal afferent fibres. 
 
1.3.3 Peripheral messengers: Gut hormones influence short-term satiety 
 
Whilst acyl-ghrelin represents the primary orexigenic hormone, the hormones CCK, 
PYY, and GLP-1 provide short-term satiety signalling in response to feeding (for 
review, see Wren & Bloom, 2007). First, CCK represents the prototypical satiety 
hormone, which rises by approximately 5-fold post-prandially to inhibit feeding and 
delay gastric emptying (Wren & Bloom, 2007). The peptide is primarily synthesised 
in the duodenum and jejunum, where the presence of nutrients, particularly fat and 
protein, stimulates rapid CCK release (Degen et al., 2001). In addition to inhibiting 
gastric motility, CCK stimulates pancreatic enzyme secretion and gall bladder 
contraction, which promotes efficient digestion of fat. The satiety-inducing effects of 
CCK depend on agonism of CCK-A receptors, which are expressed by vagal afferent 
neurones, brainstem loci (e.g., nucleus of the solitary tract, area postrema) and the 
hypothalamic PVN (Y. Li et al., 1997; Mönnikes et al., 1997). As would be expected 
from a satiety signal, exogenous CCK infusion in animals and humans reduces food 
intake and meal duration (Gibbs et al., 1973; Kissileff et al., 1981).  
 
Second, PYY is an anorectic peptide that belongs to the pancreatic polypeptide 
family, which also includes NPY and pancreatic peptide. Although these three 
peptides share a similar structural motif, their functional effects depend on different 
subtypes of the gamma (γ) family of G protein-coupled receptors, which are 
expressed in the hypothalamus (Larhammar, 1996). Circulating PYY occurs in two 
forms, PYY1-36 (i.e. total PYY) and the truncated PYY3-36, where the former binds to 
all Y family receptors with equivalent affinity, and the latter shows some selectivity 
for the Y2 receptor on hypothalamic NPY neurones (Keire et al., 2000). PYY is 
reduced during fasting and primarily secreted from enteroendocrine cells in the ileum 
and colon in response to nutrients, initiating a cascade of functions to terminate food 
intake and aid digestion (e.g., reduced gastric emptying and secretions). 
Accordingly, exogenous PYY3-36 administration robustly reduces appetite and 
moderately decreases calorie intake in humans (Batterham et al., 2002), and these 
anorectic effects are mediated by Y2 receptor agonism of arcuate nucleus NPY 
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neurones and ascending vagal pathways (Abbott et al., 2005; C. H. Chen & Rogers, 
1997). Whilst post-prandial PYY levels peak between 1 and 2 hours following meal 
consumption, preclinical studies indicate that secretion occurs before nutrients reach 
the lower intestine (Wren & Bloom, 2007). This could implicate the vagal nerve 
efferents in the control of PYY secretion (Onaga et al., 2002). 
 
Third, ingestion also potentiates release of GLP-1 from L cells in the distal ileum and 
colon. Meals rich in fats and carbohydrates, as well as oral glucose administration, 
elicit robust, biphasic GLP-1 secretion (Brubaker, 2006; Herrmann et al., 1995). 
GLP-1 is an incretin, whose release, along with that of gastric inhibitory polypeptide 
(GIP), primarily regulates insulin secretion from pancreatic islet cells in both rodents 
(Schmidt et al., 1985) and humans (Kreymann et al., 1987). This increase in insulin, 
in turn, reduces blood glucose levels. The mechanism of action for both GLP-1 and 
GIP involves agonism of G-protein coupled receptors on pancreatic β cells (reviewed 
by Baggio & Drucker, 2007). In addition to its insulinotropic effects, GLP-1 secretion 
induces satiety by slowing gastric emptying via an ileal brake mechanism (Näslund 
et al., 1999; Nauck et al., 1997). The anorectic effects of GLP-1 also involve GLP-1 
receptors in the PVN, where central administration inhibits feeding (Turton et al., 
1996) and attenuates weight gain in rodents (Meeran et al., 1999). 
 
1.3.4 A false dichotomy: Metabolic markers modulate functional responses of higher-order 
neural circuits 
 
Taken together, complex interactions between the hypothalamus, circulating 
peptides like leptin and ghrelin, and vagal afferents subserve homeostatic control of 
feeding and metabolic homeostasis. However, hypothalamic responses to 
peripherally circulating peptides engender equally complex interactions with higher-
order neural circuits involved in reward processing and motivated behaviour (Figure 
1.2). Specifically, LHA neurones represent the primary source of input to the ventral 
tegmental area (Phillipson, 1979), where LHA neurones secrete orexins onto VTA 
dopamine neurones (Hagan et al., 1999). Findings of high orexin 2 receptor 
expression in the VTA provide further evidence of functional interplay between the 
LHA and midbrain dopamine neurones (Lu, Bagnol, Burke, Akil, & Watson, 2000). 
Moreover, optogenetic stimulation of gastric vagal afferents in rodents induces 
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dopamine release in both the VTA and the substantia nigra pars compacta (Han et 
al., 2018). These rodents also demonstrated increased conditioned place preference 
and self-stimulation behaviour during vagal stimulation, suggesting that the gut-brain 
axis may modulate general (as opposed to food-specific) reward processing. As 
dopaminergic VTA neurones innervate corticolimbic regions, including the amygdala, 
nucleus accumbens (NAcc) and prefrontal cortex (PFC), orexigenic signalling from 
the LHA is fundamental step that integrates ‘bottom-up’, homeostatic signalling with 




Figure 1.2 Ghrelin signalling modulates hypothalamic and dopaminergic projections. Acyl-
ghrelin modulates hypothalamic activity via growth hormone secretagogue receptors (GSH-
R) on vagal nerve afferents and agouti-related protein (AgRP) neurones in the arcuate nucleus 
(ARC), which co-express GSH-Rs. AgRP neurones project to the lateral hypothalamic area 
(LHA), which, in turn, provides orexigenic input to the ventral tegmental area and mesolimbic 
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dopamine system. Ghrelin may also bind directly to GSH-R-expressing neurones within the 
hypothalamic paraventricular nucleus (PVN) and VTA, where the latter potentiates responses 
in cortical ‘reward’ regions via the mesolimbic pathway. NTS = nucleus of the solitary tract.  
 
Indeed, functional magnetic resonance imaging (fMRI) studies have begun to link 
homeostatic signals to neural responses in ‘reward regions’ of the primate brain. For 
example, a landmark study showed that augmented ventral striatal responses to 
food cues amongst congenitally leptin-deficient individuals normalised with leptin 
replacement therapy (Farooqi et al., 2007). Subsequent work has identified a 
positive correlation between blood glucose levels and functional activity of the 
posterior insula when viewing food stimuli (Simmons et al., 2013). Finally, post-
prandial declines in acyl ghrelin have been correlated with decreased BOLD 
responses to milkshake receipt in corticolimbic regions, the midbrain and the 
pallidum (Sun et al., 2014). However, hippocampal responses to the milkshake 
tastant were moderated by the type of meal consumed (e.g., fixed-portion vs ad 
libitum) despite nonsignificant differences in kilocalorie intake and subjective hunger. 
This could suggest that perceived choice or control over eating moderates brain 
responses to food intake in the absence of hunger.  
 
1.3.5 Altered gut hormones levels in (binge-)eating disorders: State of the evidence 
 
As I established in the preceding section, homeostatic regulation of food intake relies  
on the gut-brain axis, which facilitates signalling from the gastrointestinal tract to the 
brain via the vagus nerve and circulating gut hormones. These small, lipophilic 
peptides are capable of crossing the blood-brain barrier, and as I have explained, 
they have been associated with functional responses of brain regions that coordinate 
food-seeking behaviour. Given their potential as targets of novel pharmacotherapies, 
gut hormones have been extensively studied in obesity (De Silva & Bloom, 2012), 
and a growing body of literature has examined potential alterations in eating 
disorders (Prince et al., 2009).  
 
Investigation of gut-hormone and metabolite variation in eating disorders has yielded 
promising but largely inconsistent results. In 2009, Prince and colleagues (Prince et 
al., 2009) completed the largest systematic review and meta-analysis (N = 28 
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studies) of gut hormone disturbances in both AN subtypes and BN following either a 
test meal or oral glucose load. Patients with AN-R were expected to have elevated 
levels of fasting ghrelin and reduced satiety hormones, and they were predicted to 
have normative hormonal responses to eating; however, this prediction was not 
extended to AN-BP. Fasting ghrelin and PYY were hypothesised to be increased in 
binge-eating disorders compared to controls, yet patients with binge-eating were 
predicted to show blunted post-prandial changes. Meta-analytic findings identified 
significant increases in fasting (i.e., baseline) ghrelin, PYY and CCK in any eating 
disorder, where ghrelin alterations had the largest effect size. Both AN and BN 
patients also demonstrated blunted insulin responses to standardised meals, but 
patients did not show altered postprandial ghrelin, PYY, CCK or pancreatic peptide 
responses. However, findings were limited by significant heterogeneity across study 
designs, low statistical power, a lack of standardised meals across studies and 
variable hormone assays.  
 
The findings of recent studies examining gut hormone and metabolite disturbances 
in eating disorders associated with binge-eating have been summarised in Table 1.1. 
Studies of AN and BN were restricted to those published after 2009, as prior studies 
were examined by Prince and colleagues. Due to the minimal research in this area, 
two earlier studies of BED have been included. These studies broadly recapitulated 
previous findings of increased fasting and post-prandial ghrelin in AN and BN and 
nonsignificant differences in some satiety hormones (e.g., PYY, CCK). Although 
there is some evidence of reduced GLP-1 in BN, variable study designs and assays 
continue to complicate the interpretation of findings in this area.  
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Table 1.1 Gut hormone variations associated with eating disorders and binge-eating 
 
Paper Hormones Participants Paradigm Results 





Obese BED  
(n = 10) 
Obese non-BED (n 
= 9) 
Overnight fast and 
breakfast 
Reduced pre- and postprandial ghrelin in BED > non-BED. 
Blunted postprandial ghrelin decline in BED > non-BED. NS 
group differences in pre- and postprandial PYY and GLP-1. 
Abnormal ghrelin values normalised following 6-week CBT 
and dietary intervention.  







(n = 18; 4 male) 
HC  
(n = 19; 1 male)  
 
Overnight fast and 
breakfast pre- and post-
CBT intervention 
NS preprandial group differences in all hormones. 
Postprandial, NS difference in ghrelin but increased PYY 
and CCK in BED < HC. NS effects of CBT on hormones in 
BED.   
(P. Monteleone et 
al., 2010) 
Ghrelin BN (n = 7) 
HC (n = 6) 
Modified sham feeding 
(i.e., chewing food 
without swallowing it)  
Increased ghrelin after MSF in all participants. Greater 
increase in BN > HC.  





AN-R (n = 22) 
AN-BP (n = 10) 
BN (n = 16) 
HC (n = 9) 
Twelve-point circadian 
profiling  
Ghrelin and obestatin increased in AN-R > HC but 
decreased in AN-BP/BN > HC. Obestatin to acylated-ghrelin 
ratio increased in AN-BP/BN > AN-R/HC. 
 
PYY decreased in AN-R/AN-BP/BN > HC. PYY to acylated-
ghrelin ratio increased in AN-BP/BN > AN-R/HC. 





BN (n = 21) 
HC (n = 17) 
Overnight fast and 
breakfast  
Reduced fasting and postprandial GLP-1 and PP in BN > 
HC.    







AN (n = 14) 
BN (n = 14) 
HC (n = 15) 
High-carbohydrate and 
high-protein breakfast  
Fasting:  
Ghrelin, obestatin and NPY elevated in AN > BN/HC. Leptin 
increased in HC > AN/BN. NS ghrelin differences between 
BN and HC. NS PYY group differences. 
Postprandial:  
Ghrelin and obestatin decreased across all groups, but 
remained elevated in AN/BN > HC. Postprandial ghrelin 
decline (90 min post-meal) differed by meal type across all 
groups.  NS NPY differences in AN but significant decline in 
BN/HC following high-carb. NS differences across all groups 
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with high-protein breakfast. Greater PYY increase in AN/BN 
> HC moderated by breakfast type; greater increases in 
AN/BN with high-protein.    




Recovered BN (n = 
20) 





NS group differences in ghrelin or PYY following 
catecholamine depletion. NS group by time (pre- or post-
meal) interaction on ghrelin or PYY.  
 
(Dossat et al., 2015) GLP-1 BN (n = 19) 
PD (n = 14) 
HC (n = 14) 
Standardised test meal Postprandial increase in GLP-1 in all subjects but reduced in 
BN > PD/HC.  




AN-R (n = 50) 
AN-BP (n = 22) 
HC (n = 20)  
Profiling upon waking 
(non-fasted) 
Reduced PYY and leptin but increased BDNF in AN-BP > 
AN-R. After controlling for BMI, PYY and leptin differences 
remain significant. NS differences between full AN group 
and HC group when controlling for BMI.  
(Fernández-Aranda 




AN-R (n = 64) 
OB (n = 59) 
HC young (n = 80) 
HC old (n = 36) 
Overnight fast NS group differences in CCK and PYY. Ghrelin was reduced 
in OB > AN and OB > HC.  
(Keel et al., 2018) Ghrelin 
PYY 
BN (n = 26) 
PD (n = 25) 
HC (n = 26) 
 
Overnight fast and 
breakfast (repeated 2x) 
Increased post-prandial PYY in PD > BN and HC. Increased 
ghrelin in PD and BN > HC.  
(Tam et al., 2020) PYY AN-R (n = 47) 
AN-R recovered (n 
= 35) 
HC (n = 58) 
Overnight fasting 
(repeated 2x) 
NS group differences in PYY. NS differences in fasting PYY 
throughout weight restoration.  





AN (n = 36) 
HC (n = 32) 
Overnight fast and 
breakfast 
Increased ghrelin in AN > HC across all time points (0, +30, 
+60, +120 min) but NS differences in post-prandial ghrelin 
change. Increased PYY in AN > HC at 0 and 30 min. 
Reduced BDNF in AN > HC but increased post-prandial 
BDNF change.  
 
Notes: GLP-1 = glucagon-like peptide 1 (anorectic); PYY = peptide tyrosine tyrosine (anorectic); CCK = cholecystokinin (anorectic); PP = 
pancreatic peptide (anorectic); NPY = neuropeptide Y (anorectic); BDNF = bone-derived neurotrophic factor; ghrelin = orexigenic hormone; 
obestatin = anorectic but function is debated; PD = purging disorder; HC = healthy control; NS = nonsignificant   
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1.4 Higher-order cognitive control of (binge-)eating behaviour  
 
Despite complex interplay between ‘bottom-up’ homeostatic signals and functional 
activity of ‘higher-order’ brain regions, neurocognitive models of binge-eating have 
largely discounted the role of energy homeostasis (although there are some 
exceptions (Keel et al., 2019; Monteleone et al., 2018)). Neurocognitive models 
instead propose that the syndrome emerges from dysfunction in neural systems 
involved in reward processing, learning and cognitive control. An overarching theory 
of binge-eating suggests that it reflects an imbalance of hedonic and self-regulatory 
processes. Critically, dysfunction across each cognitive domain is posited to offer 
only a partial explanation for the overall syndrome, thereby upholding the principles 
of integrative pluralism. In this section, I review the evidence of altered food reward 
processing and self-regulation in binge-eating disorders, as well as the theory that 
the syndrome reflects a shift from impulsive to compulsive eating.   
 
1.4.1 Food reward processing 
 
The perceived reward of a given food item can be conceptualised as its ‘subjective 
value,’ which is derived from a combination of multisensory (e.g., taste, viscosity, 
olfaction), nutritive (calorific versus non-calorific) and cognitive (perceived 
palatability, healthfulness) factors. The construct of subjective value emerged from 
decision-making theory, which suggests that, when choosing between two rewards, 
an organism must integrate various dimensions of each option into a single ‘common 
currency’ of subjective value in order to optimise choice behaviour (Kable & 
Glimcher, 2007). In the brain, dopaminergic neurones in the VTA play a key role in 
the subjective value computation (Schultz et al., 1997), as dopamine encodes 
violations of expectations (i.e., prediction errors), which guide learning about reward 
outcomes. Dopaminergic VTA neurones innervate corticolimbic regions via the 
mesocortical pathway, forming a putative reward network. Specifically, the 
ventromedial prefrontal cortex (vmPFC), orbitofrontal cortex (OFC), striatum, anterior 
(ACC) and posterior cingulate cortex (PCC), anterior insula, posterior parietal cortex 
and the lateral intraparietal cortex comprise this network, where each region 
encodes distinct aspects of valuation (Bartra et al., 2013; Kable & Glimcher, 2007). 
Whilst these regions have been implicated in the valuation of various reward types 
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(e.g., food, water, social, monetary), functional activity of the hypothalamus has been 
uniquely associated with food reward (Levy & Glimcher, 2011). Moreover, the 
amygdala also appears to encode the incentive value of palatable food cues 
(Gottfried et al., 2003), and the anticipation of both food odour (Small et al., 2008) 
and sweet taste (O’Doherty et al., 2002) relates to increased amygdalar BOLD 
response.  
 
Critically, the reward network facilitates associative learning, whereby an individual 
develops heightened sensitivity to visual food cues, which have previously been 
predictive of highly-valued foods. Visual food cues elicit robust functional responses 
from the bilateral OFC, insula, striatum and left amygdala (Tang et al., 2012), and 
although satiety state moderates food cue reactivity (LaBar et al., 2001; Stockburger 
et al., 2009), food cues can override homeostatic signalling to promote excess intake 
(Petrovich et al., 2002). As such, several functional neuroimaging studies have 
interrogated altered food cue reactivity as a potential endophenotype, which would 
implicate altered reward processing in binge-eating disorders; however, findings are 
inconsistent.  
 
Viewing appetitive food images has been related to increased reward sensitivity and 
medial OFC activity in BED, whereas stimuli elicited greater arousal, ACC activity 
and insula responses in BN (Schienle et al., 2009). A subsequent study reported 
increased ACC activity in subthreshold BED as compared to BMI-matched controls 
when viewing high-energy density relative to low-energy density foods (Geliebter et 
al., 2016). Similarly, food cues evoked increased left medial OFC and ACC activation 
in a mixed sample of women with AN (n=9 AN-R, n=7 AN-BP) and BN compared to 
controls at 1.5 Tesla (Uher et al., 2004). At 3 Tesla, women with BN had reduced 
bilateral insula and left visual cortex responses to food cues relative to controls, as 
well as altered posterior cingulate, temporoparietal and supplementary motor area 
responses compared to women with AN (n=11 AN-R, n=8 AN-BP) (Brooks et al., 
2011). However, others have found nonsignificant differences in neural responses to 
food cues when comparing women with BN to unaffected controls (Van den Eynde et 
al., 2013). Assessment of brain responses to a food incentive delay paradigm also 
found equivalent functional responses during the anticipation of food reward across 
patients with BN, BED and controls (Simon et al., 2016). Discrepancies across these 
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studies may reflect a variety of methodological factors, including small sample sizes, 
low statistical power and use of liberal fMRI statistical thresholds that fail to 
adequately control for Type 1 error rates (Eklund et al., 2016; Woo et al., 2014). As 
such, although some studies offer preliminary evidence of altered ACC and OFC 
responses to visual food stimuli in binge-eating disorders, these findings should be 
interpreted cautiously. 
 
When examining potential dysfunction of reward processing in disordered eating, 
one must consider the anticipation and receipt of reward to be distinct, but related, 
drivers of eating behaviour. Gustatory stimuli, such as sweetened liquids and 
milkshakes, are typically used to examine neural responses to consummatory food 
reward in the MRI environment. However, some common reward paradigms, such as 
the monetary incentive delay task, have also been adapted to assess neural 
responses to food reward receipt (e.g., Simon et al., 2016). Palatable taste stimuli 
have been shown to increase functional activation of primary sensory (e.g., 
thalamus, olfactory bulb) and interoceptive (e.g., anterior insula) regions in addition 
to nodes within the reward network (e.g., ACC, OFC and striatum). Functional 
responses within this circuit are elicited by depolarisation of taste receptors on the 
tongue, which propagates sensory input to the ventroposteromedial thalamic 
nucleus. Afferent thalamic neurones then innervate the primary gustatory cortex 
within the anterior insula (Rolls, 2005). In primates, projections from the anterior 
insula target the striatum, amygdala and OFC, where the latter encodes reward 
value while also integrating inputs from the five sensory modalities (Fudge et al., 
2005; Kringelbach & Radcliffe, 2005). The OFC also sends large projections to the 
amygdala, which, in turn, gates striatal responses via cortico-amygdala-striatal 
circuits (Cho et al., 2013). However, striatal circuits also receive ‘bottom-up’ input 
from taste receptors and the gut to encode the hedonic and nutritive value of food, 
respectively (Tellez et al., 2016). Finally, the ACC has been shown to be responsive 
to somatosensory stimulation of the mouth, and functional responses to taste stimuli 
suggest a role in flavour processing (Small & Prescott, 2005).  
 
Although several lines of evidence suggest altered gustatory processing in acute and 
recovered AN-R (Cowdrey et al., 2011; Holsen et al., 2012; Kaye et al., 2020), 
findings amongst binge-eating disorders are less consistent. Compared to healthy 
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women, those with both subthreshold and recovered BN have shown nonsignificant 
differences in brain responses to sweet chocolate taste relative to a tasteless 
solution (Bohon & Stice, 2011). Monteleone et al. (2017) similarly found 
nonsignificant differences in neural responses to sweet and bitter taste across acute 
AN (n = 16 AN-R, n = 5 AN-BP), BN and control groups. To my knowledge, neural 
responses to taste have yet to be examined in BED via fMRI, yet increased binge-
eating severity scores have been related to hyperactivation across the reward 
network (Filbey et al., 2012). Moreover, patients with BN or BED had augmented 
medial OFC responses during reward receipt in a food incentive delay paradigm. 
Whole-brain analysis further identified increased posterior cingulate cortex, 
anteromedial PFC and angular gyrus activation amongst patients relative to controls 
(Simon et al., 2016).  
 
Assessment of individuals who have recovered from an eating disorder might 
suggest that neural responses to food reward change in the course of the illness. For 
example, women in recovery from AN-R and BN demonstrate divergent neural 
responses to sucrose (caloric) and sucralose (non-caloric) tastants when compared 
to healthy controls (Oberndorfer et al., 2013). Those in recovery from BN showed 
augmented right anterior insula response to sucrose, but not sucralose, relative to 
controls, and the opposite activation pattern was observed in recovered AN-R. A 
follow-up study of this sample suggested altered sensitization to sucralose in 
recovered BN and AN-R, as evidenced by increased left middle frontal gyrus and 
thalamus responses, respectively, relative to controls (Wagner et al., 2015). 
However, the precise relevance of these cross-sectional observations to the 
pathogenesis of eating disorders remains unclear, as alterations may reflect a ‘scar’ 
of the illness, an underlying vulnerability or a positive prognostic indicator.  
 
Taken together, evidence of altered neural processing of food reward amongst 
individuals who suffer with BN and BED is equivocal, and such processing has not 
been explicitly examined in AN-BP. The existing literature has identified potentially 
important distinctions between neural responses to anticipatory versus 
consummatory reward, where passive viewing of food stimuli has been more 
robustly associated with altered brain activation in binge-eating than perception of 
sweet taste.  
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1.4.2 Self-regulatory control  
 
Deficient self-regulatory control has gained empirical support as both a behavioural 
and neural correlate of binge-eating disorders. At-risk individuals are characterised 
by elevated trait impulsivity, a multidimensional construct that refers to the tendency 
to take rash action, which is poorly conceived or inappropriate for the present 
situation and often results in negative consequences (Dalley et al., 2011). Indeed, 
increased impulsiveness, measured by self-report, has been reported amongst 
women with BN (Engel et al., 2005; Fischer et al., 2008), obese individuals with BED 
(Schag et al., 2013) and, to a lesser extent, AN-BP (Hoffman et al., 2012). However, 
objective assessment of impulsivity, or ‘self-control’, has proven challenging, in part, 
due to the heterogenous nature of this theoretical construct (Caswell et al., 2015; 
Whiteside & Lynam, 2001).  
 
Impulsivity encompasses a broad range of behaviours that can be classified into 
three taxa: choice impulsivity, or alterations in value- or reward-based responding; 
reflection impulsivity, which refers to premature decision-making; and motor 
impulsivity, which reflects alterations in motor responding or action cancellation 
(Caswell et al., 2015; Dalley & Robbins, 2017). Alterations in choice impulsivity may 
reflect either reduced temporal discounting of rewards, where smaller, immediate 
rewards are preferred to smaller, distal ones, or ‘risky impulsivity’. The latter 
describes a preference for high-risk, high-reward options over safer options that 
have low value. Despite being interrelated, measures of impulsivity across these 
domains are often uncorrelated, or weakly correlated, with one another (Duckworth & 
Kern, 2011; MacKillop et al., 2016). Moreover, emerging evidence suggests that the 
neural circuits subserving these domains may be relatively distinct from each other 
(see (Dalley & Robbins, 2017) and Figure 1.3). These dissociable behavioural and 
neural correlates have been differentially related to psychiatric illness (MacKillop et 
al., 2016; Stevens et al., 2014; A. C. Swann et al., 2008), further underscoring the 





Figure 1.3 Fronto-striatal circuits associated with distinct facets of impulsivity in humans. 
Schematic of frontal and striatal circuits that subserve risky choice, reflection impulsivity and 
motor (stopping) impulsivity from Dalley & Robbins (2017). Regions showing functional 
connectivity during resting state fMRI share the same colour. Reprinted by permission from 
Springer Nature: Nature Publishing Group, Nature Reviews Neuroscience, Dalley, J., 
Robbins, T. Fractioning impulsivity: neuropsychiatric implications. Copyright 2017. 
 
The neural correlates of choice and reflection impulsivity broadly align with the dual 
systems model of decision-making, which proposes that two, distinct neural circuits 
subserve preference for short-term versus future rewards (Ballard & Knutson, 2009; 
McClure et al., 2004). In this model, a ‘beta system,’ comprised of the ventromedial 
PFC and ventral striatum, encodes the values of a given reward independently of a 
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temporal component, and the ‘delta system’, which includes dorso- and ventro-lateral 
frontal and parietal cortices, computes reward value across the delay period. 
Functional neuroimaging has identified a negative relationship between activation of 
dorsolateral cortical regions and the time to reward delivery, where more impulsive 
individuals showed reduced activity across this circuit (Ballard & Knutson, 2009). 
Moreover, ventral striatal responses to the magnitude of future rewards are reduced 
in these highly-impulsive participants. The inferior frontal cortex, among other 
functions, integrates information pertaining to both reward value and delay, 
representing a putative link between the beta and delta systems (Ballard & Knutson, 
2009). In line with this, both choice and reflection impulsivity are associated with a 
fronto-striatal circuit comprised of the dorsolateral and inferior prefrontal cortex, the 
ventral striatum and the caudate, whereas only choice impulsivity further relates to a 
medial PFC-ventral striatal circuit (Figure 1.3).   
 
Several lines of evidence have related binge-eating to increased temporal 
impulsivity, which has been exclusively measured as delay discounting of monetary 
reward. Women with BN show a stronger preference for small, immediate monetary 
rewards than controls (Kekic et al., 2016) and AN (Bartholdy, Rennalls, Danby, et al., 
2017) groups; however, patients with BED have not shown altered discounting. 
Steward et al. (2017) quantified delay discounting in AN-R, AN-BP, BED and control 
groups via the hyperbolic free parameter, k, which indexes the rate at which rewards 
are devalued as a function of time. Both AN-BP and BED groups demonstrated 
steeper discounting than controls and AN-R; however, the binge-eating groups did 
not differ significantly from each other. Moreover, several behavioural studies have 
related binge-eating in the context of obesity to increased delay discounting (see 
McClelland et al., 2016), which could suggest additive effects of overweight and 
binge-eating on this facet of impulsivity. Despite this compelling behavioural 
evidence, the neural correlates of temporal discounting in AN-BP, BN or BED have 
yet to be examined.  
 
Evidence from non-human primate research, lesion studies and functional 
neuroimaging has related inhibitory control to engagement of fronto-basal-ganglia 
and fronto-parietal networks (for review, see Aron et al., 2014). Although several 
definitions of inhibitory control have been proposed in cognitive neuroscience, here a 
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relatively narrow definition is used, where inhibitory control reflects one’s capacity to 
slow or stop a response tendency (see Aron et al., 2014). Briefly, motor movements 
are initiated and modulated by functional loops, which form reciprocal connections 
between cortical regions (e.g., inferior frontal cortex, primary and supplementary 
motor cortex), the basal ganglia and the cerebellum (DeLong et al., 2007; Middleton 
& Strick, 2000). Within the basal ganglia, medium spiny neurons of the striatum, 
expressing gamma-Aminobutyric acid (GABA), dopamine D1 (DRD1) or dopamine D2 
(DRD2) receptors, receive cortical input, and the globus pallidus interna (GPi) 
represents the primary output structure, providing feedback to the cortex and 
striatum through the thalamus. DRD1 neurons are thought to modulate activation of 
the ‘direct’ pathway, which facilitates movement, whereas DRD2 neurons activate 
the ‘indirect’ pathway that inhibits motor movement. The direct pathway enables 
movement via inhibition of the GPi and disinhibition of the thalamus, which relays 
excitatory glutamatergic signals to the cortex and striatum. The indirect pathway, 
however, inhibits movement through activity of the globus pallidus externa (GPe), 
which in turn inhibits the glutamatergic output of the subthalamic nucleus to the GPi 
and back to the GPe. Activity of the indirect pathway inhibits thalamic output to 
cortical and striatal targets.  
 
In addition to the direct and indirect pathways, several cortical regions work with the 
basal ganglia to facilitate response inhibition. Activation of primary and 
supplementary motor areas (M1 and SMA), ACC, inferior frontal and posterior 
parietal cortices work with the basal ganglia to slow or stop motor responses to 
Go/No-Go and Stop Signal tasks (Rubia et al., 2001). The right inferior frontal cortex, 
specifically the pars opercularis, is considered a key node within inhibitory control 
networks, and activity not only enables outright stopping, but also pausing or 
‘braking’ that may be generated by internal goals, unexpected cues or subliminal 
stimuli related to a need to stop action (Aron et al., 2014). 
 
As I review the neuroimaging literature on motor impulsivity, specifically inhibitory 
control, in binge-eating disorders in Chapter 4, a cursory overview is provided here. 
Patients with BN have increased stop-signal reaction time compared to matched 
healthy controls; however, nonsignificant differences have been observed between 
BED and healthy control groups (Wu, Giel, et al., 2013). Others have reported slower 
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stop-signal reaction time in both AN subtypes, but not BN, compared to controls 
(Galimberti et al., 2012). Meta-analytic findings show that patients with binge-eating 
(N = 563) demonstrate small-to-moderate decrements in inhibitory control (Hedge’s g 
= - .32), which are pronounced with the presentation of disease-salient stimuli (i.e., 
body shape, food) (Wu, Hartmann, et al., 2013). A sub-group analysis of AN-BP 
patients indicated more significant inhibitory control impairment (Hedge’s g = - .91); 
however, underrepresentation of this group (n = 42) likely resulted in an inflated 
effect size. The relationship between inhibitory control and binge-eating may be 
complicated by obesity, where a recent meta-analysis demonstrated that, while 
performance across several inhibitory control tasks (e.g., delay discounting, 
Go/NoGo and Stroop tasks) is impaired in obesity, a diagnosis of BED in obesity did 
not affect inhibitory control (Lavagnino et al., 2016). In contrast, obese adults with 
and without BED showed comparable performance on a waiting impulsivity task 
relative to their lean counterparts (Voon et al., 2014). This could suggest that binge-
eating relates to impairments in response inhibition, which are distinct from waiting 
impulsivity (i.e., the tendency to response prematurely to target stimuli), yet further 
research is needed. 
 
In summary, the partitioning of impulsivity and assessment of its constituent domains 
has identified promising associations with binge-eating disorders, where patient 
groups show alterations in both temporal and motor impulsivity. Some evidence 
suggests that the presentation of disorder-salient stimuli may exacerbate impulsive 
action in affected individuals; however, these cross-sectional findings cannot 
determine whether such impulsive action would lead to altered eating behaviour. 
Functional neuroimaging studies have largely focused on potentially aberrant motor 
impulsivity in binge-eating, which will be reviewed in Chapters 2 and 4, and fMRI 
studies of temporal and choice impulsivity in binge-eating are lacking. Despite the 
sparsity of evidence, a prominent transdiagnostic model has emerged that draws 
comparisons between binge-eating disorders and substance misuse. As I argue in 
the next section, such conclusions are unsupported and potentially specious. 
 
1.4.3 Does binge-eating reflect a transition from impulsive to compulsive eating?  
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Observations of potentially altered reward processing and poor self-regulation in 
binge-eating have given rise to the theory that recurrent, loss-of-control eating 
reflects a shift from impulsive to compulsive behaviour. Whilst impulsivity refers to 
rash or ill-conceived actions in a given circumstance, ‘compulsivity’ reflects the 
erosion of goal-directed action, which is instead superseded by stimulus-driven 
(‘habitual’) responding. Critically, this stimulus-driven responding persists in the face 
of negative consequences, and the behaviour is unrelated to any overarching goal of 
the organism (Robbins et al., 2012). Evidence implicating compulsivity in binge-
eating has primarily emerged from preclinical neuroscience research, particularly 
studies which draw strong parallels between binge-like eating of palatable foods and 
drug addiction. These studies propose that consumption of certain foods alters 
dopaminergic signalling in the midbrain in a manner similar to drugs of abuse, 
thereby leading to compulsive eating (Avena et al., 2008; Johnson & Kenny, 2010). 
Briefly, voluntary consumption of palatable foods leads to dopamine efflux in the 
nucleus accumbens (NAcc) shell, which may, under certain conditions, become 
blunted following food consumption and instead responsive to environmental cues 
(e.g., candy wrappers, food adverts). This model further posits that ventral striatal 
activity drives food craving, but over time, food seeking becomes increasingly 
governed by dorsal striatal (putamen, dorsolateral striatum) control and consolidated 
as a stimulus-response habit. The transition from goal-directed to habitual food-
seeking has been putatively associated with four ‘fronto-striatal loops’ (see Figure 
1.4), where impulsivity relates to both ventral and dorsal striatal ‘loops’ and 
compulsivity solely to dorsal striatal projections, primarily to the lateral prefrontal 




Figure 1.4 Schematic of four fronto-striatal loops putatively associated with impulsivity and 
compulsivity. Adapted from Robbins et al. (2012), panels A & B represent open ‘loops’ that 
have been associated with two cognitive processes that underly impulsivity, delay discounting 
and stop-signal inhibition. Panels C & D depict functional loops, which have been implicated 
in habit-based responding. Created with Biorender.com. ACC = anterior cingulate cortex; 
dlPFC = dorsolateral prefrontal cortex; lOFC = lateral orbitofrontal cortex; NAcc = nucleus 
accumbens; pre-SMA = pre-supplementary motor area; vmPFC = ventromedial prefrontal 
cortex; vlPFC = ventrolateral prefrontal cortex; VS = ventral striatum. 
 
While this model outlines a robust neurobiological framework, several limitations 
impede the model from fully capturing the mechanisms of binge-eating as a 
transdiagnostic phenomenon. A primary concern arises from direct comparisons to 
the development of drug addiction, where the progression from recreational to 
compulsive drug use results from the pharmacokinetic and pharmacodynamics 
effects of the drug and accompanying structural and functional changes in vulnerable 
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individuals. The ‘addictive’ potential of foods has been the focus of serious scientific 
debate, and little evidence has been presented to support the existence of ‘food 
addition’ in humans (García-García et al., 2020; Westwater et al., 2016; Ziauddeen 
et al., 2012; Ziauddeen & Fletcher, 2013). Moreover, superficial comparisons of 
binge-eating and drug addiction fail to account for the post-ingestive effects of food 
and how these relate to, among other neurotransmitter systems, dopaminergic 
signalling in the brain. For example, distinct neural circuits appear to encode the 
hedonic and caloric value of food, where sweet taste leads to dopamine efflux in the 
ventral striatum and caloric value elicits dopamine release in the dorsal striatum 
(Tellez et al., 2016). Evidence of dorsal striatal activity in response to nutritive 
signalling would suggest that the neural circuitry of addiction is only partially 
recapitulated in binge-eating.  
 
In addition, the hypothesised role of reward sensitivity in the development and 
maintenance of loss-of-control eating has been guided largely by studies of obesity 
and BED, as opposed to AN-BP or BN. As I have reviewed, findings of altered neural 
responses to food cues in binge-eating disorders are equivocal, and functional 
responses to sweet tastants do not differ significantly between women with and 
without (subthreshold) BN (Bohon & Stice, 2011; Monteleone et al., 2017). The 
relevance of reward processing to binge-eating in AN-BP remains an open empirical 
question. In contrast, hyperreactivity of the reward network to palatable food cues 
and taste has been associated with both overweight status and future weight gain 
(for review, see Stice & Burger, 2019). Comparatively fewer studies have probed 
reward sensitivity in BED, yet binge-eating severity has been correlated with 
augmented BOLD responses to palatable tastes across the reward network (Filbey 
et al., 2012). However, food exposure has only been related to altered D2 dopamine 
receptor availability in BED when presented in combination with methylphenidate, a 
dopamine agonist (Wang et al., 2011). These findings point to a potentially 
significant role of reward sensitivity in obesity and BED, and this may relate to the 
tendency for affected individuals to suffer with overeating in the absence of hunger 
(i.e., after a meal).  
 
Despite the paucity of transdiagnostic research in this area, the proposed role of 
reward sensitivity in binge-eating has gained significant traction, and it underpins the 
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hypothesised transition from impulsive to compulsive eating. The development of 
compulsive eating involves a degradation in goal-directed action that is usurped by 
stimulus-driven responding, and the behaviour persists despite negative 
consequences and the absence of a relationship with an overall goal (Robbins et al., 
2012). However, there are several problems with this model. First, it is difficult to 
conceptualise what exactly the original ‘goal’ of the binge-eating episode might be. A 
binge episode may, for example, serve the goal of restoring a positive energy state, 
relieving negative affective states or a combination of both homeostatic and cognitive 
goals. The lack of precise characterisation of the original goal complicates attempts 
to describe the degradation of a behaviour that at one time fulfilled it. Second, the 
proposed development of stimulus-driven binge-eating discounts the role of 
interoceptive signalling in feeding. A large body of literature indicates that satiety 
modulates food cue-reactivity (Goldstone et al., 2009; van der Laan et al., 2011), and 
this, by extension, would modulate food-seeking behaviour in response to food cues. 
Third, although binge-eating may persist despite negative consequences (e.g., 
feelings of shame, weight gain, health comorbidities), the initial ‘goal’ and the 
subsequent dissociation from it are less clear. Binge-eating in the absence of a 
negative energy balance could be argued to represent a separation between action 
and goal (e.g., weight stability), yet this fails generalise to binge-eating as it often 
occurs in AN-BP or BN: in a state of extreme malnutrition or following significant 
caloric restriction. For these individuals, the binge episode aligns with the goal of 
restoring a positive energy balance despite conflict with maladaptive goals of weight 
loss, altered body shape or adherence to dietary rules. As such, the accordance of 
action and goal at the initiation of the episode following fasting, or in the context of 
sustained malnourishment, suggests that binge-eating would be better 
conceptualised as ‘impulsive eating.’  
 
1.5 Stress and binge-eating  
 
As I stress in Section 1.3, homeostatic regulation of energy intake relies on dynamic 
communication between the gut and the brain, which enables an organism to flexibly 
engage in a series of behaviours to meet its metabolic demands. However, an 
organism cannot solely rely on internally generated cues to guide eating behaviour; it 
must also navigate and adapt to an ever-changing environment. Environmental 
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factors have profound effects on eating behaviour, as evidenced by the contribution 
of the ‘obesogenic environment’ to the modern obesity epidemic (Swinburn et al., 
2011). Specifically, environmental stressors have been associated with both 
increases and decreases in food intake and weight (Stone & Brownell, 1994). 
Research has begun to characterise common biological responses to both 
psychological and physiological stress and how these pathways influence hunger 
and satiety signalling. However, the relationship between stress and food intake is 
complicated in individuals with eating disorders by the nature of the illness, its effects 
on interoceptive signalling and its chronicity. 
 
Stress can be defined broadly as an organism’s response to environmental demands 
that exceed its physiological regulatory capacity (Koolhaas et al., 2011). Preclinical 
neuroscience research further characterises environmental ‘stressors’ as noxious 
stimuli that are uncontrollable and unpredictable, where uncontrollability renders any 
action taken by the organism futile because it cannot alter the conditions through 
action. Conditions characterised by threat uncertainty prevent an organism from 
mounting an anticipatory response, leading to the loss of control of biological 
regulatory responses. Importantly, stressors may reflect either physiological 
challenges (e.g., hunger, thirst, cold exposure, pain), subjective psychological 
experiences (isolation, social or performance evaluation) or a combination of these 
two factors.  
 
An organism’s response to these stressors depends upon rapid activation of the 
hypothalamic-pituitary-adrenal (HPA) axis and subsequent recovery. Within this axis, 
corticotropin-releasing factor (CRF) release from parvocellular neurones of the PVN 
serves as the primary regulator of the stress response (Turnbull & Rivier, 1997). The 
binding of CRF to CRF1 receptors in the pituitary induces release of 
adrenocorticotropic hormone (ACTH) into circulation, which, in turn, stimulates 
glucocorticoid synthesis and secretion from the adrenal cortex. High levels of 
circulating glucocorticoids, such as cortisol, and catecholamines contribute to the 
organism’s ‘fight or flight’ response to the stressor, which is characterised by 
increased arousal, vigilance and attention. HPA axis activity is regulated via negative 
feedback mechanisms, which involve binding of glucocorticoids to mineralocorticoid 
and glucocorticoid receptor-expressing neurones within limbic structures. 
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Additionally, the CRF2 receptor-mediated actions of the neuropeptides urocortin II 
and III elicit anxiolytic effects that aid the stress recovery process (Henckens et al., 
2017; Lewis et al., 2001; Reyes et al., 2001). In humans, healthy cortisol reactivity 
peaks approximately 15 to 30 minutes from stressor onset, returning to baseline 
levels between 60 and 90 minutes following termination of the stressor; however, 
recovery time is positively correlated with the magnitude of the peak response 
(Dickerson & Kemeny, 2004).  
 
Excessive or prolonged stress responses may disrupt allostasis, or the organism’s 
homeostatic regulatory capacity, and such dysregulation has been related to 
deleterious health outcomes. Acute stress can alter neuroplasticity of the amygdala, 
hippocampus and medial prefrontal cortex (McEwen, 2008; McEwen & Morrison, 
2013). Although the precise anatomical boundaries of ‘medial prefrontal cortex’ in 
rodents vary substantially across studies (Laubach et al., 2018), this region is loosely 
homologous to the ventromedial PFC in (non-human) primates, which serves at the 
primary cortical target of limbic projections (Averbeck & Seo, 2008). Although acute, 
stress-induced increases in glucocorticoids potentiate adaptive emotional memory 
formation (Roozendaal et al., 2009), sustained elevation of glucocorticoid levels 
elicits maladaptive dendritic remodelling in the medial PFC and hippocampus, which 
has been related to memory impairment in murine animals (McEwen, 2008). Stress-
induced alterations in amygdala morphology have also been reported; however, both 
the type and duration of stress exposure relate to distinct functional and 
morphological changes in rodent amygdala nuclei (e.g., basolateral amygdala, 
central nucleus of the amygdala; Wilson et al., 2015). In addition to altering neural 
structure, heightened glucocorticoid levels can ‘sensitise’ HPA axis activation to 
subsequent stressors in rodents (Imaki et al., 1991). This purported sensitisation 
underlies prominent aetiological models of several psychiatric disorders, most 
notably depression, posttraumatic stress disorder and chronic substance misuse (de 
Kloet et al., 2005; Kendler et al., 2000; Koob, 2008).  
 
Regarding disordered eating, stress serves not only as a risk factor for eating 
disorder onset (Degortes et al., 2014; Jacobi et al., 2004; Raffi et al., 2000) but also 
as a key precipitating factor for loss-of-control eating specifically (Goldschmidt et al., 
2014; Greeno & Wing, 1994; Zellner et al., 2006). A prominent model of binge-eating 
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in BN suggests that acute, ego-threatening stimuli, such as self-referential negative 
evaluation, promotes disinhibition of food intake (Heatherton & Baumeister, 1991). 
Within this framework, the individual is posited to regulate negative affective states 
by shifting her attention away from the stressor and toward an immediate stimulus 
(e.g., food). At the same time, the model argues that acute stress reduces her 
capacity for self-regulatory control, and it is this combination of attending to external 
food stimuli and poor self-control that increases the likelihood of overeating 
(Baumeister & Heatherton, 1996). This model has given rise to a large body of 
empirical studies, linking laboratory-induced and naturalistic stress to increased 
intake in both normative and clinical samples (Epel et al., 2001; Freeman & Gil, 
2004; Smyth et al., 2007; Wallis & Hetherington, 2004). However, the mechanisms 
that subserve this association remain poorly characterised and fragmented (e.g., 
Naish et al., 2019), where observations made across different levels of analysis have 
yet to be incorporated into a unifying framework.   
 
Dietary restraint has arguably garnered the most support as a potential mediator of 
the association between stress and increased food consumption. Early indications of 
the role of caloric restriction in binge-eating emerged from rodent studies, where tail 
pinch stress augmented consumption of caloric liquid in food-deprived animals 
(Marques et al., 1979). Moreover, the combination of sustained caloric restriction and 
foot shock stress has led to a 40% increase in palatable food intake in young female 
rats (Hagan et al., 2002). Further study suggests that whilst the combination of 
dietary restriction and stress is necessary for the initiation of binge-like eating in 
female rodents, this eating pattern can persist in the absence of weight loss (Artiga 
et al., 2007). In humans, prospective studies have associated chronic psychological 
stress with increased consumption of energy-dense foods, where dietary restraint 
further augmented stress-induced consumption in otherwise healthy adults (Wardle 
et al., 2000). Laboratory-based, cross-sectional studies have replicated this 
association in normative populations (Epel et al., 2001; Wallis & Hetherington, 2004), 
but not in BN, where patients often engage in cyclical binge-eating and caloric 
restriction (Levine & Marcus, 1997). Moreover, it remains unknown if significantly low 




The aforementioned studies further suggest that the presence of palatable foods 
might increase binge-eating liability in restrained individuals under stress. As 
mentioned above, foot shock stress increases palatable food intake in restricted 
female rodents (Hagan et al., 2002); however, cyclical deprivation and stress only 
augments ad libitum chow intake if the animal has first tasted palatable food (Hagan 
et al., 2003). These findings complement a larger literature (see Section 1.4.3), 
which has established that palatable foods may elicit overeating in the absence of 
homeostatic need. Whilst there is insufficient evidence to conclude that reward 
sensitivity initiates habit-based responding to food in binge-eating disorders, stress 
can bias an organism toward habit-based behaviours (reviewed by Schwabe & Wolf, 
2011). In healthy adults, a combination of induced psychological and pain stress has 
been shown to reduce sensitivity to outcome devaluation in a food reward learning 
paradigm, evoking habit-like responding instead (Schwabe & Wolf, 2009). Acute 
stress also alters choice behaviour amongst individuals attempting to diet, where 
stressed individuals are more likely to choose foods based on palatability than those 
in line with their weight loss goals (Maier et al., 2015). Although habit-based 
responding has yet to be studied in binge-eating disorders under stress, these 
findings lend support to the notion that stress reduces an individual’s capacity for 
self-regulatory control, thereby increasing the likelihood of loss-of-control eating.  
 
Taken together, the current literature provides descriptive evidence of an association 
between acute, psychological stress and overeating; however, knowledge of the 
specific neurobiological and cognitive mechanisms underlying the relationship 
remains elusive. Moreover, few studies have examined these processes amongst 
individuals with diagnosed binge-eating disorders, and complexities related to the 
pathogenesis of these illnesses impede direct translation from preclinical research, 
or even studies of otherwise healthy individuals. Suffering with mental illness is, in 
and of itself, a stressor, and elevated ‘baseline’ stress relates to an altered hormonal 
milieu of those with (binge-)eating disorders as I will review in Chapter 3. The 
significant weight loss inherent to AN-BP presents an additional physiological 
stressor; however, the effects of low body weight on basal stress, hormones and 
binge-eating remains extremely understudied. As I have described in Section 1.3, 
hormones act as neuromodulators in the brain, serving as the primary regulators of 
food intake and the stress response. The gut-brain axis and the stress response may 
 36 
therefore be dysregulated at baseline in binge-eating disorders, and rigorous 
assessment will be necessary and central to any examination of the effect of acute 
stress on behaviour.  
 
1.6 Thesis outline  
 
An outstanding question in the field of psychiatry is the degree to which diagnostic 
demarcation at the level of behaviour maps to distinct biological mechanisms, and 
resolving this ambiguity will be central to improving treatment of mental illness. 
Binge-eating represents a core diagnostic feature of multiple eating disorders; 
however, knowledge of the physiological correlates of this syndrome and whether 
they differ across diagnoses is limited. As I discuss in this Chapter, any attempt to 
advance understanding of the aetiology of binge-eating disorders must consider a 
complex set of interacting factors, which include metabolic regulators of energy 
intake, higher-order cognitive factors and environmental determinants, such as 
stressors. Such efforts require a high level of interdisciplinary expertise, and this has 
been reflected in the trajectory of my training.  
 
I spent the first six months of my doctoral training working away at the National 
Institutes of Diabetes, Digestive and Kidney Diseases (NIDDK), where I developed 
an understanding of best practices in inpatient, metabolic testing of obesity and 
weight disorders. Then, I returned to Cambridge for two years to design and 
undertake an integrative neuroimaging study of the effects of acute stress on 
metabolic, neural and behavioural responses AN-BP and BN. This project acquired 
empirical evidence across different ‘levels’ in order to validate or refute the current 
diagnostic distinctions of two binge-eating disorders, serving as an exercise in 
epistemic iteration. Upon completion of data collection, I returned to the National 
Institute of Mental Health (NIMH) in the US to analyse the resulting data. As such, 
Chapters 2-5 present original work from this integrative neuroimaging protocol, 
whereas Chapter 6 provides perspective on the implications of this work for future 





Chapter 2: Environmental and metabolic determinants of eating behaviour – 
Methods  
 
As noted in Chapter 1, this thesis presents original findings from an integrative, 
experimental medicine study of the role of metabolic, neurobiological and 
environmental factors in AN-BP and BN. This chapter will provide an outline and 
justification of the general methodological approaches that were chosen for this 
study, whereas more detailed description for the experimental manipulations will be 
provided in Chapters 3 through 5. 
 
2.1 Introduction  
 
The previous chapter reviewed an extensive body of interdisciplinary work, which 
implicates complex physiological, neurobiological and environmental factors in the 
regulation of eating behaviour. Pathological disturbances in eating, such as binge-
eating disorders, are proposed to reflect dysregulation at both biological and 
psychological levels, which may be further exacerbated by acute, environmental 
stressors. Indeed, a prominent theoretical model suggests psychological stress is an 
antecedent to binge-eating (Heatherton & Baumeister, 1991), and behavioural 
studies have lent empirical support to this model, particularly amongst individuals 
who restrict their energy intake. However, the precise relationship between stress, 
binge-eating pathology and cognitive and metabolic control of eating remains largely 
unknown. Characterising these associations will be central to improving our 
understanding of the aetiology of binge-eating disorders, as well as their current 
classification and treatment. As such, to quantify functioning under neutral and 
stressful conditions in a highly-controlled inpatient setting, I designed a multimodal 
study protocol, which implemented repeated, within-subject measurements of 
metabolic markers, neural responses and behaviour.  
 
Prior literature has shown that acute stress potentiates habit-based responding 
(Maier et al., 2015; Schwabe & Wolf, 2009), aligning with the theory that decreased 
self-regulatory control mediates the association between stress and binge-eating. 
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Indeed, behavioural studies suggest that individuals with binge-eating disorders 
show increased motor and temporal impulsivity relative to controls (see Chapter 1 
Section 1.4.2), which may give rise to the subjective reports of a ‘loss of control’ 
during binge-eating episodes. However, the impact of stress on self-regulatory 
control in binge-eating disorders remains unknown. Attempts to characterise this 
association at neural and behavioural levels must first consider how a heterogenous 
construct like self-control can be parsed and measured.   
 
Several paradigms have been widely used in cognitive neuroscience studies of self-
regulatory control, including Go/NoGo (Donders, 1969), stop-signal (Logan & 
Cowan, 1984), Simon spatial compatibility (Craft & Simon, 1970), Flanker (Eriksen & 
Eriksen, 1974) and Stroop tasks (Stroop, 1935). These tasks have been 
implemented in both normative and psychiatric groups; however, they are by 
necessity reductionistic as each paradigm measures specific cognitive mechanism(s) 
that reflect related but distinct facets of self-control (Littman & Takács, 2017; Wessel, 
2018). For example, whereas Go/NoGo and stop-signal tasks aim to index one’s 
capacity to stop an ongoing motor response, the latter three tasks measure one’s 
ability to respond appropriately in the context of perceptual interference. Perceptual 
interference can be introduced by including or modifying stimulus features that are 
irrelevant to the stimulus-response relationship, such as using a blue colour for the 
stimulus ‘yellow’. Thus, when a participant is asked to respond to a series of colour-
coded words in a Stroop task, the conflict between the irrelevant stimulus feature 
(i.e., the colour) and the relevant stimulus feature (i.e., the word) must be resolved. 
Although this provides an index of cognitive control, the introduction of conflict 
monitoring increases demands on other executive functioning processes, such as 
working memory and attentional control. While it would be specious to suggest that 
Go/NoGo and stop-signal task performance is not influenced by attentional 
processes, as I describe below, these tasks provide more a specific index of 
inhibitory control, which is advantageous for studies of complex syndromes like 
binge-eating behaviour.  
 
Each trial of a Go/NoGo task presents either a ‘go’ or a ‘no-go’ stimulus, which is 
either presented with or instead of the ‘go’ stimulus, prompting either a motor 
response or action cancellation, respectively. As the task aims to measure inhibitory 
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control, or an individual’s ability to stop a motor response, a high proportion of ‘go’ 
trials are presented relative to ‘no-go’ trials. The combination of short trial durations 
and rare ‘no-go’ stimuli aims to build prepotent motor responding throughout the 
task, thus enabling effective assessment of participants’ ability to stop a response. 
However, there is substantial variability in Go/NoGo tasks across studies, and 
designs with long stimulus-stimulus intervals and equiprobable go/no-go trails do not 
sufficiently engage inhibitory control processes (Wessel, 2018). Moreover, even in 
optimal designs, the repeated presentation of stimuli associated with stopping 
throughout Go/No-Go tasks has been shown to increase the likelihood of automatic 
(response) inhibition (Verbruggen & Logan, 2008a). As automatic inhibition would 
involve stopping before a motor response has been elicited, this suggests that 
Go/NoGo tasks do not provide the optimal assessment of one’s capacity to stop an 
ongoing response.  
 
The stop-signal task similarly aims to index inhibitory control by building prepotent 
responding to ‘go’ signal trials. However, stop-signals are presented on a minority of 
trials at a variable delay following the onset of the go signal (Verbruggen & Logan, 
2008b). This ‘stop-signal delay’ ensures that the participant has engaged the ‘go’ 
process of generating a motor response before the stop-signal signal has been 
presented to trigger the theoretical ‘stop’ process. Stop-signal performance depends 
on the outcome of a ‘race’ between the go and stop processes as response inhibition 
reflects the relative finishing time of these two processes (Verbruggen & Logan, 
2009b). That is, once the go process has been triggered by a go stimulus and 
subsequently a stop process is initiated by a stop-signal, the ensuing motor 
response (or successful suppression thereof) will reflect whichever process finishes 
first. The latency of the stop process, or the stop-signal reaction time (SSRT), 
represents the primary outcome of interest and measure of inhibitory control. As 
shown in Figure 2.1, the probability of responding to a stop-signal relates to the stop-
signal delay, distribution of go response times and the SSRT. When modelling the 
stop-signal task, it is assumed that the stop-signal delay directly influences the 
relative finishing time of the stop process: as the stop-signal delay increases, 
initiation of the stop process is delayed, and the go process is more likely to finish 
first. As the finishing time of the stop process cannot be observed, it is inferred from 
integrating a participant’s ‘go’ RT distribution and determining the point where the 
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integral equals the probability of responding to a stop-signal (i.e., the dashed line in 
Figure 2.1). Stop-signal paradigms commonly produce a .50 probability of stopping 
given a stop-signal, which can be achieved via a ‘tracking’ procedure that 
dynamically adjusts the stop-signal delay based on performance throughout the task.  
 
 
Figure 2.1 Illustration of the independent race model of Go and Stop processes. The length 
of each horizontal line reflects the duration of each process (SSD = stop-signal delay, SSRT 
= stop-signal reaction time). The probability of responding (p(respond|signal)) and inhibiting a 
response (p(stop|signal)) when presented with a stop-signal depends on the distribution of ‘go’ 
RTs, the SSD and the SSRT.  
 
By dissociating ‘go’ and 'stop’ processes, the stop-signal task arguably represents a 
superior paradigm for assessment of response inhibition than the Go/NoGo task. 
Several direct comparisons of Go/NoGo and stop-signal tasks have also identified 
only partial overlap in their neural correlates. Whilst both tasks elicit activation of 
canonical motor circuitry (e.g., basal ganglia, pre-SMA, M1, inferior frontal cortex), 
activation uniquely associated with Go/NoGo performance could reflect recruitment 
of other executive functions to optimise performance. For example, it has been 
suggested that dlPFC activity during Go/NoGo performance reflects an increased 
working memory demand relative to the stop-signal task (Rubia et al., 2001; 
Simmonds et al., 2008). This would align with the idea that, during the Go/NoGo 
task, participants choose to either make an appropriate response or to commit an 
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inappropriate response, and such monitoring of would rely on other domains of 
executive functioning.  
 
Taken together, the term ‘self-regulatory control’ refers to an emergent construct that 
is influenced by various higher-order cognitive mechanisms, but the stop-signal task 
facilitates robust measurement of one core aspect of this construct, inhibitory control, 
that has well-defined neural correlates. Given that binge-eating episodes are 
characterised by a sense that one cannot stop eating (i.e., an ongoing behaviour), 
performance on the stop-signal task could model this behaviour. These reasons 
influenced my decision to include a version of the stop-signal task in the protocol that 
will be described in the following section. Within the protocol, I sought to address two 
primary aims. First, I aimed to determine whether behavioural performance and the 
BOLD response to a response inhibition task significantly differed between AN-BP, 
BN and HC and if this response was negatively impacted by acute stress. The 
second aim focused on determining the effects of stress on circulating gut hormones 
levels and subsequent food intake in a naturalistic laboratory setting. An exploratory 
component of the study tested whether local metabolites, such as glutamate, in 
inferior frontal and occipital cortices differ between patient groups and whether 
metabolic properties of neural tissue relate to metabolic markers in the periphery.  
 




Eighty-five right-handed, women (Mage ± SD = 23.96 ± 3.98y) were recruited through 
posted advertisements in Cambridgeshire, on social media, via the B-eat charity and 
from the Cambridgeshire and Peterborough NHS Foundation Trust Adult Eating 
Disorders Service (AEDS) at Addenbrooke’s hospital.  
 
English-speaking women between 18 and 40 years were eligible for the study. All ED 
participants met the Diagnostic and Statistical Manual of Mental Disorders 5th Edition 
(DSM-5; 4) criteria for current AN-BP or BN. The general exclusion criteria included 
left handedness, estimated IQ<80, body mass index (BMI)>29.9 kg/m2, MRI 
contraindications (e.g., pregnancy, some metallic implants), anaemia or thyroid 
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dysfunction, lactation, previous bariatric surgery and high nicotine dependence as 
per the Fagerström Test for Nicotine Dependence (FTND; Heatherton, Kozlowski, 
Frecker, & Fagerström, 1991). Healthy controls with a lifetime history of any 
psychiatric disorder were excluded. Additional exclusion criteria for ED participants 
included diagnoses of DSM-5 BED, neurodevelopmental disorders, serious mental 
illness (e.g., schizophrenia, bipolar disorder) or substance or alcohol use disorder 
within the past 6 months. Finally, ED participants from AEDS were only included 
after consultation with their clinician to ensure that participation would not negatively 
impact on their health or ongoing treatment. 
 
Participants provided written, informed consent prior to participation and received 
compensation for their time and travel expenses. The Cambridge East Research 
Ethics Committee (Ref. 17/EE/0304) approved the study.  
 
2.2.2 Study Design 
 
Following telephone pre-screening to determine initial eligibility, volunteers 
completed the DSM-5 Cross-Cutting Symptom Measure (American Psychiatric 
Association, 2013b) to rule out exclusionary psychopathology symptoms. Eligible 
volunteers then completed an outpatient screening prior to remote saliva sampling 
and an inpatient study session. An overview of the study design is shown in Figure 




Figure 2.2 Overview of study design and blood sampling protocol. A) Following the screening 
session, participants completed remote saliva sampling prior to the two-day, inpatient study 
session. Induction (stress vs. neutral) order was counterbalanced amongst participants in 
each group. B) Inpatient study session daily timeline. Participants were provided standardised 
meals prior to a 6-hour fast on each day. Baseline blood samples were collected ~2 minutes 
prior to the start of the induction. Remaining samples were collected at T2 M±SD = 12.7 ± 2.7, 
T3 = 33.5 ± 3.7, T4 = 53.0 ± 3.8 and T5 = 72.9 ± 4.6 minutes relative to baseline. C) Trial 
structure for stress and control tasks. Both tasks involved 48 multiple choice maths problems 
that were matched on difficulty. For the stress induction, participants were told that they must 
meet the group average score; however, a sliding response window ensured low accuracy. 
Electrical stimulation was delivered to the participant’s abdomen for both tasks; however, for 
the stress induction, it was delivered at unpredictable frequencies and intensities to induce 
uncertainty. Stimulation was highly predictable for the control task. D) Manipulation check of 
change in subjective stress following neutral and stress induction. Stress ratings ranged from 
0 = not at all to 100 = extremely. Error bars = SEM. 
 
Outpatient screening  
 
With the exception of 12 ED participants who completed remote screening, all 
remaining participants attended screening sessions at Addenbrooke’s hospital after 
an overnight fast. Following informed consent, a blood sample was collected and 
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processed for full blood count and thyroid hormones. Next, height and weight were 
measured, and after a negative pregnancy test, body composition was determined 
via dual X-ray absorptiometry (GE Lunar iDXA). Following a light breakfast, 
participants completed the National Adult Reading Test (Blair & Spreen, 1989), an 
online progressive matrices test (Kosinski et al., 2012), the Structured Clinical 
Interview for DSM-5 (SCID-5; First, Williams, Karg, & Spitzer, 2015), and the Eating 
Disorder Examination (EDE v16; Cooper & Fairburn, 1987), and they were given 
saliva sampling materials.  
 
To reduce study burden, patient volunteers who resided outside of Cambridgeshire 
county completed a remote screening session via telephone or videocall. 
Participants signed an electronic informed consent form prior to completing the 
SCID-5 and EDE clinical assessments, the cognitive assessments, and the FTND 
questionnaire. Fixed meal choices were recorded, and participants were asked to 
self-report their height and weight for meal preparation purposes. The remaining 
screening procedures, namely the DXA body composition scan, pregnancy test and 
blood sampling, were completed during the participant’s study session. 
   
Remote saliva sampling   
 
Following the screening session, participants collected saliva samples using 
Salivette swabs (Sarstedt, UK) immediately upon waking and 30, 45 and 60 minutes 
after waking on two workdays of their choice. Participants were asked to awaken 
between 06.00 and 08.30h and not to eat or drink during the hour of sample 
collection. If a participant was not in work, she was asked to collect the samples 
between Monday and Friday. Compliance and timing of sample acquisition were self-




A timeline of the two-day, inpatient study session is depicted in Figure 2.2B. These 
sessions began at either 08.00 or 09.00h, lasting no more than 36 hours (one 
participant arrived late at 10.30h). Upon admission, participants’ height and weight 
were recorded on a seca 285 measuring station (seca GmbH & Co, Germany), and 
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they were provided with standardised meals prior to a 6-hour fast. During the fast, 
participants underwent functional MRI scanning, either an acute stress or neutral 
induction and blood sampling. The fast ended with a 30-minute ad libitum meal, and 
an evening snack was offered at 19.00h for those who had not met their estimated 
energy requirements (EER) in the buffet. Momentary mood ratings were collected 
(PANAS; D. Watson, Clark, & Tellegen, 1988) at all meal times. On Day 2, a blood 
sample was collected upon waking to assess sex hormones (to determine menstrual 
phase) and a metabolic panel. Then, the same testing schedule was repeated. ED 
participants continued any prescribed medication(s) throughout the study.  
 
Standardised meal plan and ad libitum meal 
 
As macronutrient composition can impact on gut-brain signalling (Ren et al., 2010), 
participants were provided fixed meals (50% carbohydrate, 35% fat and 15% protein) 
for breakfast and snacks (see Appendix Table 1). Participants were asked to choose 
their fixed meals from a study-specific menu. Given the high prevalence of dietary 
restrictions in ED populations (e.g., vegan or vegetarian diets), meal composition 
was modified by a metabolic nutritionist to suit a participant’s dietary requirements 
when necessary. All resulting meals adhered to the standard macronutrient 
breakdown. Total daily calorie content was determined from participants’ sex, height, 
weight, age and the Schofield equation, which estimates basal energy expenditure, 
where height and weight were recorded at the screening session or self-reported for 
out-of-area participants. All participants were (re)weighed upon admission on Day 1 
of the study session, and the EER, and subsequent calorie content of the meals, was 
adjusted if necessary. One AN-BP participant was provided 2,000 kcal per day to 
adhere to her ongoing treatment plan. 
 
Participants were offered 35% of their EER prior to fasting; however, given that 
forced consumption can be extremely distressing to individuals who are acutely ill 
with an ED, only healthy controls were asked to consume the full 35% of their EER. 
The ad libitum meal included various sweet (e.g., grapes, biscuits) and savoury (e.g., 
vegetable pasta, chicken goujons) foods that were selected due to their suitability for 
examining food choice behaviour in an ED population (Table 2.1). Approximately 
4060 kcals were available in the buffet. Prior to the meal, participants were told that 
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they would be eating alone in a naturalistic lounge environment for 30 minutes, 
where a nature documentary would be playing on television, and they could eat as 
much or as little as they would like. Participants who did not meet their EER in the ad 
libitum meal were offered an evening snack, where the calorie content was adjusted 
based on the percentage of EER remaining. 
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Table 2.1. Ad libitum meal contents and macronutrient information  
 


















Semi-Skimmed Milk 254.0 1.8 4.6 4.8 12.2 3.6 9.2 127.08 
Tripoca Trop 50 Orange 
Juice 254.0 0.0 0.0 3.9 9.9 0.3 0.8 53.37 
The Food Doctor High 
Fibre and Cereal Pitta 
(x2) 
102.0 1.7 1.7 24.2 24.6 5.9 6.0 145.38 
Tesco Reduced Fat Sour 
Cream Dip 85.0 14.6 12.4 7.3 6.2 3.9 3.3 149.10 
Tesco Reduced Fat 
Hummus 
85.0 10.5 8.9 11.0 9.3 6.4 5.4 152.49 
Doritos 42.0 14.0 5.9 31.0 13.1 3.4 1.4 115.64 
Walkers Baked Ready 
Salted Crisps 
42.0 13.5 5.7 69.0 29.2 6.6 2.8 184.68 
Carrot Batons 68.0 0.3 0.2 7.7 5.2 0.6 0.4 28.47 




42.0 29.0 12.3 55.0 23.3 5.4 2.3 221.96 
Oreo Biscuits 56.0 20.0 11.2 69.0 38.6 5.0 2.8 268.39 
Rice Krispie Squares 
(x2) 47.0 12.0 5.7 76.0 36.1 3.0 1.4 201.15 
Be Good To Yourself 
Vegetable Pasta 424.0 1.4 5.9 15.2 64.4 2.8 11.9 376.99 
Tesco Breaded Chicken 
Goujons 
169.0 13.9 23.6 19.3 32.7 18.4 31.2 469.34 
Tesco Stonebaked Four 
Cheese Pizza 280.0 9.5 26.6 27.2 76.0 12.9 36.1 701.72 
Tesco Chocolate 
Brownie Traybake (serve 
whole traybake) 
188.0 20.0 37.6 54.8 103.1 6.1 11.5 808.71 
TOTAL 2223.0 - 162.3 - 497.0 - 126.7 4060.4 
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Stop-signal anticipation task  
 
The stop-signal anticipation task (SSAT; Figure 2.3) was presented using 
Presentation software (v. 20; Neurobehavioral Systems). A background of three 
horizontal lines was present throughout the task. On each trial, a bar moved at a 
constant speed from the bottom line, reaching the top line in 1000ms. The main task 
(i.e., go-signal trials) involved stopping the moving bar as it reached the middle line 
with one’s right index finger, yielding a target response time of 800ms. On stop-
signal trials, the moving bar stopped automatically before reaching the middle line, 
signalling that a motor response had to be suppressed. The colour of the middle line 
indicated the probability of a stop-signal occurring on a given trial, where green = 
0%, yellow = 17%, amber = 20%, orange = 25% and red = 33%.  
 
 
Figure 2.3 Schematic of the stop-signal anticipation task. Stop-signal anticipation trials were 
presented as either A) go-signal trials, where participants were instructed to press a button 
with their index finger when the moving bar reached the middle line, or B) stop-signal trials. 
On stop-signal trials, the moving bar stopped automatically before reaching the middle line, 
and participants were told to withhold their response. C) The colour of the middle line 
indicated the probability of a stop-signal occurring on that trial.  
 
The initial stop-signal onset time was set to 500ms (i.e., 300ms before the target 
response time) for each stop-signal probability level. Throughout the task, the stop-
signal onset time was adjusted using a staircase procedure (with steps of 25ms) 
depending on stopping accuracy. These adjustments were made separately across 
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each stop-signal probability level, ensuring roughly equal numbers of successful and 
failed stop-signal trials.  
 
Trials were presented in either baseline or experimental blocks that were comprised 
of 12 to 15 trials each. The inter-stimulus interval was 1000ms. During baseline 
blocks, participants responded to trials in which the stop-signal probability was 0%, 
as indicated by the green stop-signal probability cue. Experimental blocks were 
comprised of go-signal trials with a stop-signal probability >0% (i.e., non-green cues) 
and stop-signal trials (also non-green cues). Stop-signal trials occurred pseudo-
randomly throughout experimental blocks, and stop-signal probability level varied 
across trials. Distinct trial orders were used for pre- and post-induction runs to 
account for practice effects within each day, where the trial orders were the same 
across all participants and scan sessions. Simulations to determine the optimal trial 
order indicated that correlations between the different model regressors were 
sufficiently weak to generate parameter estimates.  
 
In total, the SSAT included 474 trials: 234 go-signal trials with a stop-signal 
probability of 0%, 180 go-signal trials with a stop-signal probability >0% and 60 stop-
signal trials. In other words, the proportion of stop-signal trials was 33.3%. Two, 24s 
rest blocks were presented after one-third and two-thirds of the trials had elapsed. 
The task duration was 16min 36s. Participants completed a behavioural practice 
session prior to fMRI scanning on Day 1, in which they were trained on the Go and 
Stop tasks. Participants were notified that it was equally important to stop the moving 
bar at the target and withhold their response in the presence of a stop-signal. We 
informed participants that stop-signals would never occur on trials with green cues, 
and the likelihood of a stop-signal occurring was lowest on ‘yellow’ cue trials and 
highest on ‘red’ cue trials, increasing as the cue colour transitioned to red. On Day 2, 
participants were reminded of the task instructions prior to scanning.  
 
Acute stress induction 
 
In each MRI session, participants completed either a stress induction or a control 
task (i.e., neutral condition) on each day (Figure 2.2C), with manipulation order 
counterbalanced across participants. The computerised induction incorporated three 
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elements that have been shown to reliably increase subjective stress and circulating 
cortisol, and they have been used extensively in other psychological stress 
inductions, such as the Trier Social Stress task (Kirschbaum et al., 1993) and the 
Montreal Imaging Stress Test (Dedovic et al., 2005). These elements included: a 
motivated performance task, negative feedback on performance and threat 
uncertainty (Dickerson & Kemeny, 2004).  
 
In both tasks, participants completed 48 multiple-choice math problems of equivalent 
difficulty while they received somatic distractors (i.e., trains of electrical shocks to the 
abdomen). Performance was not evaluated during the control task, but for the stress 
induction, participants were told that their performance must meet the group 
average. However, correct responses were penalised, resulting in a shorter 
response window and therefore poorer performance, and incorrect responses 
elicited negative feedback. Finally, threat uncertainty was induced through 
unpredictable sequences of mildly painful electrical stimulation, which has been 
shown to increase state anxiety (Carlsson et al., 2006; Grillon, Baas, Lissek, Smith, 
& Milstein, 2004).  
 
Prior to the induction, the intensity of the electrical stimulation was titrated on the 
basis of each participant’s pain threshold (see below). This represented a key 
methodological advantage for the induction of stress in women, especially those with 
disordered eating, as within-subject adjustments served to mitigate the impact of 
menstrual phase (or amenorrhea) on the female stress response (Kirschbaum et al., 
1999). Subjective stress and hunger were recorded pre- and post-induction (0=Not at 
all, 100=Extremely; see Figure 2.3 for stimulation ratings). Participants were 
debriefed on the stress induction at the end of the study. 
 
Electrical stimulation protocol  
 
Prior to the induction, two BIOPAC radio translucent electrodes (EL509) were filled 
with isotonic paste (GEL101) and placed 1 – 2 inches to the right of the participant’s 
navel, between dermatomes T10 and T12. Electrical stimuli were generated using a 
DS7A constant current stimulator (Digitimer, UK). Shock intensity was calibrated for 
each participant to control for individual differences in shock tolerance. Participants 
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were asked to indicate two thresholds: 1) when the stimulation was detectable but 
not uncomfortable and 2) the first moment when the stimulation was uncomfortable 
but not painful, corresponding to pain ratings of 0 – 2 and 5 – 7, respectively (0 = no 
pain, 10 = very painful). Each individual shock pulse lasted 500μs. Throughout the 
stress induction, shocks were delivered in sequences of 5 – 20 pulses at intermittent 
intervals (inter-pulse interval range: 0.1 – 1s; inter-train interval range: 0.1 – 3.9s), 
which were randomly sampled in MATLAB (v2017b; The Mathworks, Natick, MA, 
USA), and variable intensities. Intensity was manually adjusted between the 
participant’s two threshold values. Throughout the control task, stimulation was 
delivered at predictable intervals; trains of 5 pulses were delivered at an inter-pulse 
interval of 0.55s, inter-train interval of 2s, and a constant intensity, corresponding to 
the participant’s detection threshold. Shock delivery was not contingent on 
performance in either task. Participants were asked to verbally indicate if the 
stimulation became painful at any point during the task, in which case it would be 
reduced. No participants reported discomfort. 
 
Mental maths control and stress task   
 
Maths task stimuli were presented in MATLAB, using Psychophysics Toolbox (v3; 
Brainard, 1997), and code may be retrieved from: 
https://github.com/mwestwater/STRIvE-ED. Prior to scanning on each day, 
participants completed a practice maths task, consisting of 25 multiple-choice 
problems of varying difficulty (n = 10 easy, n = 9 medium, n = 6 hard), with three 
choices of solutions. Participants were instructed to try their best to respond 
accurately without taking too much time to make their response. Stimuli were 
presented for a maximum of 30s, during which participants had to respond by 
selecting one of the 3 choices. Feedback (2500ms) was presented either 500ms 
after the response, or after the 30s period. After a variable interval (500 – 2500ms, 
jitter = 100ms), a new trial was presented. ‘Easy’ trials were restricted to addition or 
subtraction of up to three, single-digit integers (e.g., 9 – 3 – 4). On medium-difficulty 
trials, problems included addition, subtraction and multiplication of three to four 
single- or double-digit integers (e.g., 66 - 9 * 6 - 1). ‘Hard’ problems required 
addition, multiplication and/or division of four single- or double-digit integers (e.g., 72 
/ 8 + 31 * 41).  
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The stress induction and control task (Figure 2.2C) each included 48 multiple-choice 
mental arithmetic problems, which were matched on difficulty (n = 14 easy, n = 22 
medium, n = 12 hard). Prior to the study, both sets of maths problems were pilot 
tested in an online sample of healthy adults, where n = 50 completed Set 1 and n = 
56 solved the equations in Set 2. Pilot testing ensured that 1) a sufficiently high 
accuracy rate could be achieved (Set 1 M±SD = 81 ± 12%, Set 2 = 83 ± 12%); 2) the 
task duration was of a suitable length (Set 1 = 8.5 ± 2.1 min, Set 2 = 9.1 ± 2.9 min); 
and 3) that neither mean accuracy (t(df) = -0.85(96.80), p = 0.40) nor completion 
time (t(df) = -1.34(98.64), p = 0.18) differed significantly between Sets 1 and 2. 
Maths Sets 1 and 2 were randomised across stress and control conditions for each 
participant.  
 
For the stress induction, participants were encouraged to try their best, being told 
that only data from participants whose performance met the group average could be 
used in the study. Additionally, they were informed that ‘physical distractors’ would 
be delivered to their abdomen, and that they would be watched on a video camera to 
ensure they paid attention to the task. Prior to the control task, participants were told 
that their performance would not be evaluated, and they were asked to respond 
without taking too much time. These tasks had the same trial structure as the 
practice task; however, for the stress induction, the stimulus presentation and 
response time (30s in the practice task) was set to 10% less than the average 
response time on the practice task. As in the Montreal Imaging Stress Test (Dedovic 
et al., 2005), accurate responses on 3 consecutive trials shortened the maximal 
response window by 10%, ensuring low performance. As this reduced the overall 
task duration, the ITI was set to 6 seconds on every 6th trial to ensure that the task 
duration was sufficiently long for the stress induction to be effective. Participants 
received negative feedback to nonresponses (i.e., “Too slow! Try harder!”) and 
incorrect responses (e.g., “Your performance is below average.”) while no feedback 
was provided following correct responses. At the end of the task, participants were 
informed that their performance did not meet the group average. For the control task, 
the stimulus presentation and response time was 30s on each trial. Participants 
received neutral feedback on accurate responses (i.e., “Correct”) and no feedback 
on incorrect or nonresponses.  
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Blood sampling protocol    
 
An intra-venous cannula was inserted at least 1 hour prior to blood sampling, which 
occurred between approximately 14.00 and 17.30h on both days to control for 
diurnal fluctuations in cortisol. Blood samples were collected approximately 2 
minutes pre- and post-induction, and three additional post-induction samples were 
collected at 20-minute intervals. Plasma cortisol and ghrelin were assessed at all 
timepoints while PYY and GLP-1 were measured at timepoint 5 only.  
 
On Day 2, a blood sample was collected immediately upon waking to assay fasting 
glucose, insulin, leptin, cortisol, potassium and sex hormones (oestradiol, leutenising 
hormone, follicular stimulating hormone).  
 
2.2.3 Hormone assays 
 
Full sample handling procedures for all hormone assays are described in the 
Appendix. 
  
2.2.4 MRI data acquisition 
 
MR images were acquired on a 3T Siemens SkyraFit scanner (Erlangen, Germany) 
fitted with a 32-channel, GRAPPA parallel-imaging head coil. On each day, 1.0mm 
isotropic T1-weighted structural images were acquired (TE = 2.95ms, TR = 2300ms, 
flip angle = 9°, acquisition matrix = 256 X 256mm). Echo-planar images were 
acquired across 30 interleaved slices with the following parameters: TR = 1600ms, 
TE = 23ms, flip angle = 78°, acquisition matrix = 64x64, 3.0mm isotropic voxels, 631 
volumes. One participant was excluded for an incidental finding of white matter 
abnormalities, and this participant received clinical follow-up. 
 
Proton (1H) MRS spectra were measured from two, 20mm isotropic voxels of interest 
(VOIs) in the right inferior frontal gyrus and right medial occipital cortex. 
Measurements were taken on the participant’s ‘neutral’ scan day before EPI 
acquisition. I positioned the voxels manually, referencing the participant’s T1-
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weighted structural scan. For each VOI, first- and second-order B0 field shims were 
adjusted using 3D gradient-echo shimming. Then, the RF pulses were calibrated in 
semiLASER and for water suppression by 1) monitoring the water signal intensity 
across increasing levels of RF power and 2) choosing the settings for maximum 
signal (Deelchand et al., 2015). Spectra were acquired using a semiLASER 
sequence (total TE = 28ms, TR = 5000ms, 64 transients), which uses a single slice-
selective 90° excitation pulse (Marjańska et al., 2012; Öz & Tkáč, 2011; Scheenen et 
al., 2008). Water signal suppression was achieved using variable pulse power and 
optimisation relaxation delays (VAPOR) water suppression, with one additional pulse 
following the seventh VAPOR pulse to optimally reduce in vivo water signal (Tkáč et 
al., 1999). VAPOR pulses were interleaved with outer volume suppression pulses to 
control for saturation effects. In addition to metabolite spectra, unsuppressed water 




2.3.1 Participants  
 
One hundred and forty-seven women underwent phone screening in response to 
advertisements for women who were not affected by an eating disorder, and 77 of 
these women were eligible for participation, provided that they could be age- and 
BMI-matched to patient groups. Of those who responded to advertisements for 
women with BN or AN-BP symptoms, a total of 208 women completed the phone 
screening. Fifty-three of these individuals met eligibility criteria for the BN group, and 
28 were eligible for the AN-BP group.  
 
Of the 100 volunteers who completed the screening session, 15 participants were 
excluded from the study session: one participant was anaemic, four participants 
had a body mass index (BMI) outside of the range, one participant had substance 
use disorder, two participants had an Otherwise Specified Feeding or Eating 
Disorder (OSFED), one participant moved abroad, two participants could not be 
contacted to continue with the study, one participant was subsequently found to have 
had a previous abnormal brain scan and one withdrew from the study. Finally, two 
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participants were excluded as both the study team and the treating clinician agreed 
that participation would jeopardise their ongoing treatment. 
 
Participant groups in the final sample of 85 women (n=22 AN-BP, n=33 BN, n=30 
HC) were matched on age and estimated IQ, and BN and HC groups were BMI-
matched (t(61)=0.19, p=.85; Table 2.2). Women with AN-BP had a greater lifetime 
incidence of AN-R (64% versus 30% in BN; p=.015) while excessive exercise 
episodes were more frequent in BN (11±9 versus 7±14 in AN-BP; p=.04). All 
remaining clinical variables (e.g., binge-eating and purging episodes, psychiatric 




Table 2.2. Clinical and demographic information by participant group 
 
Characteristic AN (n = 22) BN (n = 33) HC (n = 
30) 
Analysis 




Age (y) 24.6 (4.7) 23.6 (3.9) 23.9 (3.5) Χ2(2)= 0.8 .69 
BMI (kg/m2) 16.4 (1.4) 22.0 (2.4) 21.9 (2.1) Χ2(2)= 48.4 <.001 
NART IQ score (full) 116 (5) 114 (5) 114 (5) Χ2(2)= 3.2 .21 
RPM IQ score  100 (11) 99 (9) 100 (9) Χ2(2)= 0.2 .89 
BDI-II 35.3 (12.0) 32.7 (10.5) 2.4 (2.8) Χ2(2)= 57.7 <.001 
TAI 63.1 (10.4) 62.8 (7.3) 33.0 (6.9) F(2) = 151.1 <.001 
EDE-Q 4.4 (0.8) 4.6 (0.8) 0.2 (0.2) Χ2(2)= 58.0 <.001 
EDE ratings      
     OBEs 38.1 (47.9) 23.0 (29.1) - W = 325.0 .51 
     SBEs 9.5 (12.8) 6.6 (6.2) - W = 341.5 .93 
     Vomiting episodes 43.5 (51.6) 24.2 (31.0) - W = 304.0 .31 
     Laxative episodes 1.1 (3.4) 2.0 (3.9) - W = 421.5 .18 
     Exercise episodes 7.4 (13.6) 10.9 (9.4) - W = 478.5 .04 
Age of onset (y) 15.6 (2.4) 16.2 (3.1) - t(51.8) = -0.8 .42 
Illness duration (y) 9.0 (5.8) 7.4 (4.0) - t(34.4) = 1.1 .27 
Psychiatric comorbidity      
Anxiety (%) 13.6 9.1 - Χ2(1)= 0.3 .69 
Excoriation (%) - 6.0 - Χ2(1)= 1.3 .53 
MDE (%) 68.2 48.5 - Χ2(1)= 2.1 .15 
OCD (%) - 3.0 - Χ2(1)= 0.7 1.0 
Personality (%) 9.1 15.2 - Χ2(1)= 0.4 .69 
PTSD (%) 4.5 3.0 - Χ2(1)= 0.1 1.0 
Trichotillomania (%) 4.5 - - Χ2(1)= 1.5 .40 
Any current treatment 
(%) 
59.0 45.5 - Χ2(1)= 1.0 .32 
     Psychotherapy (%) 40.9 27.3 - Χ2(1)= 1.1 .29 
     Medication (%) 45.5 30.3 - Χ2(1)= 1.3 .25 
Prior AN-R (%) 63.6 30.3 - Χ2(1)= 6.0 .01 
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Note: BMI = body mass index, NART = National Adult Reading Test, RPM = Online Raven’s 
Progressive Matrices, BDI-II = Beck Depression Inventory-II, TAI = Trait Anxiety Inventory, 
EDE-Q = Eating Disorder Examination Questionnaire, EDE = Eating Disorder Examination, 
OBE = objective binge-eating episode, SBE = subjective binge-eating episode, MDE = major 
depressive episode, OCD = obsessive-compulsive disorder, PTSD = posttraumatic stress 
disorder, AN-R = anorexia nervosa restrictive subtype. EDE ratings reflect counts over the 
previous 28 days. Group differences were evaluated using one-way ANOVA and, for non-
normally distributed data, the nonparametric Kruskal-Wallis test. The two-samples t-test (two-
sided), Mann-Whitney U test and chi-square test were used to assess differences between 
AN and BN groups. 
 
As depicted in Table 2.2., approximately 45% and 30% of AN-BP and BN 
participants, respectively, were prescribed psychotropic medication at the time of the 
study. The majority of participants were prescribed either selective serotonin 
reuptake inhibitors (SSRIs) or serotonin-norepinephrine reuptake inhibitors with high 
serotonin affinity (see Table 2.3). All participants reported stable medication use for 
at least two weeks prior to the inpatient testing session.  
 
Table 2.3. Psychotropic medication use by patient group 
Medication AN-BP BN 
 # (%) Dose (mg) # (%) Dose (mg) 
Amitriptyline 1 (4.5) 20 - - 
Aripiprazole 1 (4.5) 5 - - 
Bupropion 1 (4.5) 300 - - 
Duloxetine 1 (4.5) 60 - - 
Fluoxetine 3 (13.6) 40 – 60 4 (12.1) 30 - 60 
Mirtazapine - - 1 (3.0) 15 
Olanzapine 1 (4.5) 5 - - 
Sertraline 2 (9.1) 20 – 150 3 (9.1) 100 
Venlafaxine 1 (4.5) 112.5 3 (9.1) 150 – 300 
Zopiclone - - 1 (3.0) 3.75 
 
Note: Several participants were prescribed more than one medication. Dose indicates 
mg/day. 
 
2.3.2 Acute stress manipulation check  
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The stress induction and control task lasted M±SD=7±1 minutes and 9±2 minutes, 
respectively. Compared to the neutral condition, participants reported significantly 
higher post-induction stress (β=41.14, t(84)=11.98, p<.001; Figures 2.2C & 2.4) and 
increased negative affect (NA) at pre-meal, post-meal and 30 minutes post-meal 
timepoints (β=1.40, t(84)=2.98, p=.004) following the stress induction. Math accuracy 
was significantly lower in the stress induction (β=-21.77, t(84)=-15.73, p<.001). While 
both AN-BP (β=9.12, t(82)=6.20, p<.001) and BN (β=8.95, t(82)=6.77, p<.001) 
reported greater NA relative to controls, a group-by-condition interaction was 
nonsignificant (χ2(2)=5.18, p=.08), suggesting that the induction was similarly 
effective across groups. 
 
 
Figure 2.4 Acute stress increased negative affect across pre- and post-ad libitum meal time 
points.  
 
Participants’ subjective experience of the electrical stimulation was rated 
immediately post-induction (Figure 2.5). While pain (β=37.3, t(81)=13.76, p<.0001), 
intensity (β=36.6, t(80)=12.7, p<.0001) and unpleasantness (β=42.6, t(81)=14.4, 
p<.0001) were significantly increased following the stress induction, main effects of 
group and a group-by-condition interaction term were nonsignificant. That is, patient 
participants did not perceive the simulation to be significantly more painful, intense or 




Figure 2.5 Subjective ratings of electrical stimulation. As expected, self-report ratings of 
stimulation A) pain, B) intensity and C) unpleasantness were increased following the stress 
induction compared to the neutral task. Importantly, ratings did not differ between AN-BP, BN 
and control groups (all p’s >.05), indicating similar subjective experience of the stimulation. 
Error bars denote 95% confidence interval. 
 
2.4 Discussion  
 
This study represents the first attempt to identify mechanisms by which acute stress 
impacts on metabolic signalling and cognition in women who suffer with binge-eating 
in BN and AN-BP. Within a carefully controlled inpatient setting, I executed repeated 
task-based, fMRI scanning and serial blood sampling procedures, which yielded a 
comprehensive set of metabolic, neurocognitive and behavioural indices of 
participants’ stress responses and inhibitory control. Despite numerous strengths, 
this ambitious protocol presented several challenges, relating to the assessment of 
metabolic functioning in patients acutely ill with EDs and potential confounds of acute 
stress responses in women.  
 
The core strengths of this design included recruitment of a rare patient population, 
AN-BP, implementation of a rigorous, inpatient study protocol and the integration of 
blood sampling with the MR environment. With respect to recruitment, I recruited 55 
women who were acutely ill with either AN-BP or BN in approximately 14 months, 
and this rapid recruitment hinged upon the support of the Adult Eating Disorders 
Service at Addenbrooke’s hospital. I attended weekly clinical meetings at the service, 
in which I developed a working relationship with the clinical team who helped to 
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identify potential patient participants. Following these meetings, I would attend 
assessment sessions, where I provided study information materials to potential 
volunteers after they expressed an interest participation to their treating clinician. 
While this approach proved effective, recruitment of the AN-BP group remained 
challenging due to low incidence rates (<1%; Udo & Grilo, 2018), as well as the 
presence of serious medical comorbidities in some individuals that precluded 
participation. I therefore amended the study protocol to permit remote screening 
sessions for ED participants who did not reside in Cambridgeshire county, which 
both increased geographical reach for recruitment and reduced the study burden for 
these women (n=12).   
 
2.4.1 Assessment metabolic functioning and eating behaviour in acute eating disorders  
 
Use of a bespoke metabolic research unit within the Cambridge Clinical Research 
Centre at Addenbrooke’s hospital not only provided a highly-controlled environment, 
but also reduced rates of attrition by facilitating testing on two, consecutive days. 
Moreover, participant’s food intake was meticulously controlled during the inpatient 
session through participant-specific meal plans that adhered to a standard 
macronutrient breakdown. Although patient participants were not required to 
consume their full pre-fast EER, I effectively controlled for between-subject 
differences in macronutrient intake that have been shown to impact on gut-brain 
signalling (de Araujo et al., 2010; Ren et al., 2010). Moreover, all participants 
completed fMRI scanning within the context of a 6-hour fasting period, which 
effectively controlled for individual differences in satiety. Finally, by providing the ad 
libitum meal in a naturalistic eating behaviour unit, I simulated the environmental 
conditions that a participant might find herself in following a stressful experience in 
daily life.  
 
Despite these strengths, the assessment of metabolic functioning in individuals who 
suffer with frequent binge-eating and purging encompasses two core challenges that 
could not be accommodated by the study design. First, as gut hormone responses 
are influenced by a myriad of dietary factors, including meal macronutrient 
composition (Wren & Bloom, 2007) and overfeeding (Cahill et al., 2011; Wadden et 
al., 2013), metabolic studies often incorporate a run-in periods, during which 
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participants consume standardised meals and/or maintain their body weight for 
between 5 and 28 days prior to experimental testing (e.g., Affuso et al., 2014; Hall et 
al., 2016; Krempf et al., 2003; Pablos-Méndez et al., 1998). Such protocols would 
not be suitable for individuals who are acutely ill with EDs as these individuals would 
struggle with both weight maintenance and adherence to a standard diet, particularly 
if they suffer with frequent binge-eating and purging behaviours. However, an 
alternative approach would be to assess metabolic signalling amongst individuals 
who are remitted from an ED since these individuals could presumably adhere to a 
standardised meal plan without enduring significant distress. Assessment of 
individuals with restrictive AN throughout the course of refeeding would also provide 
an opportunity for careful dietary monitoring prior to a testing session, but such a 
design would not have addressed my aim of identifying metabolic determinants of 
binge-eating disorders.  
 
Second, participants’ free-choice food intake in the laboratory likely differs from that 
in daily life, and this may obfuscate associations between hormone responses, 
neural responses and disease-relevant behaviour. Patients with EDs in particular 
often report heightened fears of negative evaluation during meal times (Levinson et 
al., 2018; Levinson & Rodebaugh, 2012), which may, in turn, lead to altered eating 
behaviour during a research study. Moreover, to address the aim of understanding 
associations between stress and binge-eating, participants were presented with a 
buffet, and some patient participants found this to be overwhelming. An added 
complexity for experimental studies of binge-eating behaviour relates to individual 
differences in food preference. For example, it is not uncommon for individuals with 
binge-eating disorders to consume specific ‘binge foods,’ and while these are often 
palatable, energy-dense foods, individuals may have specific preferences within this 
broad category of energy-dense foods (e.g., bourbon biscuits as opposed to any 
biscuit). Other individuals report a particular sequence within binge-eating episode 
(e.g., beginning with bowls of soup or salad before multiple servings of an entrée, 
which is finally followed by dessert), and some patients prefer to prepare the food 
that they consume during a binge-eating episode. Therefore, the study design could 
have been strengthened by the addition of an ecological momentary assessment 
(EMA) protocol to survey binge-eating episodes following the inpatient study session. 
EMA has been used extensively to identify affective antecedents of binge-eating 
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episodes in daily life (Berg et al., 2013; Culbert, Lavender, et al., 2016; Smyth et al., 
2007; Wonderlich et al., 2015), and the incorporation of this methodology would have 
offered additional opportunities to examine associations between metabolic and 
inhibitory control markers with binge-eating behaviours. However, as this complex 
and intensive protocol already placed a substantial burden on participants, it might 
have been inappropriate to impose further demands with a daily monitoring protocol.   
 
2.4.2 Induction and measurement of acute stress in women during MR scanning  
 
Another challenge in this protocol related to the induction and measurement of an 
acute, psychological stress responses in women during fMRI scanning. Although the 
integration of serial blood sampling within the MR environment was successful, other 
aspects of the environment may have limited my ability to precisely capture 
participants’ stress responses. First, the MR environment can engender stress, in 
and of itself, due to physical discomfort, aversive noise and general uncertainty 
surrounding the experience, particularly for individuals who are naïve to fMRI 
scanning. Although participants were screened for claustrophobia, it remains 
possible that some women found the MR environment aversive, which may have 
confounded cortisol sampling by increasing baseline cortisol. Increases in baseline 
cortisol could create a ceiling effect with respect to stress reactivity; however, ceiling 
effects have not been reported in other acute stress inductions that have been 
specifically designed for fMRI (e.g., the Montreal Imaging Stress Task; Dedovic et 
al., 2005). Nevertheless, incorporation of a baseline habituation scanning session 
prior to experimental scans (i.e., stress and control scans) might have ameliorated 
confounding effects of the MR environment. The addition of a third MRI scan would 
have significantly increased the overall costs of the study, the participant burden and 
the timeline to completion, yet this would be a potentially useful design for future 
research. Second, due to the length of the fMRI task, blood samples for total cortisol 
were collected at 20-minute intervals upon completion of each manipulation, and this 
sampling protocol might not have captured peak cortisol for some participants. Meta-
analytic findings suggest that plasma and salivary cortisol responses peak 
approximately 30 to 40 minutes post-stressor, and samples are therefore typically 
collected at 10 to 15 minute intervals (Dickerson & Kemeny, 2004). As such, while 
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not possible with our fMRI task, acquiring cortisol samples at 10-minute intervals 
may have increased the likelihood of capturing each participant’s peak cortisol 
response following the stressor.  
 
Finally, had I chosen to exclude women who were prescribed hormonal 
contraceptives and the use of additional cortisol assays, it may have increased the 
interpretability of my stress reactivity data. Although menstrual phase does not 
significantly affect basal salivary cortisol (Boisseau et al., 2013), oral contraceptive 
pills (OCPs) have been shown to blunt both waking (Bouma et al., 2009) and post-
stress salivary cortisol (Kirschbaum et al., 1995; Nielsen et al., 2013; Roche et al., 
2013). When assaying cortisol in saliva, values reflect unbound, or ‘free’, cortisol, 
which comprises approximately 5-10% of total circulating cortisol. At any given time, 
the majority of the glucocorticoid remains bound to either corticotropin-binding 
globulin (CBG or transcortin; 80%) or albumin (10%; Hamrahian et al., 2004). It has 
been proposed that OCPs, particularly those containing an oestrogen compound 
(typically ethinyl oestradiol), reduce the fraction of free salivary cortisol via 
oestrogen-induced increases in CBG (Moore et al., 1978). However, despite blunted 
salivary cortisol responses, Kirschbaum et al. (1999) reported nonsignificant 
differences in plasma cortisol responses to the Trier Social Stress Task in OCP 
users as compared to non-users. Based on these data, and in order to optimise 
recruitment and maximise generalisability of my observations, I elected to include 
women who used OCPs and other hormonal contraceptives (e.g., vaginal ring, 
intrauterine device, implant) in the study.  
 
2.4.3 Complexities related to hormonal contraceptive use and cortisol secretion 
 
Alternative evidence suggests that oestradiol-containing contraceptives increase 
total plasma cortisol levels in a dose-dependent manner (Burke, 1969), which may 
indeed have downstream effects on cortisol reactivity. For example, total plasma 
cortisol concentration over 24 hours is approximately doubled in OCP users when 
compared to non-users (Seidegård et al., 2000). Others report increases in total 
plasma cortisol throughout the 28-day ‘cycle’ of women who use combination 
oestrogen and progestogen OCPs (Durber et al., 1976). Although the physiological 
mechanism underlying increased extracellular cortisol in response to oestradiol is not 
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fully understood, it may reflect the effects of oestrogen on hepatic metabolism 
(Seidegård et al., 2000). Hepatic uptake of cortisol represents the primary 
mechanism of gluconeogenesis, so any alteration in liver enzyme activity could 
feasibly affect circulating cortisol levels, both at baseline and following an acute 
stressor. Additionally, it has been reported that OCP users have reduced excretion of 
cortisol metabolites in urine, where altered cortisol clearance could arise from 
oestradiol-induced increases in CBG (Lucis & Lucis, 1972).  
 
Although documentation of hormonal contraceptive use and quantification of plasma 
sex hormone levels allowed me to statistically control for potential effects of OCPs 
and menstrual phase on outcomes of interest, the design may have been further 
improved. First, the addition of a CBG assay and/or salivary cortisol sampling would 
have enabled estimation of both bound and unbound cortisol responses to a 
psychological stressor. While collection of salivary cortisol samples alongside the 
blood sampling protocol would perhaps have been feasible, most salivary sampling 
protocols require the participant to either passively drool into a vial or chew a cotton 
swab. It is unclear if passive drooling would be possible as an individual lays supine 
in the scanner, and chewing may result in undesirable head motion; however, these 
avenues could be investigated in future work. Second, hormonal contraceptive use 
within the past 8 weeks could have been an exclusion criterion for the study; 
however, as 30% of patient participants and 50% of controls would not have met that 
criterion, this would have significantly slowed recruitment efforts. Moreover, as 
approximately 50% of women of reproductive age (15 – 49 years) in the UK use 
hormonal contraceptives (United Nations, Department of Economic and Social 
Affairs, 2019), the exclusion of these women would introduce ascertainment bias. 
Finally, much of the extant literature on hormonal contraceptives and cortisol has 
focused on combination OCPs, and the effects of other drug delivery modalities 
(e.g., vaginal ring, intrauterine system, contraceptive implant) on plasma cortisol are 
not well understood. Examination of the potential effect(s) of route of administration 
will be critical to understanding how oestradiol-containing medications affect stress 
responses.   
 
In summary, this study protocol enabled within-subject assessment of metabolic, 
neural and behavioural responses to psychological stress, leveraging a highly-
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controlled inpatient setting and a bespoke eating behaviour unit. Chapter 3 presents 
findings of altered metabolic signalling in relation to eating disorder psychopathology 
and stress, whereas Chapters 4 and 5 detail results from the fMRI and proton 
magnetic resonance spectroscopy components of the protocol, respectively.  
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Chapter 3: Dissociable hormonal profiles for psychopathology and stress in 





Anorexia Nervosa (AN) and Bulimia Nervosa (BN) are characterised by abnormal 
eating behaviour, distorted thoughts surrounding food and elevated shape and 
weight concerns. They are serious conditions, afflicting 0.8–3.6% and 1–2.6% of the 
population, respectively (Mustelin et al., 2016; Stice, Nathan Marti, et al., 2013). AN 
is further classified into restrictive (AN-R) and binge-eating and purging (AN-BP) 
subtypes, where the latter resembles BN but with recurrent binge-eating and/or 
compensatory behaviours occurring while underweight (American Psychiatric 
Association, 2013a). Longitudinal studies have shown diagnostic ‘crossover’ from 
AN-BP to BN, but rarely from BN to AN-BP (Eddy et al., 2008, 2016), suggesting that 
these conditions may partly reflect dissociable aetiologies. While dominant models of 
ED development and treatment have emphasised psychological mechanisms, both 
experimental medicine (Misra & Klibanski, 2014) and genome-wide association 
studies (H. J. Watson et al., 2019) have implicated metabolic dysfunction in their 
pathogenesis. Therefore, understanding how peripheral metabolic and endocrine 
signals interact with brain mechanisms to shape the characteristic behaviours and 
psychopathology of EDs remains an important challenge. 
 
There is a growing knowledge of the role of circulating hormones as regulators of 
energy balance (Murphy & Bloom, 2006). Gut hormones and neuropeptides have 
critical effects on eating behaviour, which may be affected by the altered 
macronutrient intake (Van Avesaat et al., 2015) and chronic stress intrinsic to EDs 
(Culbert, Racine, et al., 2016). Indeed, pre-prandial levels of the orexigenic hormone, 
ghrelin, and satiety hormones, PYY and CCK, are increased in AN and to a lesser 
degree in BN (Prince et al., 2009) compared to controls. Moreover, increased fasting 
levels of the anorexigenic neuropeptide, bone-derived neurotrophic factor, and 
decreased 24-hour ghrelin have been reported in AN-BP relative to AN-R (Eddy et 
al., 2015; Germain et al., 2010), though the precise associations with binge-eating 
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are unknown. The normal postprandial decline in ghrelin and rise of the anorexigenic 
peptide, GLP-1, is attenuated in BN (Dossat et al., 2015; Naessen et al., 2011), 
aligning with observations of reduced postprandial PYY in both AN and BN (Prince et 
al., 2009).  
 
Cortisol has been more extensively investigated in EDs, and alterations in both basal 
levels and in reactivity have been reported (reviewed by Culbert et al. (2016)). As 
cortisol secretion follows a diurnal rhythm, basal levels may be estimated from 
saliva, plasma or urine sampling over a 24-hour period or, more commonly, within 
the first hour of waking from sleep. Waking cortisol levels are typically elevated in AN 
and, to a lesser extent, in BN (Culbert, Racine, et al., 2016). The relative 
hypercortisolaemia observed in acute AN may arise from elevated ghrelin and 
corticotropin releasing factor levels that stimulate ACTH release and cortisol 
synthesis (Misra & Klibanski, 2014). Therefore, cortisol upregulation could serve to 
maintain euglycemia in states of malnutrition, but this mechanism would not explain 
hypercortisolaemia in BN, where individuals are not underweight. Intermittent dieting 
may stimulate HPA axis activity in BN, leading to elevated basal cortisol, but another 
possibility is that cortisol alterations relate to recurrent binge-eating (Culbert, Racine, 
et al., 2016).  
 
A key consideration in this regard is stress, which precipitates binge-eating episodes 
in BN (Goldschmidt et al., 2014). Stress may induce binge-eating via HPA axis 
activation; indeed, acute stress has elicited significant increases in cortisol, caloric 
consumption and preference for high-fat/high-sugar foods in lean healthy women 
(Epel et al., 2001; Torres & Nowson, 2007). Stress-induced cortisol responses have 
been positively correlated with food intake in BED (Gluck, Geliebter, & Lorence, 
2004); however, this finding has neither been replicated (Rosenberg et al., 2013) nor 
tested in BN or AN-BP. Moreover, reports of blunted cortisol reactivity to acute stress 
in both BN (Ginty, Phillips, Higgs, Heaney, & Carroll, 2012; Monteleone et al., 2011; 
Pirke, Platte, Laessle, Seidl, & Fichter, 1992) and a mixed sample of AN and BN 
(Het et al., 2015) could suggest divergent associations between stress, cortisol and 
binge-eating across disorders. For example, acute stress may augment ghrelin 
secretion, leading to increased food intake (Morris et al., 2018). Prolonged stress 
elicits ghrelin secretion in rodents (Ochi et al., 2008), and there is mixed evidence of 
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increased plasma cortisol and ghrelin following acute stress in obesity and BED 
(Gluck et al., 2014; Rouach et al., 2007). While acute stress augmented salivary 
ghrelin in a pilot study of BN (Monteleone et al., 2012), salivary total ghrelin may not 
correlate with functionally active acyl ghrelin in plasma, warranting further study.  
 
Although extant research has identified endocrine dysfunction in EDs, the confounds 
arising from low statistical power, unstandardised meals and variable hormone 
assays obfuscate associations with ED psychopathology. Moreover, examination of 
acute changes in psychological state and associations with hormonal markers will be 
central to the identification of physiological mechanisms that sub-serve binge-eating 
disorders. I therefore examined associations between acute, psychological stress 
and subsequent hormonal responses and food consumption in women with AN-BP, 
BN and matched controls. Participants completed remote saliva sampling prior to a 
two-day, inpatient assessment of cognitive function, eating behaviour and endocrine 
responses. The cortisol awakening response (CAR) was assessed on two days and 
related to diagnosis, ED-related psychopathology and anthropometric measures. In 
an experimental manipulation, we related ED status and acute stress to circulating 
cortisol, acylated ghrelin, PYY and GLP-1 levels, as well as ad libitum food 
consumption in a custom-designed, naturalistic environment. I predicted elevated 
plasma ghrelin, cortisol, PYY and GLP-1 in both patient groups relative to controls, 
as well as an increased stress response, indexed as cortisol and ghrelin levels. I 
anticipated that, while ad libitum intake would be reduced in both AN-BP and BN 
compared to controls, intake in these groups would increase following experimentally 
induced stress. Finally, I completed exploratory analyses, examining associations 
between pre-prandial hormones and ad libitum intake. 
 




Eighty-five right-handed, English-speaking women (Mage ± SD = 23.96 ± 3.98y) were 
recruited to the study. All ED participants met the DSM-5 criteria for current AN-BP 
or BN, whereas control participants did not have a lifetime history of 
psychopathology. Exclusion criteria included left handedness, estimated IQ<80, 
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obesity or prior bariatric surgery, MRI contraindications, metabolic or blood 
disorders, lactation and high nicotine dependence. In addition, diagnoses of BED, 
neurodevelopmental disorders, recent (<6 months) substance or alcohol use 
disorder and lifetime serious mental illness were exclusion criteria for ED 
participants. All participants provided written, informed consent prior to participation 




As I provide a detailed overview of the study protocol in Chapter 2, I will summarise 
the primary elements here. Interested volunteers completed a telephone screening 
to determine initial eligibility, and 100 volunteers underwent an outpatient screening 
session, which included: anthropometric measurement, blood and urine sampling 
(for metabolic comorbidity and pregnancy, respectively), cognitive testing and clinical 
assessment. Following the screening, eligible participants (n = 85) were provided 
saliva sampling materials, and they were asked to collect samples 0, 30, 45 and 60 
minutes after waking on two days of their choice. 
 
Participants (n=22 AN-BP, n=33 BN, n=30 HC) returned to Addenbrooke’s hospital 
for the two-day, inpatient study session, which began at either 08.00 or 09.00h. 
Participants’ height and weight were recorded upon admission, and they were 
provided with standardised meals prior to a 6-hour fast and ad libitum meal. On each 
day, participants underwent fMRI scanning, blood sampling and either a stress 
induction or control task during the fasting period, where induction order was 
counterbalanced across participants. The testing schedule was identical on both 
days, and participants were discharged following the ad libitum meal on Day 2. 
 
The ad libitum meal included various sweet (e.g., grapes, biscuits) and savoury (e.g., 
vegetable pasta, chicken goujons) foods that were selected due to their suitability for 
examining food choice behaviour in an ED population (see Table 2.1). Approximately 
4060 kcals were available in the buffet. Prior to the meal, participants were told that 
they would be eating alone in a naturalistic lounge environment for 30 minutes, and 
they could eat as much or as little as they would like. 
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Acute stress induction 
Participants completed either a stress induction or a control task (i.e., neutral 
condition) on each day, which included 48 multiple-choice math problems of 
equivalent difficulty and administration of somatic distractors (i.e., trains of electrical 
shocks to the abdomen). Performance was not evaluated during the control task; 
however, for the stress induction, participants were told that their performance must 
meet the group average in order to be useful. At the same time, correct responses 
during the stress induction were penalised, resulting in a shorter response window 
and therefore poorer performance, and incorrect responses elicited negative 
feedback. Unpredictable sequences of mildly painful electrical stimulation added an 
element of threat uncertainty throughout the induction. Finally, participants reported 
their subjective stress and hunger immediately pre- and post-manipulation (0=Not at 
all, 100=Extremely; see Figure 2.3 for stimulation ratings). The stress induction and 
control task lasted M±SD=7±1 minutes and 9±2 minutes, respectively. 
 
Blood sampling protocol    
An intra-venous cannula was inserted at least 1 hour prior to blood sampling, which 
occurred between approximately 14.00 and 17.30h on both days to control for 
diurnal fluctuations in cortisol. Blood samples were collected approximately 2 
minutes pre- and post-induction, and three additional post-induction samples were 
collected at 20-minute intervals. Plasma cortisol and ghrelin were assessed at all 
timepoints while PYY and GLP-1 were measured at timepoint 5 only.  
 
3.2.3 Hormone assays 
 
Full sample handling procedures for all hormone assays are described in the 
Appendix.  
 
3.2.4 Analytic plan 
 
Cortisol awakening response analysis 
I assessed the CAR using the linear mixed-effects modelling (LMM) package ‘nlme’ 
in R (Pinheiro et al., 2016; R Core Team, 2015), where group, day and time were 
included as fixed effects, and random intercepts for time and day were nested within 
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the random effect of the participant. Within this regression framework, group 
differences were tested using non-orthogonal ‘treatment’ contrasts, in which each 
patient group was compared to the same control group (e.g., ANBP versus HC, BN 
versus HC). It should be noted that the number of possible contrasts in a regression 
model is k – 1, where k represents the number of factor levels, and treatment 
contrasts are well-suited to designs where experimental conditions (in this case, 
diagnostic groups) may show unique deviations from the control condition. This 
framework therefore represents a more theoretically-driven approach than an 
analysis of variance (ANOVA), where evidence of an omnibus difference in group 
means is succeeded by post-hoc comparisons of all factor levels. To account for the 
nonlinear shape of CAR, I also included a quadratic time term in our model. 
Hormonal contraceptive use (i.e., oral, injection, implant) was entered as a binary 
covariate to control for reported effects on salivary cortisol (Boisseau et al., 2013). In 
addition to outlier observations (i.e., values ±3 SDs from the mean per timepoint), 
five observations were excluded due to either contamination or incorrect timing of 
sample acquisition.  
 
Commonality analysis 
Associations between dimensional psychopathology measures and salivary CAR 
were assessed using regression commonality analysis (R package 'yhat'; Nimon, 
Oswald, & Roberts, 2013). This method extends multiple regression by decomposing 
the total variance explained by a given regression model (R2) into unique and shared 
effects of each predictor (Ray-Mukherjee et al., 2014), increasing interpretability of 
beta estimates in instances of high multicollinearity between predictors. I modelled 
five predictors of interest, sum scores from the EDE Questionnaire (Fairburn & 
Beglin, 1994), Beck Depression Inventory-II (Beck et al., 1996), State and Trait 
Anxiety Inventory (Spielberger & Sydeman, 1994), BMI, and total body fat 
percentage, and contraceptive use. Area-under-the-curve estimates with respect to 
ground (AUC) were calculated as summary measures of CAR using ‘MESS’ and 
‘dplyr’ R packages and averaged across days.  
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Acute stress reactivity analyses 
Associations between group, acute stress and plasma cortisol, ghrelin, PYY, GLP-1, 
and food consumption were tested using linear mixed-effects modelling. Fixed 
effects of group and induction condition (stress and neutral) were included in all 
models, and a random intercept for condition was nested within the random effect of 
the participant. As cortisol and ghrelin were measured over time, these models 
included fixed effects (linear and quadratic) and a random intercept for time. A five-
level factor of menstrual phase (amenorrhea (n=9), follicular (n=17), luteal (n=22), 
periovulatory (n=5) and hormonal contraceptive use (n=32)) was included as a 
covariate in the plasma cortisol model. Finally, exploratory correlation analyses 
related pre-prandial hormone levels (i.e., timepoint 5) on stress and neutral days to 
ad libitum consumption, BMI and objective binge-eating (OBE) counts.  
 
One participant declined to provide blood samples, leaving 84 participants for 
analysis. For each assay, haemolysed samples and outlier values were excluded 
from analysis. Assays that demonstrated a log-normal distribution were log-
transformed prior to analysis. To account for statistical tests across five LMMs, 
results were Bonferroni corrected, yielding an alpha threshold of p=.01 (.05/5). 
Results were considered ‘nominally significant’ if corresponding p-values were ≤.05 
but >.01. Correlation analyses were adjusted for multiple comparisons using the 






Participant groups were matched on age and estimated IQ, and BN and HC groups 
were BMI-matched. With the exception of women with AB-BP reporting a higher 
lifetime frequency of AN-R and those with BN reported greater driven exercise on the 
EDE, patient groups did not differ significantly on primary clinical variables (e.g., 
binge-eating and purging episodes, psychiatric comorbidity, medication use; see 
Table 2.2). Use of hormonal contraceptives was lower in both patient groups relative 
to unaffected women, whereas 36% of women with AN-BP reported amenorrhea 
(Table 3.1).   
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Table 3.1. Body composition and menstrual phase by group 
 






Total body fat (%) 22.6 (6.0) 30.7 (6.6) 30.3 (5.7) 
Menstrual phase (%)    
Amenorrhea  36.4 3.0 - 
Hormonal contraceptive 27.3 30.3 53.3 
Follicular 13.6 27.3 16.7 
Luteal 22.7 36.4 16.7 
Periovulatory - 3.0 13.3 
 
 
3.3.2 Salivary cortisol awakening response 
  
Saliva samples were unavailable for two participants, so the final sample included 83 
participants. Salivary cortisol was elevated in AN-BP compared to controls (β=4.08, 
t(79)=2.92, p=.005), but differences between BN and control groups were 
nonsignificant (p=.81; Figure 3.1A&B). The main effect of time (βlinear=40.54, 
t(479)=9.93, p<.001; βquadratic=-38.60, t(479)=-9.45, p<.001) was also significant, 
showing nonlinear increases in cortisol over time that are characteristic of CAR. 
Moreover, a significant group-by-timelinear interaction confirmed greater CAR in AN-
BP relative to controls (β=38.20, t(475)=3.66, p=.0003). Contraceptive use was 
related to reduced salivary cortisol (β=-3.15, t(79)=-2.84, p=.006). Model fit indices 
supported the inclusion of a quadratic term for time (χ2(1)=82.63, p<.0001) and the 




Figure 3.1 Diagnostic and dimensional correlates of salivary cortisol awakening response. A 
& B) Salivary cortisol awakening response (CAR) was augmented in women with AN-BP 
relative to controls across two days of sampling. C) Correlation matrix of commonality analysis 
variables, showing strong correlations between several predictors. D) Commonality R2 
estimates for dimensional predictor combinations explaining the most variance in salivary 
CAR, which was operationalised as area-under-the-curve (AUC) with respect to ground. All 
depicted subsets explained at least 2% of total variance in AUC (R2 = .22). Errors bars depict 
SEM. EDEQ = Eating Disorder Examination Questionnaire, TAI = Trait Anxiety Inventory, BDI-
II = Beck Depression Inventory-II, BMI = body mass index, HCU = hormonal contraceptive 
use. 
 
3.3.3 Associations between psychopathology, anthropometric measures and CAR 
 
Commonality analyses were completed in the 80 participants with AUC estimates for 
both days. Of the six predictors, hormonal contraceptive use and BMI, but not total 
body fat, were negatively associated with salivary cortisol AUC (Table 3.2). In 
addition, I used commonality analysis to partition total variance into that uniquely 
attributable to each predictor and that shared across predictor sets. Hormonal 
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contraceptive use accounted for the most variance in cortisol AUC, as evidenced by 
both its unique effect and its shared effects with other predictors, namely BMI (Figure 
3.1D). Both eating disorder and trait anxiety symptomatology explained unique 
variance in cortisol AUC, but depressive symptoms did not.  
 
Table 3.2. Regression results for psychopathology symptoms predicting salivary 
cortisol awakening response 
 
Predictor (x) R2 R2adj B p-value r Unique Common Total % of 
R2 
Model 1 .22 .16        
Constant   0.00 1.15x10-8      
EDE-Q   0.50 .07 0.36 0.04 -0.01 0.03 13.63 
BDI-II   0.01 .98 0.28 0.00 0.02 0.02 9.09 
TAI   -
0.54 
.07 0.18 0.04 -0.03 0.01 4.54 
BMI   -
0.36 
.03* -0.60 0.05 0.03 0.08 36.36 





.01* -0.68 0.07 0.03 0.10 45.45 
 
Note: r = predictor’s structure coefficient, Unique = predictor’s unique effect; Common = 
summed predictor’s common effects; Total = Unique + Common; % R2 = Total/ R2  
 
3.3.4 Acute stress manipulation check  
 
Compared to the neutral condition, participants reported greater post-induction 
stress (β=41.14, t(84)=11.98, p<.001; Figure 2.2D) and increased negative affect 
(NA) at pre-meal, post-meal and 30 minutes post-meal timepoints (β=1.40, 
t(84)=2.98, p=.004; Figure 2.4) following the stress induction. Math accuracy was 
significantly lower in the stress induction (β=-21.77, t(84)=-15.73, p<.001). While 
both AN-BP (β=9.12, t(82)=6.20, p<.001) and BN (β=8.95, t(82)=6.77, p<.001) 
reported greater NA relative to controls, a group-by-condition interaction was 
nonsignificant (χ2(2)=5.18, p=.08), suggesting that the induction was similarly 
effective across groups.  
 
3.3.5 Associations between acute stress and hormone profiles 
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Plasma cortisol  
Both AN-BP (β=0.23, t(77)=4.72, p<.001) and BN (β=0.20, t(77)=4.97, p<.001) 
groups had increased cortisol (log-transformed) compared to controls (Figure 3.2A). 
Cortisol significantly increased over time (βlinear=0.27, t(624)=2.57, p=.01), and the 
shape of this association was nonlinear (βquadratic=0.34, t(624)=3.20, p=.001). The 
main effects of condition and menstrual phase were nonsignificant (all p’s >.05), 
except for nominally increased cortisol in amenorrhea compared to hormonal 
contraceptive users (β=0.13, t(77)=2.08, p=.04). Finally, a nominally significant 
group-by-condition interaction indicated decreased cortisol reactivity to acute stress 
in BN as compared to controls (β=-0.10, t(81)=-2.23, p=.028). Both quadratic time 
(χ2(1)=10.36, p=.001) and interaction (χ2(2)=6.07, p =.048) terms significantly 
improved model fit indices. 
 
Acyl ghrelin  
Three participants had outlier acyl ghrelin values across multiple timepoints and 
were excluded from analysis. The main effect of condition was nominally significant 
(β=39.90, t(78)=1.99, p=.049), with increased ghrelin following acute stress (Figure 
3.2B). The main effects of group and time were nonsignificant, and the inclusion of a 
quadratic time term did not significantly improve model fit (χ2(1)=3.15, p=.08). A 
significant group-by-condition interaction indicated increased ghrelin levels in AN-BP 
relative to controls following acute stress (β=134.0, t(76)=2.77, p=.007), and the 
interaction term significantly improved model fit indices (χ2(2)=6.50, p=.01).  
 
Peptide tyrosine tyrosine 
Fasting PYY levels (log transformed) were elevated in women with AN-BP (β= 0.08, 
t(80)=3.12, p=.003), but women with BN did not differ significantly from controls 
(p=.64). The main effect of condition was nonsignificant (p=.79). Moreover, a 
significant group-by-condition interaction showed augmented PYY in AN-BP 
compared to controls after stress (β=0.05, t(76)=3.11, p=.003; Figure 3.2C). 









Figure 3.2. Associations between acute psychological stress and metabolic markers. A) 
Change in plasma cortisol relative to baseline by condition. Compared to controls, plasma 
cortisol was increased in both AN-BP (p<.001) and BN (p<.001), yet cortisol reactivity (shown 
here) was nominally reduced following stress in BN relative to controls (p=.028). A group-by-
condition interaction showed augmented functionally active ghrelin (p=.007) (B) and PYY 
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(p=.003) (C) in AN-BP after stress. D) Ad libitum consumption was reduced in AN-BP (p=.005) 
and nominally in BN (p=.016) compared to controls, and stress did not alter consumption. 
Error bars = SEM.  
 
3.3.6 Associations between acute stress and meal consumption 
 
As one participant reported severe nausea prior to the buffet meal and another 
declined initiating the meal on Day 2, I modelled observations from 83 participants. 
AN-BP (β=-373.53, t(77)=-2.90, p=.005; Figure 3.2D) and BN (β=-284.18, t(77)=-
2.47, p=.016) groups consumed fewer kilocalories than controls; however, this effect 
was only nominally significant in BN. The main effect of condition was nonsignificant, 
and the addition of a covariate for menstrual phase did not explain additional 
variance in consumption (χ2(5)=6.26, p=.18). Moreover, the group-by-condition 
interaction term did not significantly improve model fit (χ2(2)=2.60, p=.27). 
 
3.3.7 Exploratory analysis of pre-prandial hormones and eating behaviour 
  
Correlation analyses largely recapitulated LMM results. BMI was negatively 
correlated with OBEs and pre-prandial ghrelin and positively associated with ad 
libitum consumption across both days (Figure 3.3; Appendix Tables 2 & 3). Following 
stress, BMI was also negatively associated with pre-prandial cortisol and PYY.  
 
On the neutral day, momentary negative affect was positively related to pre-prandial 
cortisol; however, this association was nonsignificant following stress, where 
negative affect was only negatively related to BMI. As the neutral day represents an 
individual’s baseline, the observed cortisol-negative affect association might reflect 
longer-term low mood and chronic stress. Indeed, our main analyses identified 
significant main effects of group, where negative affect and plasma cortisol were 
increased in patients compared to controls (see Results sections 3.3.4 and 3.3.5). 
However, while the main effect of condition was related to increased negative affect, 
it was not significantly related to cortisol. This would suggest that cortisol is not 
related to momentary increases in negative affect approximately one hour following 
an acute stressor. Finally, pre-meal cortisol on the neutral day, but not following 





Figure 3.3 Associations between pre-prandial hormones, BMI and eating behaviour across 
neutral and stress conditions. NAFF = pre-meal negative affect. Values represent correlation 
coefficients (Pearson or point-biserial). BNvHC and ANvHC variables represent group contrast 
variables, which are coded as treatment contrasts. PYY, GLP-1 and cortisol values were log-
transformed prior to analysis. Asterisks reflect significant FDR-corrected p-values: * = q<.05, 
** = q<.01, *** = q<.001.  
 
3.3.8 Robustness checks 
 
As visual inspection of the salivary cortisol and ghrelin model residuals indicated 
slight deviations from normality, I conducted a robustness check after excluding 
observations whose residuals were ±2 SD from the mean. Robustness results 




This study examined whether peripheral metabolic markers differentiated patients 
with AN-BP and BN from unaffected women and, critically, whether acute stress 
modulated plasma ghrelin, cortisol, PYY and GLP-1 in these groups. I report three 
key findings. First, salivary CAR was elevated in AN-BP, but not BN, compared to 
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controls. Second, both AN-BP and BN groups had increased plasma cortisol, and a 
condition-by-group interaction indicated nominally reduced cortisol reactivity in BN 
compared to controls. Third, acyl ghrelin and PYY showed elevated acute stress 
responses in the AN-BP group, whereas responses in the BN group did not 
significantly differ from controls. Finally, both patient groups consumed less than 
controls in a naturalistic, ad libitum meal, and consumption was unchanged following 
acute stress. 
 
Our findings extend previous reports of elevated waking cortisol in mixed samples of 
AN-R and AN-BP (Monteleone et al., 2016; Monteleone, Scognamiglio, Monteleone, 
Perillo, & Maj, 2014), by demonstrating this effect in an AN-BP group. To identify 
potential sources of this variation, I examined relative influences of dimensional 
psychopathology scores and anthropometric features on CAR in the full sample. Of 
our variables of interest, BMI explained the most variability (36%) in CAR, which 
might suggest that the observed differences in AN-BP largely reflect low body mass 
as opposed to binge-eating and purging per se. Indeed, examination of acutely ill 
and weight-restored AN has indicated that CAR augmentation is specific to low-BMI 
states (Monteleone et al., 2016), and this may explain the absence of CAR 
alterations in BN in both the present study and previous research (Monteleone et al., 
2014). 
 
Both ED groups had increased total cortisol relative to controls, yet reduced cortisol 
reactivity following acute stress was only found in BN. As such, despite normative 
CAR, individuals with BN exhibited alterations in other indicators of HPA axis activity, 
namely elevated basal activation and blunted reactivity (Het et al., 2015; Pirke et al., 
1992). Aberrant cortisol reactivity has been reported in various mental illnesses 
(Zorn et al., 2017); however, as our BN finding was nonsignificant at a corrected 
alpha threshold, interpretations should be made cautiously. I observed a weak, 
positive association between neutral day, pre-prandial cortisol and OBEs, but the 
correlation was nonsignificant following stress. Taken together, results could suggest 
that stress-induced cortisol decreases relate to binge-eating in BN, but future efforts 
should test this hypothesis directly.  
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I observed elevated PYY in AN-BP, extending similar observations in AN-R 
(Nakahara et al., 2007; Utz et al., 2008) and purging disorder (Keel et al., 2018), and 
strikingly, acute stress increased both the hunger hormone, acyl ghrelin, and the 
satiety hormone, PYY, in AN-BP compared to controls. The elevation of both hunger 
and satiety peptides suggests a significant dysregulation of peripheral hunger and 
satiety signalling in AN-BP. This may relate to difficulties in sensing hunger and 
internal energy state that occur in AN (Holsen et al., 2012). Critically, the poor 
precision of these vital, bottom-up signals may increase the contribution of top-down, 
cognitive control of food intake, making individuals vulnerable to abnormal intake 
(i.e., restriction, binge-eating) under stress.  
 
The stress-induced ghrelin and PYY increases could reflect the altered sympathetic 
nervous system activity intrinsic to the stress response (Stengel & Taché, 2009). For 
example, preclinical research has shown that adrenaline, noradrenaline and direct 
stimulation of sympathetic nerves in the gut augment ghrelin secretion in rodents (de 
la Cour et al., 2007; Mundinger et al., 2006). While PYY release from L cells in the 
ileum and colon is largely mediated by nutrient sensing (Onaga et al., 2002), 
catecholamines also induce PYY secretion via activation of L cell beta-
adrenoreceptors (Brechet et al., 2001). Both gastric ghrelin and enteroendocrine L 
cells are enriched for several G protein-coupled receptors, including the 
melanocortion-4 receptor (MC4R), whose activation stimulates ghrelin (Engelstoft et 
al., 2013) and PYY secretion (H. M. Cox et al., 2010; Panaro et al., 2014). Although 
an endogenous ligand capable of activating MC4R in gastric ghrelin or L cells has 
not been identified, the most prevalent circulating melanocortin, ACTH, is one 
candidate. Acute stress stimulates ACTH release from the pituitary, which could 
theoretically activate gastric ghrelin and L cell MC4R to induce ghrelin and PYY 
release. However, our finding of significant alterations in AN-BP and not BN 
suggests that this may only occur in underweight, where HPA axis activity is 
significantly perturbed at baseline.  
 
Despite notable strengths in our rigorous, inpatient design, several limitations should 
be considered. First, due to the nature of AN-BP and BN, pre-fast energy intake 
could not be strictly controlled to the same degree as in controls. Permitting this was 
crucial for many patient participants for whom enforced consumption is extremely 
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distressing, and many requested reassurance on this prior to participation. Moreover, 
in recruiting a representative sample of ED participants, a majority had comorbid 
psychopathology and many used prescribed medication as expected. The effects of 
these factors on metabolic-signalling in AN-BP and BN are unknown. Additionally, 
participants self-reported waking time for CAR sampling; however, future studies 
should incorporate objective monitoring methods (Stalder et al., 2016). Acute stress 
responses may be influenced by hormonal contraceptive use, which although 
accounted for statistically, could have impacted cortisol reactivity (Roche et al., 
2013). Finally, despite our naturalistic setting, laboratory eating behaviour likely 
differs from that in daily life, and integration of metabolic profiling with real-world, 
experience sampling of eating patterns is warranted.  
 
Our results support previous suggestions of distinct physiological profiles in AN and 
BN despite similar psychopathology symptoms (Kaye et al., 1990), for the first time 
identifying differing hormonal responses to psychological stress in AN-BP and BN 
compared to unaffected women. Individuals with BN demonstrate normative gut 
hormone profiles at baseline and following stress; however, there is some evidence 
of reduced cortisol reactivity to stress. In contrast, AN-BP can be conceptualised as 
a state of extreme stress, in which chronic malnutrition elicits profound metabolic 
changes to maintain homeostasis. This would account for markedly elevated CAR 
and high cortisol levels irrespective of experimental stress induction. I suggest that, 
in the context of chronic metabolic dysfunction, acute stress exacerbates the broader 
‘physiological alarm’ system in AN-BP, which may contribute to the maintenance of 
abnormal eating by impaired interoceptive signalling. Our findings illustrate potential 
mechanisms that link psychopathology to metabolic signalling, lending important 
insights into the aetiology of eating disorders.
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Chapter 4: Prefrontal responses during proactive and reactive inhibition are 
differentially impacted by stress in anorexia and bulimia nervosa 
 
 
4.1  Introduction 
 
Anorexia Nervosa (AN) and Bulimia Nervosa (BN) are complex psychiatric 
conditions marked by abnormal eating behaviour and distorted thoughts surrounding 
food, eating and body perception. They share cardinal symptoms, including recurrent 
binge-eating and compensatory behaviours (e.g., vomiting, laxative use), which 
occur in both BN and the binge-eating and purging subtype of AN (AN-BP; 1). Binge-
eating engenders substantial distress, and it is associated with significant impairment 
and comorbidity (Foulon et al., 2007; Udo & Grilo, 2019). Although this syndrome 
has been related to aberrant reward and self-regulatory processing (Berner & Marsh, 
2014; Frank et al., 2011; Schienle et al., 2009), its pathophysiological correlates 
remain poorly characterised, particularly in the severely understudied condition, AN-
BP. As binge-eating has been predominantly studied in BN and binge-eating 
disorder, it remains unclear if models of binge-eating based on these conditions 
generalise to AN-BP, where individuals endure significant weight loss. 
 
An influential model of binge-eating posits that it emerges in response to negative 
affective states, which reduce an individual’s capacity for self-control, thereby 
leading to loss-of-control eating (Heatherton & Baumeister, 1991). While elevated 
trait impulsivity in BN (Fischer et al., 2008) and, to a lesser extent AN-BP (Hoffman 
et al., 2012), lends some support to this model, experimental studies of self-
regulation are more equivocal due to inconsistencies across neural and behavioural 
findings. For example, fMRI studies of adolescent (Marsh et al., 2011) and adult 
(Marsh et al., 2009; Skunde et al., 2016) BN report reduced fronto-striatal activity 
during conflict and action inhibition trials on Simon Spatial and Go/NoGo tasks, 
respectively, yet behavioural impairments were only observed on the Simon Spatial 
task in adult BN. Similarly, adolescents with mixed binge-purge pathology have 
shown increased bilateral hypothalamic, precentral gyrus and right dlPFC, ACC and 
middle temporal gyrus activity relative to controls (Lock et al., 2011) during intact 
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Go/NoGo performance. Altered brain activity in the absence of behavioural 
impairment could indicate either inefficient or compensatory neural responses to 
preserve task performance. Interestingly, despite nonsignificant differences in stop-
signal performance at baseline, augmented medial prefrontal and ACC activity on 
failed stop-signal trials predicted the onset of ED behaviours at two-year, longitudinal 
follow-up (Bartholdy et al., 2019). 
 
Inconsistencies across levels of analysis and cognitive tasks could partly reflect 
heterogeneity within the theoretical construct of ‘self-control.’ Behavioural (Caswell et 
al., 2015; MacKillop et al., 2016; Whiteside & Lynam, 2001) and neurobiological data 
support related but dissociable forms of impulsivity, including 'temporal impulsivity’, 
relating to the delayed receipt of reward, and ‘response inhibition’, or ‘inhibitory 
control’, which is the capacity to slow or stop a response tendency (Dalley et al., 
2011). Moreover, theoretical frameworks suggest that inhibitory control is modulated 
by both proactive and reactive processes (Aron, 2011; Fletcher, 2011). ‘Proactive 
inhibition’ describes a goal-directed process, elicited by predictive cues, which is 
used to restrain actions in preparation for stopping. In contrast, 'reactive inhibition’ is 
a stimulus-driven process, where a salient signal triggers action cancellation. These 
inhibitory modes have both shared and unique neural correlates (Chikazoe et al., 
2009). Bilateral frontoparietal and basal ganglia regions form a broad inhibitory 
control network that subserves both processes, but bilateral superior parietal and 
right-dominant, frontal, temporal and parietal regions have been uniquely related to 
proactive and reactive inhibition, respectively (van Belle et al., 2014; Zandbelt et al., 
2013). As such, the neural and behavioural distinctions between proactive and 
reactive inhibition should be considered when attempting to identify the specific self-
regulatory impairment(s) associated with binge-eating disorders. 
 
In addition to examining specific self-regulatory deficits in AN-BP and BN, efforts to 
validate the model must also consider the impact of negative mood states on this 
process. While experience sampling has shown that momentary increases in stress 
and negative affect precede binge-eating and purging in BN (Berg et al., 2013; 
Smyth et al., 2007) and AN (Culbert, Lavender, et al., 2016), it is unknown if   
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inhibitory control mediates this association. Acute stress has increased preference 
for palatable foods among dieters, which co-occurred with augmented fronto-limbic-
striatal functional connectivity and reduced connectivity between the vmPFC and 
dlPFC (Maier et al., 2015). Thus, acute stress may impair goal-directed, prefrontal 
control and instead evoke habitual responding to food. Indeed, a pilot study of BN 
reported stress-induced decreases in bilateral precuneus, ACC and dlPFC 
responses to palatable food cues, which moderated the association between stress 
and binge-eating in daily life (Fischer et al., 2017).  
 
Taken together, there is some evidence of fronto-striatal deficits in BN during self-
regulatory tasks; however, the precise inhibitory control deficits that subserve binge-
eating have not been characterised. Moreover, acute, psychological stress may 
potentiate binge-eating via impaired inhibitory control, yet the impact of stress on 
neural and behavioural correlates of inhibitory control is unknown. I therefore 
conducted the first examination of the effect of acute stress on two key inhibitory 
modes—proactive and reactive inhibition—in women with AN-BP, BN and unaffected 
controls. Participants attended a two-day, inpatient study session, in which they 
completed repeated fMRI scanning under neutral and stressful conditions. Patient 
groups were expected to have reactive inhibition inefficiencies at baseline, which 
would be exacerbated by acute stress and related to reduced inferior frontal and 
striatal activity. I predicted baseline proactive inhibition to be reduced in BN but 
augmented in AN-BP compared to controls, aligning with AN-R (Bartholdy, Rennalls, 
Jacques, et al., 2017). However, I anticipated that both groups would show stress-
induced proactive inhibition impairments and correspondingly altered frontoparietal 
activity. Finally, I conducted exploratory analyses to relate neural and behavioural 
correlates of inhibitory control to laboratory-based eating behaviour.  
 
4.2 Participants and Methods 
 
4.2.1 Participants  
 
Eighty-five women (M±SD = 23.96±3.98y) were recruited to three participant groups, 
AN-BP, BN and HC, that were matched on age and estimated IQ. Eligible volunteers 
were aged 18 to 40 years, English-speaking, had normal or corrected-to-normal 
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vision and, for patient groups, met DSM-5 diagnostic criteria for either AN-BP or BN. 
Healthy controls with a lifetime psychiatric disorder were ineligible. Patient volunteers 
with binge-eating disorder, neurodevelopmental disorders, lifetime serious mental 
illness, and/or substance or alcohol use disorders (SUDs) in the past 6 months were 
excluded. Full exclusion criteria are described in Chapter 2. The study was approved 
by the Cambridge East Research Ethics Committee (Ref. 17/EE/0304), and all 
participants provided signed, informed consent. All procedures were performed in 
accordance with local regulations. 
 
4.2.2 Study design 
 
Participants underwent the same study procedure as described in Chapter 2. Briefly, 
eligible volunteers completed an initial screening session, where they provided 
informed consent prior to blood sampling and administration of the Eating Disorder 
Examination (Cooper & Fairburn, 1987) and Structured Clinical Interview for DSM-5 
(First et al., 2015). Fifteen volunteers were excluded following the screening, leaving 
85 women (n=22 AN-BP, n=33 BN, n=30 HC) for the two-day, overnight study 
session. Study sessions began at either 08.00 or 09.00h, and participants’ height 
and weight were measured prior to a standardised breakfast. Participants then 
completed a questionnaire and cognitive task battery, and they were offered a mid-
morning snack before a 6-hour fast. A cannula was placed approximately 1 hour 
prior to MRI scanning on Day 1, and blood samples for cortisol and gut hormones 
were acquired at fixed timepoints (see Figure 2.2). Participants began MRI scanning 
between 13.30 and 14.30h to control for diurnal fluctuations in cortisol. While 
scanning, participants performed the stop-signal anticipation task (SSAT; Zandbelt & 
Vink, 2010) twice, immediately pre- and post-manipulation, and manipulation order 
(stress vs. neutral) was counterbalanced across participants. Then, participants had 
an unsupervised ad libitum meal, and those who did not meet their estimated energy 
requirements were offered an evening snack. The study protocol was identical on 
Day 2, and participants were discharged following the meal. 
 
4.2.3 Stop-signal anticipation task 
 
The SSAT measures both proactive (i.e., anticipation of stopping) and reactive 
(outright stopping) inhibition. The task and procedure have been described 
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previously (Zandbelt & Vink, 2010), and an overview is included in Chapter 2, as well 
as in Figure 2.3. Code may be retrieved from: 
https://github.com/bramzandbelt/SSAT.  
 
4.2.4 Stress induction 
 
On each day, participants completed either an acute, psychological stress induction 
or a control task (i.e., neutral condition) to enable within-subject assessment of 
stress responses. Details of the task structure have been described elsewhere 
(https://github.com/mwestwater/STRIvE-ED; Chapter 2). Participants completed 48 
multiple-choice, mental math problems of varying difficulty in each condition; 
however, in the stress induction, participants were motivated to respond accurately 
whereas performance was not evaluated during the control task. Moreover, incorrect 
responses elicited negative feedback (e.g., “Your performance is below average.”) in 
the stress task, and uncontrollability, a central aspect of psychological stress, was 
engendered through the delivery of mild electrical stimulation to the abdomen at 
variable frequencies and intensities. Importantly, subjective ratings of stimulation 
intensity, unpleasantness and pain did not differ significantly across groups, 
indicating that abdominal stimulation was suitable for ED participants (see Chapter 2 
and Figure 2.3). Subjective stress ratings were collected immediately pre- and post-
induction.  
 
4.2.5 Image acquisition 
 
MR images were acquired on a 3T Siemens SkyraFit scanner (Erlangen, Germany) 
fitted with a 32-channel, GRAPPA parallel-imaging head coil. MR sequences are 
described in Chapter 2. One participant was excluded for an incidental finding of 
white matter abnormalities, and this participant received clinical follow-up.  
 
4.2.6 Data analysis – SSAT performance 
 
I assessed proactive inhibition by examining the effect of stop-signal probability on 
response time (RT), where participants tend to slow responding as the likelihood of 
having to stop increases (Verbruggen & Logan, 2009a; Vink et al., 2005, 2006; 
Zandbelt & Vink, 2010). Impaired proactive inhibition would be evident in a failure to 
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increase RT when stop-signal probability increases, as this would suggest weaker 
anticipation of stopping. Reactive inhibition was indexed as stop-signal reaction time 
(SSRT), which represents the latency of the inhibition process. SSRT was computed 
using the integration method (Verbruggen & Logan, 2009b) across all stop-signal 
probability levels with go omission replacement (Verbruggen et al., 2019). Slower 
SSRTs would reflect greater latency of the inhibitory process and therefore impaired 
reactive inhibition.    
 
Behavioural data were analysed in R (R Core Team, 2015). Aligning with previous 
reports (Zandbelt et al., 2011; Zandbelt & Vink, 2010), go-signal RTs that were more 
than 1.5 times the interquartile range below the 25th percentile or above the 75th 
percentile of the RT distribution at each probability level, as well as on failed stop-
signal trials, were defined as outliers. To minimise positive skew, a rank based 
inverse normal transformation was applied to RTs (R package RNOmni; McCaw, 
2019) prior to analysis. Analyses of proactive inhibition (trial RT) and reactive 
inhibition (SSRT) were conducted using the linear mixed-effects modelling (LMM) R 
package nlme (Pinheiro et al., 2016), where fixed effects of group, condition and time 
were included in both models, with random intercepts for within-subject variables 
nested within the subject’s random effect. Group differences were tested via non-
orthogonal planned contrasts, comparing AN-BP and BN to controls. Additionally, 
fixed and random effects for probability level (linear and quadratic terms) were 
included in the proactive inhibition LMM. Normality of the model residuals was 
determined by visual inspection of quantile-quantile plots.  
 
4.2.7 Data analysis – fMRI 
 
Image data were pre-processed and analysed using FreeSurfer (v6.0; Dale et al., 
1999; Fischl et al., 1999) and AFNI software (R. W. Cox, 1996). Pre-processing 
steps were completed with the afni_proc.py python script with 6mm spatial 
smoothing. Within the preprocessing pipeline, anatomical scans were first co-
registered with a linear transformation (AFNI program 3dAllineate) and averaged 
across days via 3dMean. The averaged structural image was then processed with 
the standard FreeSurfer recon-all pipeline. The resulting white matter and ventricle 
segmentations were resampled to 3mm isotropic resolution and eroded by 1 voxel 
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along each axis. Remaining pre-processing steps were completed with the 
afni_proc.py python script, in which functional images were slice-time corrected, re-
aligned to the minimum outlier functional volume, co-registered to the subject’s skull-
stripped averaged anatomical image, nonlinearly warped to the MNI152_T1_2009c 
template and smoothed using a 6mm full-width at half-maximum (FWHM) kernel. 
The first three principle components from the time series of lateral, third and fourth 
ventricle sources were estimated and regressed from functional volumes, along with 
six head motion parameters and their first-order derivatives. Local white matter was 
regressed from functional volumes using the fast ANATICOR pipeline (Jo et al., 
2010). Functional volumes with a Euclidean norm motion derivative >0.5mm were 
censored, and participants with >10% of volumes censored were excluded from 
group-level analysis.  
 
Functional MRI data from pre-stress, post-stress, pre-neutral and post-neutral 
sessions were available from n=84, n=79, n=80 and n=81 participants, respectively. 
One participant was excluded from analysis due to white matter abnormalities. In 
addition, 5 post-stress, 4 pre-neutral and 2 post-neutral runs were excluded because 
of excessive head motion. A technical error resulted in the exclusion of one 
additional post-neutral session. During a pre-neutral session, EPI acquisition had to 
be stopped due to a technical error; however, as ~70% of functional volumes had 
been acquired for this participant, their pre-neutral run was included in the group-
level analysis.  
 
Statistical analysis followed a two-level procedure, where successful stop-signal 
trials, failed stop-signal trials, go-signal trials with non-0% stop-signal probability 
were modelled as regressors of interest in the first-level general linear models. In line 
with previous work (Zandbelt et al., 2011; Zandbelt & Vink, 2010), I included two 
amplitude modulators, RT and stop-signal probability level, for go-signal trials. AFNI 
models one regressor for the constant magnitude of the blood oxygenation-
dependent (BOLD) response and separate regressors for each amplitude per time 
point unlike other packages that partition the variance of regressors sequentially. 
However, as RT (a measure of the tendency to withhold a response) and stop-signal 
probability contrasts may provide complementary information, both were used as 
measures of proactive inhibition. In addition, incorrect go-signal trials and rest blocks 
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were included as nuisance regressors; go-signal trials with a stop-signal probability 
of 0% were not modelled, thus constituting an implicit baseline. Regressors were 
created by convolving gamma functions coding for response onset (or stop-signal 
delay for successful stop-signal trials) with a canonical haemodynamic response 
function. Within each subject run, I computed four contrast images: 1) the parametric 
effect of RT on go-signal activation (proactive inhibition), 2) the parametric effect of 
stop-signal probability on go-signal activation (proactive inhibition), 3) successful 
stop versus failed stop-signal trials (reactive inhibition) and 4) successful stop versus 
go-signal trials with 0% stop-signal probability (reactive inhibition). I generated two 
contrasts for reactive inhibition as there is no consensus on which contrast is most 
appropriate when investigating this inhibitory mode. Beta estimates were determined 
using restricted maximum likelihood estimation.  
 
I conducted two group analyses for each contrast. First, I examined associations 
between diagnostic group, condition (stress vs. neutral), time (pre vs. post) and their 
interaction and the BOLD response in seven predefined regions of interest (ROIs). 
ROIs selection was based on findings from previous fMRI studies of the SSAT 
(Zandbelt et al., 2011; Zandbelt & Vink, 2010), proactive and reactive inhibitory 
control networks (van Belle et al., 2014), and NeuroSynth (https://neurosynth.org) 
clusters associated with “stop signal” and “response inhibition” terms (Figure 4.3A). 
Anatomical ROIs were defined using the Brainnetome atlas (Fan et al., 2016), and 
average ROI beta estimates were extracted for each subject using 3dmaskave. For 
each ROI, main and interaction effects were tested in a LMM, and random intercepts 
for condition and time were included within the random effect of the individual. As 
seven ROIs were tested per contrast, the alpha threshold was reduced to 
p=.05/7=.007.  
 
Next, I examined whether a three-way interaction between group, time and condition 
related to differences in whole-brain activation. Whole brain analyses were 
completed using the linear-mixed effects modelling AFNI program, 3dLME (G. Chen 
et al., 2013), where general linear tests were implemented to test a priori contrasts of 
interest, including AN>HC, BN>HC, stress>neutral, post>pre and the three-way 
interaction (e.g., AN>HC*stress>neutral*post>pre). As the model tested a three-way 
interaction (AN>HC*stress>neutral*post>pre), lower-order interaction and main 
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effects were also included. Both F- and Z-statistics are reported for each effect. 
Resulting group-level statistical maps were tested for significance using cluster-level 
inference (cluster-defining threshold of p<.001, k=18.8, cluster probability of p<.05, 
family wise error-corrected). Updated versions of 3dFWHMx and 3dClustSim were 
used to correct for multiple comparisons, as these programs incorporate a mixed 
autocorrelation function to model non-Gaussian noise structure and reduce false-
positive rates (R.W. Cox et al., 2017; Eklund et al., 2016). For visualization, the 
mean percent signal change was extracted from significant whole-brain clusters 
using 3Dmaskave.  
 
4.2.8 Exploratory analysis of inhibitory control and ad libitum consumption 
 
LMMs were used to test whether impulsivity measures (SSRT, Barratt Impulsiveness 
scores (BIS-11; 48), brain regions implicated in the fMRI analyses) explained 
variance in subsequent food intake (kilocalories; Z-scored). Brain regions 
demonstrating differing neural responses between groups (e.g., left premotor cortex, 
right IFG, left SFG), or in a group-by-condition-by-time interaction (right SFG, right 
vmPFC), were included in these analyses. As described in Chapter 3, one participant 
declined to initiate the ad libitum meal on Day 2, and another reported severe 
nausea prior to the meal, so I modelled observations from 83 participants for these 
exploratory analyses. For consistency, SSRT and neural responses were modelled 
from post-manipulation runs only.  
 
Each model included fixed effects of group, condition and impulsivity measure, 
where random intercepts for within-subject variables were included within the 
subject’s random effect. Models of SSRT and brain responses also included a 
person-centred random slope for these variables. Group differences were assessed 
via non-orthogonal ‘treatment’ contrasts that compared each patient group to 
controls, and interactions between group, condition and impulsivity measure were 
also tested. Exploratory results were considered statistically significant at p=.05. 
 
4.3 Results  
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As previously reported in Chapter 2, both subjective stress and negative affect were 
significantly increased following the stress induction relative to the control condition 
(Figure 2.2). Moreover, a group-by-condition interaction identified stress-induced 
plasma cortisol decreases in BN, but not AN-BP, compared to controls (Westwater et 
al., 2020). 
 
Reduced proactive inhibition in bulimia nervosa  
 
I anticipated that proactive inhibition would be impaired in BN and augmented in AN-
BP while stress-induced impairments would be observed in both groups. RT 
increased with greater stop-signal probability (β=0.01, t(1019)=13.08, p<.0001); 
however, this effect was nonlinear, as a significant quadratic probability term 
suggested that RT slowing plateaued with increasing stop-signal probability (β=-
5.07, t(57919)=-5.28, p<.0001). RT on non-0% go-signal trials was significantly 
decreased post-manipulation (i.e., at time 2; β=-0.14, t(169)=-8.49, p<.0001), which 
is consistent with the expected practice effects on each day. Moreover, a significant 
group-by-probability interaction indicated poorer proactive inhibition in the BN group 
relative to controls (β=-6.54, t(1012)=-2.97, p=.003; Figure 4.4A), where women with 
BN demonstrated a smaller increase in RT relative to increasing stop-signal 
probability. The addition of higher-order interaction terms did not significantly 
improve model fit (χ2(13)=16.11, p=.19), indicating that proactive inhibition was not 
significantly affected by acute stress. RT on 0% stop-signal probability trials did not 
differ between AN (p=.37) or BN (p=.96) and control participants, indicating 
equivalent performance on the baseline response task (Table 4.1). 
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Table 4.1. SSAT performance metrics by group and condition 
 
  Neutral Stress 
  Pre Post Pre Post 
Measure Group M ± 95% CI M ± 95% CI M ± 95% CI M ± 95% CI 
SSRT (ms) AN 273 ± 5 269 ± 7 278 ± 5 268 ± 5 
 BN 271 ± 5 268 ± 5 270 ± 5 270 ± 5 
 HC 270 ± 6 268 ± 4 271 ± 5 267 ± 4 
Go Trial 0% AN 814.4 ± 1.1 808.7 ± 1.1 818.5 ± 1.2 813.2 ± 1.1 
(ms) BN 820.7 ± 1.0  815.0 ± 0.9  821.0 ± 1.0 816.7 ± 0.9 
 HC 823.6 ± 1.1 817.7 ± 1.0 818.9 ± 1.1  814.4 ± 1.0 
  M (SD) M (SD) M (SD) M (SD) 
Stop 
accuracy  
AN 58.7 (4.1) 57.7 (4.7) 58.6 (4.2) 58.8 (3.7) 
 (%) BN 60.2 (5.2) 59.3 (6.0) 60.1 (5.2) 58.6 (4.2) 
 HC 59.5 (4.7) 59.1 (5.4) 57.5 (5.1) 57.7 (4.7) 
Accuracy  AN 98.3 (3.8) 99.1 (0.9) 98.0 (1.9) 99.2 (0.9) 
(%) BN 98.7 (1.3) 98.9 (1.9) 97.4 (5.7) 99.4 (0.7) 
 HC 98.0 (3.3) 99.3 (0.9) 98.4 (1.7) 99.3 (0.9) 
 
Note: ‘Accuracy’ represents the percentage of go-signal trials on which participants made a 
response.   
 
No effect of patient group or stress on reactive inhibition  
 
I predicted that both AN-BP and BN groups would demonstrate impaired reactive 
inhibition relative to controls following the acute stress induction. The significant main 
effect of time indicated that SSRT was reduced post-manipulation (β=-3.29, t(166)=-
3.23, p=.002). However, all other main and interaction effects on SSRT were 
nonsignificant (all p’s>.05; Table 4.1). Data met the assumptions of the race model, 
as evidenced by faster RTs on failed stop-signal trials compared to go-signal trials 
where stop-signals could occur (β=-21.5, t(339)=-39.4, p<.0001).  
 
4.3.2 Functional MRI analysis of group, stress and interaction effects on brain responses 
during proactive inhibition  
 
Examination of the parametric effects of stop-signal probability and RT identified 
increased neural responses across frontoparietal regions that comprise the proactive 
inhibition network (Tables 4.2-4.3, Figure 4.1), indicating successful experimental 





Figure 4.1 Whole-brain activation in anorexia nervosa, bulimia nervosa and controls during 
proactive inhibition. Two-sample t-tests of A) the parametric effect of stop-signal probability 
versus the implicit baseline (i.e., Go0% trials) and B) the parametric effect of reaction time 
versus the implicit baseline activation for AN-BP, BN and control groups. Maps represent 
significant clusters (cluster-defining p-value < .001, FWE cluster probability p-value < .05) and 
are presented in neurological orientation (L=left). 
 
Table 4.2 Whole-brain fMRI responses to stop-signal probability by group 
 
 
Note: Clusters were defined at a cluster-defining threshold of p < .001 and FWE-corrected at 
p < .05 (kE = 18.8 voxels). MNI coordinates represent the peak voxel within each cluster. 
 






   X Y Z   
AN R Inferior occipital gyrus 34 -81 -6 511 7.25 
 L Inferior occipital gyrus -35 -96 -6 461 7.13 
 R Middle insula 40 15 6 174 6.03 
 L Supramarginal gyrus -62 -30 45 109 5.03 
 R Superior occipital gyrus 22 -78 45 71 4.58 
 R Precentral gyrus 52 9 33 69 4.53 
 R Supramarginal gyrus 61 -33 51 39 4.54 
 L Middle insula -35 18 12 27 4.88 
 R Cerebellar vermis 4 -72 -9 24 4.06 
 L Middle frontal gyrus -26 -3 60 21 4.39 
BN L Inferior occipital gyrus -35 -99 -9 365 6.78 
 R Inferior occipital gyrus 34 -93 -6 380 8.01 
 L Postcentral gyrus -20 -45 75 19 -4.13 
HC L Fusiform gyrus -35 -78 -9 639 7.77 
 R Inferior occipital gyrus 31 -90 -6 441 9.28 
 R Intraparietal sulcus 31 -78 45 94 4.61 
 R Precentral gyrus 46 9 33 60 5.08 
 L Rostral middle frontal gyrus -20 57 36 52 -4.35 
 L Inferior frontal gyrus (pars 
orbitalis) 
-44 27 -9 51 -5.32 
 L Middle frontal gyrus  -44 24 51 45 -4.58 
 R Postcentral gyrus 61 -24 39 31 5.17 
 L Supramarginal gyrus -62 -30 39 28 4.35 
 R SMA 4 6 60 24 4.96 
 L Superior frontal gyrus -5 42 57 23 -4.17 
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Table 4.3 Whole-brain fMRI responses to reaction time amplitude modulator by 
group 
 






   X Y Z   
AN  L Primary motor cortex -41 -27 60 1846 7.80 
 R Inferior occipital gyrus 34 -93 3 561 6.97 
 R Superior parietal lobule 16 -60 72 352 6.26 
 R SMA 1 -9 57 336 7.84 
 R Cerebellar vermis 4 -72 -30  300 6.20 
 R Superior frontal gyrus 25 -12 69 170 7.11 
 L Anterior cingulate 
cortex 
-14 42 12 157 -4.98 
 L Calcarine sulcus -14 -81 15 142 5.34 
 R Supramarginal gyrus 67 -33 33 108 4.87 
 L Middle cingulate cortex -2 -39 45 108 -4.86 
 L Angular gyrus -44 -72 57 50 -4.39 
 L Supramarginal gyrus -50 -30 21 41 5.00 
 L Thalamus (prefrontal) -14 -24 12 30 4.54 
 L Middle frontal gyrus -38 6 63 29 -4.28 
 R Frontal opercular 49 0 12 24 4.57 
 R Cerebellar cortex 16 -96 -30 19 -4.98 
 R Caudate nucleus 7 6 0 19 -3.90 
BN L Precuneus -11 -66 69 1688 8.65 
 R Precuneus 10 -60 72 818 8.74 
 L SMA -2 -6 60 382 7.50 
 R Medial frontal gyrus 7 30 -9 224 -5.37 
 R Cerebellar cortex 19 -63 -18 222 4.97 
 R Middle temporal gyrus 52 -66 25 199 4.93 
 R Superior frontal gyrus 28 -9 72 184 5.86 
 L Middle occipital gyrus -41 -81 45 172 -5.14 
 R Supramarginal gyrus 61 -36 45 147 4.70 
 L Caudate nucleus -5 6 3 126 -5.54 
 L Inferior frontal gyrus 
(pars orbitalis) 
-53 24 0 111 -4.82 
 L Superior frontal gyrus -11 57 42 85 -4.51 
 L Middle occipital gyrus -50 -87 6 75 5.00 
 L Middle cingulate cortex -5 -42 45 73 -5.04 
 L Middle frontal gyrus -23 18 57 71 -4.86 
 R Cerebellar cortex 46 -75 -30 67 -6.59 
 L Lingual gyrus -23 -96 -9 64 4.80 
 L Cerebellar cortex -35 -48 -27 62 5.09 
 R Cerebellar cortex 10 -87 -21 54 -5.03 
 L Cuneus -20 -78 9 34 4.88 
 L Parieto-occipital sulcus -11 -60 21 30 -5.04 
 L Superior frontal gyrus -23 57 9 29 -4.56 
 L Orbitofrontal cortex -26 21 -15 27 -4.74 
 L Rostral middle frontal -56 18 36 24 -4.66 
 L Caudal middle frontal -41 12 39 21 -4.68 
 L Inferior temporal gyrus -56 -51 -9 20 -5.34 
HC L Precentral gyrus -30 -7 66 2854 9.21 
 R Precuneus 7 -63 72 1601 8.43 
 R Cerebellar vermis (VII) 4 -78 -27 471 6.75 
 R Anterior cingulate 
cortex 
4 36 6 191 -5.56 
 L Middle occipital gyrus -38 -93 0 130 4.66 
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 L Cerebellar vermis (VI) -35 -48 -27 111 5.66 
 L Putamen -14 -3 -6 90 -4.69 
 L Middle orbital gyrus -5 54 3 75 -5.38 
 L Thalamus (prefrontal) -14 -24 12 64 7.23 
 R Thalamus (prefrontal) 10 -21 12 63 6.09 
 R Inferior occipital gyrus 22 -93 -3 55 5.56 
 L Calcarine sulcus -11 -60 12 33 -4.74 
 R Thalamus/red nucleus 7 -24 -6 22 4.83 
 R Fusiform gyrus 25 -87 -12 21 4.75 
 L Medial frontal gyrus -2 57 21 20 -4.16 
 L Angular gyrus -38 -78 48 20 -3.90 
 R Prostriate area 28 -54 18 19 -4.14 
 
Note: Clusters were defined at a cluster-defining threshold of p < .001 and FWE-corrected at 
p < .05 (kE = 18.8 voxels). MNI coordinates represent the peak voxel within each cluster. 
 
ROI analyses. Increasing stop-signal probability was associated with greater right 
inferior frontal gyrus activity in the AN-BP group relative to controls (β=0.007, 
t(81)=2.91, p=.005; Figure 4.2B). IFG activity decreased post-manipulation (i.e., at 
time 2) across all groups (β=-0.006, t(156)=-3.20, p=.002). In addition, the 
parametric effect of RT on left premotor cortex activity was related to a three-way 
interaction, where the BOLD response decreased in BN relative to controls following 




Figure 4.2 Region of interest analyses identify altered inferior frontal and premotor activity 
during proactive inhibition in anorexia and bulimia nervosa. A) ROI analyses were conducted 
in seven regions that have previously been associated with proactive (blue) and reactive (red) 
inhibition (van Belle et al., 2014; Zandbelt et al., 2011). The following ROIs were used in 
analysis of both proactive and reactive inhibition: right opercular inferior frontal gyrus, right 
ventral inferior frontal gyrus, bilateral caudate, bilateral pregenual anterior cingulate cortex, 
right pre-supplementary motor cortex and bilateral superior parietal cortices. Analysis of 
proactive inhibition also included the left premotor cortex, and the right putamen was included 
in reactive inhibition analysis. ROIs are displayed in neurological orientation (L=left). B) The 
parametric effect of stop-signal probability was related to increased right inferior frontal gyrus 
(pars opercularis) activity in AN-BP relative to controls (p=.005). C) A three-way interaction 
indicated that the parametric effect of reaction time was related to increased left premotor 
activity in BN compared to controls in following the control task.  
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Whole-brain analyses. Increasing RT was related to reduced left supplementary 
motor area (SMA) activity post-manipulation (Table 4.4). Moreover, the effect of 
stop-signal probability was significantly affected by time, where activity across the 
proactive inhibition network generally decreased post-manipulation (Table 4.4). In 
line with behavioural findings, the effect of stop-signal probability also differed 
significantly by group, where the parameter was related to increased activity in the 
left superior frontal gyrus (SFG) in BN relative to controls (k=25 voxels, Z=4.58; 
Figure 4.3B & Table 4.4). A significant three-way interaction was associated with 
right SFG activity (k=19 voxels, F(2,231)=10.77). However, this effect was not 
captured by my a priori contrasts, which compared the BN group to controls and the 
AN-BP group to controls. To decompose this effect, I conducted an additional 
general linear test, in which women with BN were compared to the AN-BP group. 
This test indicated augmented SFG activity in BN relative to AN-BP following stress 





Figure 4.3 Impaired proactive inhibition in bulimia nervosa is associated with increased 
superior frontal gyrus activity. A) Reaction time increased as a function of stop-signal 
probability in all groups; however, a significant group-by-probability interaction showed that 
women with BN did not slow to the same degree as controls in response to increasing stop-
signal probability (p=.003). This impairment in proactive inhibition was associated with greater 
activity in B) the left superior frontal gyrus (k = 25 voxels, Z = 4.58, MNIX,Y,Z = -23, 33, 54, 
cluster defining threshold = p<.001, FWE-corrected cluster probability = p<.05) in BN relative 
to controls. C) A three-way interaction was related to stress-induced increases in the right 
superior frontal gyrus in BN relative to AN-BP (k = 34 voxels, Z = 4.52, MNIX,Y,Z = 22, 54, 36, 
cluster defining threshold = p<.001, FWE-corrected cluster probability = p<.05). For 
illustration, whole-brain activation was thresholded at voxel-wise p<.01 (uncorrected). 
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Individual values are overlaid on the mean modulated % signal change by group. Error bars 
= SEM.   
 
Table 4.4. Whole-brain derived fMRI responses during proactive inhibition 
 








    X Y Z    
RT modulator         
Time Post < Pre L SMA -5 20 65 35 21.58 -4.22 




BN > AN X 
stress > 
neutral X 
post > pre  
R Superior frontal 
gyrus 
22 54 36 19 10.77 4.52 
Group BN > HC L Superior frontal 
gyrus 
-23 33 54 25 11.88 4.58 
Time Post < Pre L Inferior occipital 
gyrus 
-41 -84 -6 618 74.34 -8.62 
 Post < Pre R Inferior occipital 
gyrus 
37 -87 -6 430 58.05 -7.62 
 Post < Pre R Inferior frontal 
gyrus (pars 
triangularis) 
43 24 30 190 35.98 -6.00 
 Post < Pre R Cerebellar vermis 1 -45 6 170 37.29 -6.11 
 Post < Pre R Inferior parietal 
lobule 
49 -36 54 106 24.81 -4.98 
 Post < Pre L Superior parietal 
lobule 
-23 -72 45 96 28.95 -5.38 
 Post < Pre L Precentral gyrus -47 -3 42 70 32.17 -5.67 
 Post < Pre L Cingulate gyrus -23 -48 24 66 27.36 -5.23 
 Post < Pre L Inferior frontal 
gyrus (pars 
triangularis) 
-53 33 27 58 30.08 -5.48 
 Post < Pre R Caudate  25 -45 21 58 28.08 -5.30 
 Post < Pre L Anterior insula -32 21 0 56 26.08 -5.11 
 Post < Pre R Anterior insula 37 21 3 53 21.13 -4.60 
 Post < Pre R Intraparietal 
sulcus 
31 -72 36 52 28.33 -5.32 
 Post < Pre L Inferior parietal 
lobule 
-56 -39 54 50 22.22 -4.71 
 Post > Pre R Cuneus 10 -93 39 45 25.59 5.06 
 Post < Pre R Supplementary 
motor area 
7 15 51 45 33.49 -5.79 
 Post < Pre R Middle occipital 
gyrus 
40 -90 15 44 27.02 -5.20 
 Post < Pre L Middle occipital 
gyrus 
-35 -93 18 37 28.29 -5.32 
 Post < Pre L Thalamus 
(temporal) 
-5 -9 9 26 25.74 -5.07 
 -- L Thalamus 
(proper) 
-2 -21 18 26 20.18 -- 
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 Post > Pre L Angular gyrus -56 -66 51 24 17.33 4.16 
 Post < Pre L Middle frontal 
gyrus 
-26 -6 57 24 21.08 -4.59 
 Post < Pre L Middle temporal 
gyrus 
-56 -51 18 19 23.19 -4.89 
 Post < Pre L Inferior parietal 
lobule 
-35 -51 48 19 18.16 -4.26 
 
Note: RT modulator = parametric effect of reaction time during non-0% Go trials contrast; 
Stop-signal probability modulator = parametric effect of stop-signal probability during non-0% 
Go trials contrast. Clusters were identified at a voxel-wise threshold of p < .001 and FWE-
corrected at p < .05 (kE = 18.8 voxels). Cluster size corresponds to the F-statistic map. 
 
4.3.3 Functional MRI analysis of group, stress and interaction effects on brain responses 
during reactive inhibition  
 
Analyses of reactive inhibition (Stop>Go-signal and Stop>FailedStop trials) indicated 
increased neural responses across the inhibitory control network (Tables 4.5-4.6, 
Figure 4.4) with markedly similar activation patterns across groups. 
 
ROI analyses. The main effect of group and all interaction effects were 
nonsignificant across all ROIs for both reactive inhibition contrasts. A significant main 
effect of time was related to right pre-supplementary motor cortex (β=-0.02, t(156)=-
3.51, p<.001), anterior cingulate cortex (β=-0.01, t(156)=-2.79, p=.006) and bilateral 
superior parietal cortex activity (β=-0.02, t(156)=-4.46, p<.001) on Stop>Go trials, 
where activity decreased post-manipulation. Moreover, the main effects of condition 
(β=0.01, t(82)=2.77, p=.007) and time (β=0.01, t(156)=3.14, p=.002) were associated 
with ACC activity during Stop>FailedStop trials, where deactivation was less 
negative on the stress day and post-runs. Interaction effects were nonsignificant 
across all ROIs for both contrasts. As a time-by-condition interaction term was not 
significantly related to ACC activity, the observed differences likely reflect BOLD 







Figure 4.4 Whole-brain activation in anorexia nervosa, bulimia nervosa and controls during 
reactive inhibition. Two-sample t-tests of A) successful stop-signal versus baseline Go trials 
and B) successful stop-signal versus failed stop-signal activation for AN-BP, BN and control 
groups. As contrasts were computed in the 3dLME AFNI package, statistical maps represent 
Z-scores, as denoted by the colour bar. Maps represent significant clusters (cluster-defining 
p-value < .001, family-wise error (FWE) cluster-probability p-value < .05) and are presented 
in neurological orientation (L=left). 
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Table 4.5 Whole-brain fMRI responses during reactive inhibition (Successful Stop > 
Go-signal 0%) by group 






   X Y Z   
AN L Postcentral gyrus -32 -36 69 6396 -10.77 
 R Inferior frontal gyrus (pars 
opercularis) 
40 12 9 3914 10.98 
 R Medial orbitofrontal 7 33 -9 2828 -9.11 
 R Middle occipital gyrus 31 -72 39 1951 8.03 
 L Middle occipital gyrus -44 -81 42 335 -6.82 
 L Inferior parietal lobule -29 -63 54 250 7.28 
 L Fusiform gyrus -35 -63 -9 217 6.15 
 L Cerebellar cortex (VI) -35 -57 -30 200 7.30 
 R Cerebellar cortex (VIIa) 34 -84 -30 190 -6.91 
 R Superior frontal gyrus 22 30 54 172 -7.69 
 L Rostral middle frontal gyrus -38 42 36 116 5.69 
 R Angular gyrus 49 -72 39 114 -6.12 
 R Middle cingulate cortex 7 -24 33 81 5.89 
 L Supramarginal gyrus -65 -33 30 74 6.21 
 R Inferior occipital gyrus 25 -105 3 70 -6.67 
 R Superior temporal gyrus 49 -30 3 65 5.95 
 L Middle occipital gyrus -29 -102 0 56 -5.74 
 L Cerebellar cortex (VIIa) -17 -93 -33 45 -5.29 
 R Lateral orbitofrontal 37 30 -12 40 -6.98 
 R Cerebellar cortex (VI) 34 -57 -27 36 6.02 
 R Caudate nucleus 16 15 21 27 -5.32 
BN L Calcarine sulcus -8 -69 -21 6350 -10.26 
 R Inferior occipital gyrus 4 9 54 5381 12.34 
 R Intraparietal sulcus 31 -75 36 3430 10.52 
 L Medial orbitofrontal -8 39 -9 2572 -10.26 
 L Cerebellar cortex (VI) -32 -60 -27 1887 9.26 
 L Angular gyrus -53 -72 33 550 -8.69 
 R Cerebellum 16 -93 -33 227 -8.85 
 R Superior frontal gyrus 19 33 60 181 -6.82 
 L Rostral middle frontal gyrus -35 42 30 172 6.27 
 R Angular gyrus 52 -72 36 138 -6.89 
 R Superior temporal gyrus 49 -27 0 92 6.44 
 L Cerebellar cortex (VIIa) -17 -93 -33 85 -6.89 
 L Middle occipital gyrus -23 -108 3 67 -6.31 
 R Inferior occipital gyurs 28 -105 0 64 -8.25 
 R Caudate 19 -18 36 57 -6.21 
 R Prostriate area  31 -54 6 48 -6.83 
 R Inferior frontal gyrus (pars 
orbitalis) 
37 30 -12 37 -6.12 
 R Dorsolateral putamen 28 -24 9 28 5.40 
HC L Calcarine sulcus -8 -69 21 11370 -10.77 
 R Inferior frontal gyrus (pars 
opercularis) 
40 15 9 4124 12.03 
 R Middle occipital sulcus 34 -75 36 2264 9.69 
 L Insula -32 15 9 714 12.14 
 L Superior parietal lobule -26 -69 57 563 7.13 
 L Fusiform gyrus -35 -63 -6 508 8.53 
 L Middle cingulate cortex  -8 -30 33 237 7.92 
 L Cerebellar cortex (VIIa) -17 -93 -33 194 -8.09 
 R Superior frontal gyrus 22 30 54 146 -6.80 
 L Cerebellar cortex (VI) -32 -57 -30 123 8.20 
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Note: Clusters were defined at a cluster-defining threshold of p < .001 and FWE-corrected at 
p < .05 (kE = 18.8 voxels). MNI coordinates represent the peak voxel within each cluster. 
 
  
 R Angular gyrus 49 -72 39 101 -6.57 
 L Middle frontal gyrus -35 42 30 100 6.38 
 L Cerebellar cortex -8 -78 -18 75 6.28 
 R Superior temporal gyrus 49 -30 0 59 5.24 
 R Dorsal caudate 16 0 33 42 -6.21 
 R Cerebellar cortex (VI) 34 -57 -27 28 5.47 
 R Inferior frontal gyrus (pars 
orbitalis) 
37 30 -12 28 -4.94 
 R Caudate 19 -18 36 28 -6.11 
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Table 4.6 Whole-brain fMRI responses during reactive inhibition (Successful Stop > 
Failed Stop) by group 
 






   X Y Z   
AN R Cerebellum (IV-V) 10 -60 -18 3659 -9.24 
 L Postcentral gyrus -44 -24 57 1154 -9.29 
 R Middle cingulate cortex 1 18 39 1104 -7.96 
 L Inferior frontal gyrus (pars 
opercularis) 
-53 9 3 434 -8.43 
 R Inferior frontal gyrus (pars 
opercularis) 
52 9 0 393 -8.20 
 R SMA 10 6 72 273 -6.12 
 R Middle temporal gyrus 58 -48 15 141 -4.62 
 R Rostral middle frontal 28 54 30 124 -5.08 
 R Middle temporal gyrus 46 -75 18 115 -6.03 
 L Middle frontal gyrus -32 51 27 109 -4.87 
 L Superior parietal lobule -32 -69 63 70 -4.85 
 R Cerebellar vermis 4 -75 -30 45 -6.85 
 R Primary sensory cortex 19 -33 69 43 -4.61 
 R Precentral gyrus 49 3 54 42 -4.60 
 R Inferior parietal lobule 49 -51 60 29 -4.91 
 R Superior parietal lobule 22 -78 57 26 -4.06 
 L Posterior insula -38 -15 -3 23 -4.61 
 R Putamen 28 -6 6 22 4.24 
 L Middle temporal gyrus -59 -60 18 21 -4.10 
 L Caudate nucleus -8 18 6 20 -4.33 
 R Postcentral gyrus 64 -18 33 20 -4.14 
 R Precuneus 10 -75 66 20 -4.87 
BN L Middle occipital gyrus -32 -87 24 12819 -11.61 
 R Inferior occipital gyrus 34 -93 -6 725 -7.60 
 L Insula -32 15 -6 608 -7.97 
 R Superior frontal gyrus 22 51 30 164 -6.54 
 L Middle frontal gyrus -32 45 24 97 -5.18 
 R Precentral gyrus 25 -33 78 83 -5.07 
 L Putamen -29 -3 6 71 5.84 
 R Putamen 25 3 0 48 5.27 
 L Angular gyrus -50 -72 54 43 5.73 
 L Middle frontal gyrus -26 24 63 34 4.31 
 R Posterior insula 40 -15 3 31 -4.67 
 R Inferior temporal gyrus 46 -6 -27 30 -4.71 
 L Middle temporal gyrus -62 -21 6 28 4.39 
 L Inferior frontal gyrus (pars 
orbitalis) 
-41 42 -6 24 4.75 
HC L Anterior cingulate cortex -5 18 36 11517 -10.05 
 R Inferior frontal gyrus (pars 
opercularis) 
49 9 6 402 -8.04 
 R Precentral gyrus 49 3 54 273 -6.56 
 L Inferior parietal lobule -50 -66 54 50 5.12 
 L Middle temporal gyrus 49 -24 -6 39 -4.50 
 L Para-insular area -41 -18 -3 29 -5.85 
 R Middle frontal gyrus  31 36 30 26 -4.08 
 L Medial frontal gyrus -8 33 -9 23 5.39 
 L Middle frontal gyrus -29 42 33 23 -5.03 
 L Middle frontal gyrus -32 21 57 22 4.11 
 R Superior frontal gyrus 34 54 6 21 3.90 
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Note: Clusters were defined at a cluster-defining threshold of p < .001 and FWE-corrected at 
p < .05 (kE = 18.8 voxels). MNI coordinates represent the peak voxel within each cluster. 
 
Whole-brain analyses. On Stop>Go-signal trials, neural responses were 
significantly reduced across the inhibitory control network post-manipulation (Table 
4.7). Activity in left middle temporal, thalamic, posterior insular, occipital and inferior 
frontal clusters was reduced post-manipulation during Stop>FailedStop trials. 
Moreover, left precentral gyrus activity on Stop>FailedStop trials was increased on 
the stress day relative to the neutral day. Finally, a three-way interaction indicated 
reduced activity in the right vmPFC during reactive inhibition (Stop>FailedStop trials) 
in AN-BP relative to controls following stress (k=32 voxels, Z=-4.19; Figure 4.5 & 





Figure 4.5 Stress reduces right ventromedial prefrontal cortex activity in anorexia nervosa 
during reactive inhibition. A) A significant three-way interaction indicated that right vmPFC 
activity was significantly reduced following acute stress compared to the neutral condition in 
AN-BP relative to controls (k = 32 voxels, Z = -4.19, MNIX,Y,Z = 4, 45, -9, cluster defining 
threshold = p < .001, FWE corrected cluster probability = p < .05). Whole-brain activation was 
thresholded at voxel-wise p < .01 (uncorrected) for illustration. B) Change in average percent 
signal change for the vmPFC cluster from pre- to post- induction across conditions. Individual 
values are overlaid on the mean change in percent signal change (post – pre) by group.  
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Table 4.7 Whole-brain derived fMRI responses during reactive inhibition (Successful 
Stop > Fail Stop) 
 












AN > HC X  
Stress > 
Neutral X 
Post > Pre 
R Medial frontal 
gyrus 
4 45 -9 30 12.35 -4.19 
Condition Stress < 
Neutral 
L Precentral gyrus -59 -3 33 24 16.16 -4.02 
 
Time Post < Pre L Middle temporal 
gyrus 
-59 -60 18 37 14.90 -3.86 
 Post < Pre L Thalamus 
(prefrontal) 
-8 -18 12 21 17.68 -4.21 
 Post < Pre L Posterior insula -44 -3 0 21 16.33 -4.04 
 Post < Pre L Superior occipital 
gyrus 
-20 -78 33 19 15.53 -3.94 
 
Note: Clusters were identified at a voxel-wise threshold of p < .001 and FWE-corrected at p < 
.05 (kE = 18.8 voxels). Cluster size corresponds to the F-statistic map.  
 
 
4.3.4 Associations with food intake  
 
In Chapter 3, I reported that AN-BP and BN groups consumed less in the buffet than 
controls, and intake was unaffected by stress. Here, exploratory analyses linked 
post-manipulation left SFG responses during proactive inhibition to increased intake 
(Z-scored; β=3.56, t(71)=2.38, p=.02), whereas post-manipulation vmPFC responses 
during reactive inhibition were negatively related to consumption (β=-0.81, t(71)=-
2.85, p=.006). These within-subject associations are shown in Figure 4.6, which 
depicts a repeated-measures correlation for each subject. The effects of SSRT, trait 
impulsivity, as indexed by the BIS-11, and all interaction terms were nonsignificant, 
indicating that this brain-behaviour association was unaffected by diagnostic status 





Figure 4.6 Associations between prefrontal responses during inhibition and ad libitum 
consumption. A) Greater post-manipulation vmPFC responses during reactive inhibition 
(Successful Stop vs. Failed Stop) were negatively related to food consumption during the free 
choice meal. B) Increased post-manipulation left superior frontal gyrus responses to greater 
stop-signal probability were positively associated with food intake. Observations within the 
same subject are modelled with a line of best fit that reflects the overall brain-behaviour 
association. While effects were derived from linear mixed-effects models, repeated measures 
correlations were computed for visualisation, using the rmcorr R package (Bakdash & 
Marusich, 2017).  
 
4.4    Discussion 
 
As failed self-regulation in response to stressors has gained traction as a putative 
mechanism of binge-eating, it has become increasingly important to characterise the 
precise self-regulatory deficits associated with binge-eating disorders. I assessed the 
impact of induced stress on inhibitory control in women with AN-BP, BN and 
matched controls, reporting three key findings. First, women with BN, but not AN-BP, 
had impaired proactive inhibition, yet both groups demonstrated increased prefrontal 
responses during the anticipation of stopping compared to controls. Second, I found 
stress-induced changes in the neural correlates of proactive and reactive inhibition, 
with notable differences across diagnostic groups. Third, AN-BP and BN groups had 
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intact reactive inhibition, and neither proactive nor reactive inhibition performance 
was affected by acute stress. 
 
I report novel evidence of impaired proactive inhibition in BN relative to controls, 
which co-occurred with increased activity in the left dorsolateral SFG. Increased left 
SFG activity and concurrent performance deficits could reflect inefficient recruitment 
of other regions within the IC network, namely inferior and middle frontal gyri, which 
share reciprocal connections with the SFG (Li et al., 2013). Inefficient or 
compensatory responses may also explain increased right IFG responses in AN-BP 
during intact proactive inhibition. Alternatively, given the role of the pars opercularis 
in ‘braking’ motor responses (Aron et al., 2014; N. C. Swann et al., 2012), increased 
activity could reflect improved proactive adjusting in AN-BP on the neural level, 
complementing previous behavioural reports in AN-R (Bartholdy, Rennalls, Jacques, 
et al., 2017). Exploratory analyses found that left SFG responses predicted 
increased post-scan calorie intake, lending additional support to the notion of 
inefficiencies across the proactive inhibitory network that may relate to disordered 
eating behaviour.  
 
Acute, psychological stress altered right SFG and left premotor cortex responses 
during proactive inhibition, as well as right vmPFC activity during outright stopping, 
differently between groups. Specifically, stress augmented right SFG responses to 
increasing stop-signal probability in BN relative to AN-BP. In BN, these stress-
induced increases in SFG responses perhaps compensated for concomitant 
decreases in premotor activity during RT slowing, thus preserving task performance. 
Indeed, increased prefrontal activity has been reported in healthy adults following 
pain stress, where activation was presumed to support working memory 
performance (Porcelli et al., 2008).  
 
One explanation for augmented vmPFC responses in controls relative to AN-BP after 
stress could be stress-induced alterations in inter-regional modulation (Veer et al., 
2011). The vmPFC is the primary cortical target of limbic projections (Averbeck & 
Seo, 2008), and stress-induced increases in activity may provide top-down 
modulation of amygdala reactivity and negative emotions. While not typically 
associated with inhibitory control, augmented vmPFC activity during reactive 
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inhibition has been reported following methylphenidate administration (C.-S. R. Li et 
al., 2010) and neuromodulation of the pre-SMA (Yu et al., 2015). These findings, 
together with my observations following acute stress, could implicate norepinephrine 
signalling in altered vmPFC activation, but further research is needed. The finding of 
a negative relationship between vmPFC responses to reactive stopping and post-
scan calorie consumption suggests that vmPFC activation during inhibitory control 
may be important for dietary control.  
 
Stress-induced reductions in prefrontal responses during both proactive and reactive 
inhibition in AN-BP could reflect the consequences of prolonged, extreme stress, 
namely significantly low weight, which engenders various cognitive and 
neuroendocrine perturbations (Delvenne et al., 1995; Misra & Klibanski, 2014). 
Interestingly, preclinical research has identified disrupted dopaminergic signalling 
following severe stress (Hollon et al., 2015; Lemos et al., 2012); however, the effect 
of stress on dopaminergic projections to prefrontal cortex remains understudied. The 
dearth of research in this area discourages a premature interpretation of the stress 
induction effects in AN-BP. Instead, findings of task-specific, stress-induced 
reductions in prefrontal responses in AN-BP may inform future investigations into 
neurocognitive alterations associated with prolonged and increasing stress. 
 
Contrary to my prediction, reactive inhibition, indexed as SSRT, was unaffected by 
diagnostic group or stress, and it was unrelated to free-choice consumption. As I 
have reviewed, findings of impaired self-regulatory performance in BN and AN-BP 
are inconsistent (Marsh et al., 2011; Skunde et al., 2016), and my results suggest 
that the subjective ‘loss of control’ that characterises binge-eating episodes does not 
relate to deficits in one’s capacity for action cancellation. While often considered a 
valid and translational measure of inhibitory control, these findings, and a recent 
mega-analysis of polysubstance use, question the clinical utility of SSRT. Indeed, the 
latter found that increased SSRT was not significantly related to various SUDs, 
including alcohol and cocaine use disorders (Liu et al., 2019). As stress-induced 
deficits in the ability to delay food reward were found in non-clinical samples (Maier 
et al., 2015), future research should assess state changes in decision-making as a 
potential mechanism of loss-of-control eating in clinical groups.  
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Although my design had notable strengths, several limitations should be considered. 
First, I recruited a representative sample of women with EDs, and as expected, the 
majority suffered with comorbid psychopathology and many used medication. These 
characteristics may, however, improve the generalisability of my findings as 
comorbidity and medication use are the norm rather than the exception amongst 
individuals with EDs (Fazeli et al., 2012; Udo & Grilo, 2019). Moreover, of those 
using medication, most were prescribed either selective serotonin reuptake inhibitors 
or serotonin-norepinephrine reuptake inhibitors with high affinity for 5-HT, and 5-HT 
modulation has been shown to have no effect on response inhibition (Chamberlain et 
al., 2006). Second, disorder-salient stimuli (e.g., food), which may accentuate or 
reveal self-regulatory deficits (Wu, Hartmann, et al., 2013), were not used, and future 
study should examine the impact of stress on performance in these contexts. Third, 
the conditions under which stress was induced (i.e., in an MR scanner) and eating 
behaviour was assessed differed from those in daily life.  
 
These findings counsel against a simplistic, stress-induced failure of regulation as an 
overall explanation for binge-eating in AN-BP and BN, underscoring the need for 
alternative models of these illnesses. Moreover, dissociations across diagnostic 
groups suggest that models of binge-eating based on BN may not apply to AN-BP. 
Given the complex metabolic and psychological disturbances associated with these 
disorders, future efforts to identify the neurocognitive mechanisms of binge-eating 




Chapter 5: Neural chemistry of the cerebral cortex in disordered eating and 




In Chapters 3 and 4, I presented findings of altered hormonal signalling and brain 
activity during response inhibition at baseline and under acute stress in women with 
AN-BP and BN relative to unaffected controls. These data extend previous 
knowledge of the dynamic interactions between mental state, the hormonal milieu 
and cognition amongst individuals with binge-eating disorders. However, it remains 
unknown if the previously discussed metabolic perturbations in AN-BP and, to a 
lesser extent, BN, relate to altered tissue integrity in the brain, and such 
characterization will be central to our understanding of the aetiology of disordered 
eating. This Chapter will present findings from an in vivo proton magnetic resonance 
spectroscopy (1H-MRS) experiment, which sought to identify associations between 
diagnostic status, peripheral metabolites and the neurometabolic profile of two 
cortical regions.  
 
As I have described and reported (see Chapters 1 and 4), individuals who suffer with 
AN and BN demonstrate altered brain activity both at rest (Gaudio et al., 2016; 
Lavagnino et al., 2014; Stopyra et al., 2019) and during performance of various 
cognitive tasks, which may partly reflect alterations in underlying brain structure. 
Indeed, structural MRI studies have identified widespread cortical thinning during the 
acute phase of AN (Bernardoni et al., 2016; King et al., 2015; Lavagnino et al., 
2018), and both global and regional reductions in thickness and grey matter volume 
have been found in BN (Frank et al., 2013; Marsh et al., 2015; Westwater et al., 
2018). Moreover, diffusion tensor imaging studies of AN and BN groups indicate 
reduced white matter integrity in these patients across several white matter tracts 
(for review, see Frank, 2015). Cortical ‘pseudoatrophy’ in AN rapidly normalises with 
weight restoration (Bernardoni et al., 2016; King et al., 2015), suggesting that 
alterations in cortical morphometry may reflect metabolic disturbances that arise 
during starvation (reviewed by King et al., 2017). However, as metabolic 
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characteristics of neural tissue cannot be inferred from structural MR images, 
alternative neuroimaging techniques must be implemented to ascertain whether 
patients with acute AN or BN have metabolic perturbations in the cortex. 
 
5.1.1 Proton magnetic resonance spectroscopy: The source and characteristics of the signal  
 
In contrast to standard structural neuroimaging, in vivo 1H-MRS enables estimation 
of tissue metabolite concentrations within a given anatomical region. Both structural 
MR and 1H-MRS techniques leverage the magnetic properties of atomic nuclei as 
they spin, or precess, within a static magnetic field (i.e., the B0 field). The spin of 
protons imparts a magnetic moment, which can be modified with the application of 
another electromagnetic field via a radio frequency pulse. Radio frequency pulses 
move protons into a higher-energy state; however, the degree to which a radio 
frequency pulse alters the resonance of a given proton will depend on the degree to 
which the proton is magnetically shielded by electrons in the local environment (and, 
hence, on local chemical structure). That is, a proton’s local electron density 
fundamentally affects its local magnetic field, and this, in turn, determines the energy 
required to shift the proton to a higher-energy state, as well as its position on the 
energy spectrum. For example, a proton in close proximity to an electro-attractant, 
such as chlorine, would be relatively deshielded in the local environment, and it 
would therefore require a higher radio frequency pulse to be brought into resonant 
state than more distal, electronegative atoms. Based on these principles, 1H-MRS 
experiments record the resonance frequency of chemical compounds of interest, 
which can be converted into a series of ‘peaks’, or spectra, using the Fourier 
transformation (reviewed by Novotny et al., 1998).  
 
The complexity of a given spectra is influenced by two core nuclear magnetic 
resonance properties: chemical shift and spin-spin coupling. As mentioned above, 
the frequency at which a particular proton produces a signal is influenced by its local 
environment (i.e., nuclei that are one or two chemical bonds away), such that the 
signal magnitude is proportional to the number of protons in the local environment. 
This phenomenon is termed ‘chemical shift’ (Novotny et al., 1998), which is 
represented on the X axis of nuclear magnetic resonance spectral plots. The related 
characteristic of ‘spin-spin coupling’ refers to the observation that, when two groups 
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of protons are within three chemical bonds of each other, the signal of one group will 
be influenced by the other. Because spectral peaks are proportional to the number of 
protons, the concentration of the compound of interest can be determined from the 
intensity, or area, of a given peak relative to that of a ‘standard’ peak of a known 
concentration. In practice, an unsuppressed water peak commonly serves as the 
standard against which metabolite concentrations are derived. As the concentration 
of water is between two and three orders of magnitude greater than that of the 
protons attached to metabolites, the water signal must be suppressed in order to 
observe metabolite resonance signals.  
 
Identification of metabolite concentrations depends, in part, on the echo time (TE) of 
the MR sequence, where observation of most metabolites of interest requires a short 
(<40 or <20ms) as opposed to (>100ms) long TE (Soares & Law, 2009). At 3 Tesla, 
1H-MRS experiments with a short or medium-length TE commonly visualise myo-
inositol (Myo), glutamate (Glu), glutamine (Gln), glucose (Gc), aspartate (Asp), N-
acetyl aspartate (NAA), choline (Cho), creatine (Cr) and some macromolecular 
proteins and lipids (Figure 5.1). Whilst concentrations of the inhibitory 
neurotransmitter, GABA, have been reported at this field strength, the resonances of 
GABA, glutamate and glutamine form complex, overlapping peaks between 2.05 and 
2.5 parts per million (ppm) that are more reliably distinguished at 7 Tesla (Tkáč et al., 
2009).  
 
5.1.2 Common metabolites and their putative functional roles  
 
The relative and absolute concentrations of the aforementioned metabolites have 
been implicated in various physiological processes, including neurodegeneration, 
energy metabolism and glial cell proliferation (reviewed by Soares & Law, 2009). For 
example, the abundance of NAA, a mitochondrial product, in neural parenchyma 
results in this metabolite having the largest spectral peak. Although NAA is highly 
concentrated in grey matter, the amino acid has various functional roles, including 
osmoregulation, myelin synthesis, neuron-glia signalling and glutamate turnover 
(reviewed by Paslakis et al., 2014). Following synthesis from aspartate and acetyl-
CoA, NAA is transferred into neuronal cytoplasm, along axons and ultimately to 
oligodendrocytes, where it is degraded (Baslow, 2010). NAA concentrations may 
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therefore serve as a marker of neuronal density, as well as neuronal mitochondria 
functioning (Moffett et al., 2007). In contrast, choline has been used as a marker of 
cell membrane integrity with relatively poor disease specificity. Synthesised by the 
kidneys and liver, creatine has a central peak at 3.02 ppm, and as its concentration 
is assumed stable marker of energy metabolism, creatine is frequently used to 
calculate metabolite ratios (e.g., NAA:Cr). With a peak at 3.56 ppm, myo-inositol is 
similarly not produced by neurons but instead considered a marker of glial cell 
integrity. Increases in myo-inositol relate to astrocyte proliferation or growth (Brand 
et al., 1993), which may be potentiated by inflammation (e.g., in multiple sclerosis 
Chang et al., 2013). Finally, whilst glutamate represents the most abundant 
excitatory neurotransmitter in the brain, concentrations of glutamate and its 
precursor, glutamine, also relate to carbon and nitrogen metabolism (Shen, 2013).   
 
 
Figure 5.1 Example of short-echo time spectra with common metabolites. The red line depicts 
the basis spectra, and the black line represents the fitted spectra from a representative 
subject. Cho = choline; Cr = creatine; Glu = glutamate; NAA = N-acetyl aspartate. 
 
5.1.3 The state of 1H-MRS research of eating disorders and the present study 
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Assessment of cerebral metabolism via 1H-MRS in eating disorders has been 
primarily limited to AN samples, where few consistent findings have emerged. 
Schlemmer et al. (1998) reported increases in the ratio of choline to total creatine, as 
well as decreases in relative NAA, in parieto-occipital white matter amongst 
adolescents with AN; however, metabolite profiles of the thalamus were comparable 
to controls. Relative to controls, adults with AN have reduced creatine and myo-
inositol concentrations in dlPFC grey matter, and lower levels of the composite 
metabolite ‘Glx’, which reflects both glutamate and glutamine, in the ACC (Ohrmann 
et al., 2004). NAA and creatine concentrations in the dlPFC have also been 
positively correlated with performance on executive function tasks in AN, perhaps 
suggesting a role of these metabolites in higher-order cognition (Ohrmann et al., 
2004). Findings of reduced glutamate and myo-inositol have been replicated in both 
adolescent and adult AN across various brain regions, including medial frontal, 
anterior cingulate and occipital cortices and the putamen (Castro-Fornieles et al., 
2007; Godlewska et al., 2017).  
 
Neural biochemistry has yet to be explicitly studied in BN, but previous examination 
of mixed samples of patients with AN and BN lends some insight into potential 
metabolic alterations in this illness. Emerging adults with diagnoses of either AN or 
BN have reduced lipid concentrations in frontal and occipital white matter, as well as 
decreased myo-inositol in frontal white matter (Roser et al., 1999). However, 
assessment of a small sample of adults with AN, BN and matched controls revealed 
nonsignificant group differences in spectra acquired from the ACC (Joos et al., 
2011).   
 
Taken together, existing research has reported altered neural chemistry in AN, 
where alterations of glutamate, myo-inositol and NAA have been reported across 
adolescent and adult samples. However, few studies have assessed BN via 1H-
MRS, and no study, to my knowledge, has explicitly examined neural metabolite 
alterations in the binge-eating and/or purging subtype of AN. Assessment of brain 
metabolites across AN-BP and BN will be central to determining the generalisability 
of previously-reported alterations in AN to eating disorders characterised by binge-
eating, with or without significantly low body weight. As such, 85 women (n=22 AN-
BP, n=33 BN, n=30 controls) underwent 1H-MRS scanning at 3 Tesla within the 
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integrated neuroimaging protocol described in Chapter 2. Spectra were acquired 
from two voxels of interest in the right inferior frontal cortex and right medial occipital 
cortex for assessment of glutamate, myo-inositol and NAA levels. I predicted that 
glutamate would be reduced in women with AN-BP and BN whilst only women with 
AN-BP were expected to have lower myo-inositol and NAA concentrations than 
controls. Finally, exploratory correlation analyses were completed to test whether 
altered metabolites in the brain relate to symptom severity and peripheral markers of 
long-term energy homeostasis. 
 




The same cohort of 85 women (M ± SDage = 23.96 ± 3.98 years) described in 
Chapters 2 - 4 underwent 1H-MRS scanning during an inpatient study session at 
Addenbrooke’s hospital in Cambridge, UK. Briefly, adult women were recruited from 
the Cambridgeshire area to three participant groups: AN-BP, BN and matched 
controls (HC). Patient participants were free of alcohol or substance use disorders 
within the past 6 months, and they had no lifetime history of serious mental illness or 
neurodevelopmental disorders. Control participants reported no current or lifetime 
psychopathology. All participants provided written, informed consent prior to 
undergoing any study procedures.  
 
5.2.2 Study procedures 
 
As a detailed explanation of the study protocol can be found in Chapters 2 – 4, a 
brief summary has been included here. Following a telephone screening, potential 
volunteers completed an outpatient screening session prior to scanning, which 
included body composition testing, blood sampling, cognitive testing and two, semi-
structured clinical interviews (e.g., the SCID-5 (First et al., 2015) and EDE v16 
(Cooper & Fairburn, 1987)) to establish current diagnoses of AN-BP, BN an 
comorbid psychiatric conditions. Eligible participants then attended a two-day, 
inpatient study session, which included a cognitive testing and questionnaire battery, 
repeated, task-based fMRI scanning and serial blood sampling to enable 
measurement of circulating metabolites. During the inpatient session, participants 
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were randomly assigned to undergo either an acute stress induction or control task 
during each day of MRI scanning. All participants underwent 1H-MRS scanning on 
their ‘control’ day, and spectra were acquired prior to completion of the fMRI task. 
Spectra were collected from two voxels of interest, one in the right inferior frontal 
cortex and the other in the right medial occipital lobe, and the order of acquisition 
from each VOI was randomised across participants. During spectra acquisition, 
participants were instructed to remain still, keep their eyes open and gaze at a 
fixation cross. 
 
1H-MRS were acquired using a semi-LASER (sLASER) sequence as opposed to a 
vendor-provided PRESS protocol, as sLASER sequences have improved 
localisation, spectral quality and replicability (Deelchand et al., 2015, 2018). In 
particular, previous sLASER experiments have obtained highly reproducible 
neurochemical profiles for five major metabolites, including the three metabolites of 
interest in this study (e.g., glutamate, NAA and myo-inositol), where coefficients of 
variance were <5% at both 3 and 7 Tesla (Terpstra et al., 2016).   
 
5.2.3 Blood sampling 
 
As described in Chapter 2, blood samples were collected upon waking on Day 2 of 
the inpatient testing session to assay fasting leptin, glucose, insulin, potassium, 
cortisol, IL-6 and C reactive protein (CRP). All sample handling procedures have 
been described in the Appendix.  
 
5.2.4 Analytic plan 
 
Magnetic resonance spectroscopy data analysis  
Pre-processing of 1H-MRS was completed in Matlab (v2016a; The Mathworks, 
Natick, MA, USA), using the MRSpa package 
(https://www.cmrr.umn.edu/downloads/mrspa/). Raw MRS free induction decays 
(FIDs) were corrected for eddy current effects, or transient fluctuations in the main 
magnetic field (B0) that arise from rapid gradient switching during spectra acquisition, 
and a zero-order phase correction was applied. FIDs were corrected for temporal (or 
frequency) and phase drifts using the cross-correlation method, which minimises the 
frequency and phase difference, respectively, between single-shot MRS data. 
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Whereas frequency drift in the B0 field arises from the heating and cooling of passive, 
ferromagnetic shim elements of the scanner throughout data acquisition, phase drift 
can arise from various factors, including physiological motion or small head 
movements. Correction of frequency and phase drifts mitigates broadening of the 
spectra, improves the signal-to-noise ratio and prevents line shape distortion (Near 
et al., 2020). Finally, FIDs were visually inspected for outlier transients (e.g., those 
containing a large residual water peak or noise-only spectrum) as these would be 
indicative of large motion artefacts. Outlier FIDs (<10%) were removed from 26 
inferior frontal and 18 occipital spectra before summation. 
 
Next, I used the LCModel (v6.3.3; Provencher, 1993, 2001) to quantify sLASER 
spectra (Figure 5.2). Metabolite concentrations were estimated with water scaling, 
using a basis set comprised of alanine (Ala); ascorbate/vitamin C (Asc); aspartate 
(Asp); glycerophosphorylcholine (GPC); phosphorylcholine (PCho); creatine (Cr); 
phosphocreatine (PCr); GABA; glucose (Glc); glutamine (Gln); glutamate (Glu); 
glutathione (GSH);  myo-inositol (Ins); lactate (Lac); phosphoethanolamine (PE); 
scyllo-inositol (sIns); taurine (Tau); N-acetyl-aspartate (NAA); and N-
acetylaspartylglutamate (NAAG). Only metabolites that were quantified with Cramer-
Rao lower bounds= (CRLB) values <30% were classified as detected (see Table 
5.1). For metabolites of interest, participants with CRLB values >20% were classified 
as outliers; however, no participants were excluded on this basis. If the correlation 
between two metabolites was <-0.5, for a given VOI, their sum has been reported in 
Table 5.1 (e.g., NAA + NAAG = tNAA, total NAA).  
 
As estimation of 1H-MRS metabolite concentrations varies across tissue types and 
CSF (Lee et al., 2013; Quadrelli et al., 2016), I calculated the fraction of GM, WM 
and CSF within each VOI. I conducted whole-brain, voxel-based tissue segmentation 
of the T1-weighted anatomical scan in SPM12 (Wellcome Department of Clinical 
Neurology, London), using ICBM Tissue Probabilistic Atlases. Each VOI was then 
coregistered to the anatomical image, and I computed the percentage of GM, WM 
and CSF tissue within the VOIs using both the GM and WM probability maps. I 
computed these estimates using custom Matlab code that was provided by Dr 
Dinesh Deelchand of the University of Minnesota. The mean percentage of each 
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tissue was entered into the following equation used by Egerton et al. (2020) to 
generate corrected metabolite concentrations (Mcorr) of metabolite M:  
 
!"#$$ = 	!((! + 1.21 × .! + 1.55 × 012)	((! + .!)  
 
The proportion of GM, WM and CSF in each VOI did not differ significantly by group 
(all p’s > .05); however, linear mixed-effects modelling indicated reduced proportions 
of CSF (β(SE)=-3.76(0.26), t(80)=-14.50, p<.001) and GM (β(SE)=-12.58(0.82), 
t(80)=-15.37, p<.001) in occipital VOIs. These reductions were offset by increases in 




Figure 5.2 1H-MRS voxel placement and spectra from a representative subject. A) Overlay of 
right occipital (blue) and right inferior frontal (red) cortex voxels on a single participant’s T1-
weighted anatomical scan. Images are in neurological orientation (R=R). Panels B & C present 
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the corresponding spectra for the occipital (B) and inferior frontal (C) voxels, where the bottom 
plots contain the metabolite input (red), fitted spectra (blue) and the spline baseline (grey) after 
fitting. Residual plots indicate minimal deviations from the basis set (i.e., value of zero), 
suggesting good overall fit.  
 
Group differences in 1H-MRS metabolites and exploratory associations with peripheral metabolites, 
anthropometrics and symptom severity  
Using R statistical software, linear regressions were used to evaluate group 
differences in the three metabolites of interest, glutamate, myo-inositol, and NAA, in 
frontal and occipital VOIs. In keeping with the analytic framework of Chapters 3 and 
4, group differences were evaluated using non-orthogonal contrast coding, in which 
AN-BP and BN groups were compared to controls (e.g., treatment contrasts). As 
associations were tested separately for each VOI, I applied a Bonferroni correction 
for 6 tests, yielding an alpha threshold of .05/6 = .008. The Shapiro-Wilke test was 
used to determine the normality of model residuals 
 
To investigate whether cerebral metabolite concentrations related to symptom 
severity and metabolic markers in the periphery, I conducted exploratory correlation 
analyses across the full sample. Total scores on the Eating Disorder Examination 
Questionnaire (Fairburn & Beglin, 1994) were used as indices of eating disorder 
symptom severity. Additionally, plasma IL-6 and CRP were log-transformed prior to 
analysis to minimised the positive skew of both of these variables. A rank normal 
transformation was applied to plasma potassium values to negative skew (McCaw, 
2019). Results of the exploratory correlations were corrected for multiple 
comparisons using the false discovery rate.  
 
One participant was excluded on the basis of white matter abnormalities, and 
spectra from the occipital VOI could not be acquired for another participant due to a 
technical error. In total, IFG and occipital spectra from 84 and 83 participants, 
respectively, were analysed. Outlier values were defined as those ±3 SD from the 
mean value for each metabolite, which resulted in the exclusion of one additional 





5.3.1 Reduced myo-inositol and NAA in AN-BP in inferior frontal cortex 
 
A significant main effect of group indicated reduced myo-inositol in AN-BP, but not 
BN, relative to healthy women in the IFG (β(SE)=-0.50(0.18), t=-2.72, p=.008; Figure 
5.3), and this effect was nominally significant in the OCC (β(SE)=-0.49(0.21), t=-
2.37, p=.02). Group status explained approximately 9% of the variance in IFG myo-
inositol concentration (F(2,79)=4.85, p=.01, R2Adjusted =0.09). Similarly, NAA was 
reduced in AN-BP relative to controls (β(SE)=-0.57(0.20), t=-2.77, p=.007) in the IFG 
whilst nonsignificant differences were observed in BN (p=.60). This model explained 
11% of the variability in NAA concentration in the inferior frontal cortex 
(F(2,79)=6.02, p=.004, R2Adjusted =0.11). Diagnostic status was not significantly 
related to NAA concentration in the OCC or glutamate concentration in either the IFG 
or the OCC (all p’s >.05). 
 
Table 5.1 LCModel metabolite concentrations by group and region 
 IFG OCC 
Metabolite AN (n=22)  BN (n=33) HC (n=30) AN (n=22) BN (n=33) HC (n=30) 
Aspartate  3.59(0.74) 3.81(0.60) 3.74(0.64) 3.26(0.61) 3.51(0.92) 3.46(0.74 
Creatine  4.90(0.63) 5.12(0.76) 4.97(0.66) 4.58(0.36) 4.62(0.67) 4.47(0.28 
Glucose  1.27(0.48) 1.47(0.45) 1.48(0.35) 1.11(0.36) 1.23(0.35) 1.15(0.31 
Glutamine 2.52(0.79) 2.39(0.69) 2.31(0.42) 1.97(0.45) 2.14(0.95) 1.93(0.70 
Glutamate 9.52(0.88) 10.08(1.05) 9.76(1.02) 7.14(0.74) 7.67(1.31) 7.49(0.71 
Glycero- 
phosphocholine 
1.47(0.24) 1.48(0.22) 1.48(0.23) 1.03(0.20) 1.09(0.27) 1.01(0.17) 
Glutathione 1.88(0.30) 2.02(0.24) 1.94(0.25) 1.50(0.18) 1.56(0.34) 1.51(0.19) 
myo-Inositol 5.72(0.94) 6.34(0.60) 6.33(0.56) 5.34(0.96) 6.15(1.17) 5.82(0.67) 
scyllo-Inositol 0.42(0.18) 0.36(0.13) 0.34(0.12) 0.41(0.17) 0.35(0.18) 0.29(0.11) 
Pcho_GPC  1.88(0.17) 1.90(0.16) 1.88(0.20) 1.32(0.15) 1.33(0.20) 1.26(0.16) 
Total NAA 11.62(0.54) 12.28(0.80) 12.26(0.85) 12.12(0.65) 12.52(1.90) 12.24(0.55) 
 
Note: Values represent M(SD) of absolute concentration (mM) following correction for partial 




Figure 5.3 Cerebral metabolites are altered in anorexia but not bulimia nervosa. Women with 
AN-BP had reduced myo-inositol (A) and NAA (B) in the right inferior frontal cortex as 
compared to controls.  
 
5.3.2 Associations with peripheral metabolic markers and anthropometrics 
 
Exploratory correlation analyses identified clusters of moderate-to-strong 
associations in the brain and periphery; however, there were no associations linking 
neural chemistry to circulating metabolic markers (Figure 5.4). Concentrations of 
glutamate, myo-inositol and NAA significantly correlated with one another in the 
inferior frontal cortex whilst only glutamate and NAA were significantly associated in 
the occipital voxel. Myo-inositol concentrations were strongly correlated across VOIs 
(r = 0.71, q = 2.39x10-35). As expected, BMI was positively associated with leptin, 
glucose, insulin, potassium, CRP and total body fat but negatively correlated with 
eating disorder symptom severity. Symptom severity also negatively correlated with 
insulin and CRP. Several other significant associations emerged between a suite of 
metabolites involved in long-term energy metabolism, as shown in Figure 5.4 (see 





Figure 5.4 Associations between central and peripheral metabolites, anthropometrics and 
symptom severity. OCC = occipital, IFG = inferior frontal gyrus, Glu = glutamate, Ins = myo-
inositiol, NAA = N-acetyl aspartate, EDEQ = Eating Disorder Examination Questionnaire total 
score, BMI = body mass index, CRP = C-reactive protein, IL-6 = interleukin 6 
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Table 5.2 P-values of exploratory correlation analyses between central and peripheral metabolites 
 
Glu_O NAA_C Ins_O Glu_I NAA_I Ins_I EDEQ FAT BMI LEP GLC INSU K+ CRP IL6 CORT 
Glu_O 0 9.05E-09 0.15 0.35 0.56 0.86 0.49 0.84 0.49 0.90 0.78 0.72 0.20 0.09 0.03 0.10 
NAA_O 1.55E-07 0 0.05 0.12 0.05 0.40 0.15 0.30 0.37 0.83 0.28 0.81 0.95 0.35 0.98 0.29 
Ins_O 0.38 0.19 0 0.19 0.41 7.98E-37 0.42 0.64 0.06 0.47 0.91 0.07 0.02 0.41 0.96 0.99 
Glu_I 0.64 0.32 0.4 0 0.001 0.004 0.27 0.71 0.78 0.69 0.80 0.40 0.20 0.93 0.67 0.25 
NAA_I 0.83 0.19 0.7 0.01 0 1.35E-04 0.19 0.28 0.02 0.77 0.75 0.78 0.21 0.84 0.05 0.90 
Ins_I 0.96 0.68 2.39E-35 0.03 0.001 0 0.06 0.28 0.07 0.47 0.80 0.09 0.03 0.17 0.98 0.78 
EDEQ 0.75 0.38 0.69 0.55 0.45 0.22 0 0.17 0.002 0.01 0.71 0.01 0.11 0.001 0.93 0.85 
FAT 0.95 0.56 0.90 0.94 0.55 0.55 0.41 0 1.64E-40 9.40E-71 0.11 9.59E-05 0.14 6.81E-07 0.48 0.61 
BMI 0.75 0.66 0.22 0.94 0.11 0.24 0.02 6.55E-39 0 2.79E-88 0.003 3.30E-10 0.002 1.16E-06 0.26 0.74 
LEP 0.97 0.95 0.75 0.94 0.94 0.75 0.08 5.64E-69 3.35E-86 0 0.007 3.21E-12 0.16 8.96E-08 0.36 0.70 
GLC 0.94 0.55 0.97 0.94 0.94 0.94 0.94 0.30 0.02 0.04 0 3.50E-04 0.92 0.93 0.25 0.09 
INSU 0.94 0.94 0.23 0.68 0.94 0.27 0.03 0.001 6.60E-09 7.71E-11 0.003 0 0.03 2.42E-07 0.64 0.09 
K+ 0.45 0.98 0.10 0.45 0.46 0.13 0.30 0.38 0.01 0.40 0.97 0.13 0 0.57 0.80 0.05 
CRP 0.27 0.64 0.69 0.97 0.95 0.41 0.01 8.17E-06 1.27E-05 1.34E-06 0.97 3.22E-06 0.83 0 0.56 0.49 
IL6 0.13 0.99 0.98 0.92 0.19 0.99 0.97 0.75 0.55 0.64 0.54 0.90 0.94 0.83 0 0.58 
CORT 0.30 0.55 0.99 0.54 0.97 0.94 0.95 0.87 0.94 0.94 0.27 0.27 0.20 0.75 0.83 0 
 
Note: Shaded area reflects FDR-corrected values. Glu_O=occipital glutamate, NAAO=occipital NAA, Ins_O=occipital myo-inositol, Glu_I=inferior 
frontal glutamate, NAA_I=inferior frontal NAA, Ins_I=inferior frontal myo-inositol, FAT=total body fat, BMI=body mass index, LEP=leptin, 
GLC=glucose, INSU=insulin, K=potassium, CRP=C-reactive protein, IL6=interleukin-6, CORT=cortisol 
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5.4 Discussion  
 
This study implemented single-voxel 1H-MRS to quantify metabolite concentrations 
of cortical tissue in women with AN-BP and BN relative to women with no history of 
mental illness. Within a highly-controlled inpatient setting, I replicated previous 
reports of reduced myo-inositol and NAA in the prefrontal cortex of individuals with 
AN (Castro-Fornieles et al., 2007; Godlewska et al., 2017; Ohrmann et al., 2004), 
extending these findings to the binge-eating and purging subtype of the illness. 
Women with BN did not show alterations in the metabolites of interest, which could 
suggest some specificity to low body weight. However, as exploratory correlation 
analyses failed to identify significant associations between neural metabolites and 
body mass or plasma markers of long-term metabolism, the observed alterations 
likely reflect a more complex mechanism. 
 
Reduced inferior frontal cortex myo-inositol and NAA concentrations in AN-BP could 
be indicative of reduced glial and/or myelin integrity in this illness. The carbocyclic 
sugar, myo-inositol, has been considered a marker of glial integrity due to its 
presence in astrocytes and absence from neurones (Castillo et al., 1998). Myo-
inositol serves as an osmolyte, and, as a precursor of cell membrane phosphor-
inositides, the metabolite has a key role in lipid metabolism and myelin sheet 
structures (Haris et al., 2011). Whereas demyelination has been associated with 
increased concentrations of free myo-inositol, the specific mechanisms underlying 
reductions in myo-inositol remain unknown. Glial damage or impairment has been 
suggested to underlie reduced myo-inositol in other psychiatric disorders, including 
schizophrenia and major depressive disorder (Chiappelli et al., 2015; Shirayama et 
al., 2017; Xu et al., 2016). However, the combination of reductions in both myo-
inositol and NAA could be indicative of altered axonal-glial signalling in AN-BP. 
Mitochondria enzymes in neuronal cell bodies and axons facilitate NAA synthesis 
from glutamate, but the metabolite is then released into the extracellular matrix for 
uptake by oligodendrocytes. Oligodendrocyte cells produce aspartoacylase (ASPA), 
which degrades NAA to aspartate and acetate, and the resulting acetate may have a 
role in maintaining myelination (Chakraborty et al., 2001; Nordengen et al., 2015). 
NAA therefore seems to have a central role in axonal-glial signalling, where 
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reductions may reflect either reduced neuronal integrity, altered oligodendrocyte 
functioning or a combination of both (Moffett et al., 2007). However, preclinical and in 
vitro studies will be central to advancing understanding associations between 1H-
MRS-derived myo-inositol and NAA concentrations and the aforementioned cellular 
functions. 
 
Both AN-BP and BN groups had normative glutamate levels in inferior frontal and 
occipital cortices, and myo-inositol and NAA concentrations in BN did not differ from 
controls. Reductions in glutamate or ‘Glx’ have previously been reported in the 
medial PFC, ACC, occipital cortex and striatum in AN (Castro-Fornieles et al., 2007; 
Godlewska et al., 2017); however, a variety of methodological factors could have 
contributed to null findings in the present study. In addition to variable voxel 
placement, assessment of relative versus absolute metabolite concentrations 
complicates direct comparison across these studies. Although the present sample 
size exceeds many in the literature (e.g., Castro-Fornieles et al., 2007; Godlewska et 
al., 2017; Joos et al., 2011; Schlemmer et al., 1998), limited statistical power could 
have also impeded my ability to detect additional between-group differences that 
likely have a small effect size. With regard to BN more broadly, it could be that these 
patients do not differ from controls on the majority of metabolites assessed at 3 
Tesla (Joos et al., 2011), and this may warrant use of high-field MRI for reliable 
quantification of other metabolites and neurotransmitters, such as GABA. 
 
Exploratory correlation analyses lent some insight into the question of whether 
neurochemical alterations in the cortex related to metabolic alterations in the 
periphery. Whilst metabolite concentrations were moderately correlated within each 
voxel, and long-term markers of glucose metabolism and body weight were related in 
the periphery, no significant brain-body associations were found. Castro-Fornieles et 
al. (2007) similarly found null associations between relative myo-inositol, NAA and 
Glx concentrations in the frontal lobe and a series of metabolic markers (e.g., BMI, 
cortisol, insulin-like growth factor 1, triiodothyronin, zinc) in adolescent AN. These 
null findings may relate to the challenges associated with integrating physiological 
observations across molecular, cellular and systems levels. For example, the 
functional roles of myo-inositol and NAA are largely limited to the molecular and 
cellular levels, whereas several peripheral metabolites, notably leptin, cortisol, 
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glucose, contribute to a variety of physiological processes (e.g., bone growth, 
inflammatory processes, gluconeogenesis)  at the systems level. Glutamate 
transmission affects both neural and systems-level signalling across the brain. 
However, the functional properties of glutamate and the other metabolites are 
necessarily confined to the brain, whose metabolic processes differ substantially 
from other tissue types (e.g., muscular, hepatic; A. M. Brown & Ransom, 2007). As 
such, it is perhaps unsurprising that local metabolic markers in frontal and occipital 
cortex do not relate to circulating levels of various metabolites and cytokines, whose 
regulatory functions span a wide range of physiological systems (e.g., appetitive, 
inflammatory, endocrine). Future study of metabolic profiles within the hypothalamus 
may prove more fruitful in assessing synchrony between brain-body metabolism, 
especially given the region’s role in homeostasis and proximity to permeable areas 
of the blood-brain barrier (e.g., the median eminence).  
 
Although this work replicated previous findings of reduced prefrontal myo-inositol 
and NAA concentrations in AN, specifically demonstrating this effect in AN-BP, some 
limitations should be considered. First, approximately 30% and 45% of women with 
BN and AN-BP, respectively, were prescribed psychotropic medication at the time of 
scanning, which may impact on glutamate turnover and glucose metabolism (Hertz 
et al., 2015). Few studies have attempted to quantify the effects of psychotropic 
medications on 1H-MRS spectra (D. R. Rosenberg et al., 2000), but future work in 
this area would increase the interpretability of altered concentrations in individuals 
who suffer with psychiatric illness. Second, the use of single-voxel 1H-MRS 
precluded assessment of the role of metabolites in brain activation or structural 
morphometry due to limited spatial coverage. However, alternative techniques, such 
as multi-voxel functional spectroscopy (e.g., Ip et al., 2017), would facilitate analysis 
of temporal associations between metabolite concentrations, BOLD responses and 
morphometric features of the cortex. Third, although the occipital voxel was intended 
to represent a ‘control’ region, significant differences in tissue composition across 
voxels could have affected metabolite estimates despite mathematical correction. 
Restriction of 1H-MRS voxels to morphometrically similar regions, such as other 
regions within association cortex, could prove to be a more informative design. 
Nevertheless, these findings lend important insight into neural chemistry of AN-BP 
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and BN, suggesting that, despite shared symptomatology, these illnesses show 
distinct neurobiological profiles. 
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Chapter 6: Summary  
 
The work reported in this thesis aimed to advance understanding of the aetiology of 
binge-eating disorders by generating and integrating observations across biological 
and psychological levels of (dys)function in women with diagnosed eating disorders 
and those with no personal history of mental illness. To achieve this, I designed and 
implemented an ambitious experimental medicine study, which utilised integrative 
physiology and multimodal neuroimaging techniques to assess women with AN-BP, 
BN and matched controls under neutral and stressful conditions, during an inpatient 
testing session. The findings of this work highlight important avenues for future 
scientific inquiry whilst underscoring key challenges in psychiatric nosology that must 
be considered in such studies. In this Chapter, I will discuss these critical points and 
provide an overview of future research that seeks to extend this current body of 
work.  
 
6.1 Revisiting the pitfalls of biological reductionism in psychiatric research 
 
As I reviewed in Chapter 1, the field of psychiatry faces a pressing and formidable 
challenge, which arises from ambiguity surrounding links between nosology and 
aetiology in mental illness. Whilst decades of expert-driven classification of 
psychiatric illness has been rooted in clinical observation, contemporary research 
paradigms emphasise ‘bottom-up’ approaches that aim to demarcate diagnostic 
boundaries in line with putative ‘biomarkers’ of transdiagnostic processes or 
symptoms. A perhaps implicit assumption of the latter is that transdiagnostic, 
psychological processes necessarily reflect shared mechanisms at lower, biological 
levels, and as such, behavioural observations can ultimately be replaced by 
biological ones. As others have argued (Eronen, 2019; Kendler, 2005), this form of 
biological reductionism is ill-suited to psychiatry, where illnesses are grounded in 
first-person, subjective experiences (e.g., low mood, feelings of a loss of control) and 
have a complex aetiology comprised of many possible explanatory mechanisms. 
Perhaps an even more pressing flaw of this framework results from neglecting the 
agency of the individual within their environment, as mental processes arise from 
interactive and bidirectionally-causal relationships between an individual and their 
environment. In a similar vein, hard biological reductionism runs counter to the 
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philosophical principle of equifinality, or the notion that a diversity of pathways may 
lead to a common end state or outcome, which likely results in limited explanatory 
power (Cicchetti & Rogosch, 1996).  
 
Nevertheless, the possibility of a simple, biological explanation for myriad psychiatric 
illnesses remains a popular belief, and in the case of binge-eating, it has led to the 
premature acceptance of certain neurobiological models despite little direct empirical 
evidence to support them. For example, the notion that phenomenologically similar 
symptoms reflect the shared biological mechanism of dysregulated dopaminergic 
signalling has led to specious comparisons between binge-eating and substance use 
disorders (e.g., Avena et al., 2008; Gearhardt et al., 2011; Hebebrand et al., 2014). 
Such comparisons might seem academic, but they have substantial, real-world 
implications, ranging from the allocation of research funding to the repurposing of 
psychosocial or pharmacological interventions for addiction despite limited efficacy in 
disordered eating (e.g., twelve-step programs for overeating (Russell-Mayhew et al., 
2010; Weinstein et al., 2015), use of naltrexone for bulimia nervosa (Modesto-Lowe 
& Van Kirk, 2002)). That is, the assumptions we hold about the presumed links 
between aetiology and nosology have a tangible impact on the research and 
treatment of psychiatric illness. We as clinical scientists therefore have an imperative 
to test these assumptions rigorously, methodically and objectively.  
 
In contrast to biological reductionism, this thesis embraced the view that the validity 
of current diagnostic distinctions between AN-BP and BN can be empirically tested 
through an iterative process, where, at each successive stage, observations may be 
used to update current models and to shape ensuing studies that, in turn, further 
update and improve those models. This approach, formally known as ‘epistemic 
iteration’ (Kendler, 2009), aligns with the principles of integrative pluralism, whereby 
observations across many levels might offer piecemeal insight into the aetiology of 
these illnesses whilst also providing evidence for, or against, their current diagnostic 
demarcation. Taken together, findings from Chapters 3-5 spanned the levels of 
metabolic, neurobiological, neurochemical, cognitive and behavioural observation, 
and these data largely support the current diagnostic distinctions between AN-BP 
and BN. However, support for this categorisation was inconsistent across 
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psychological and biological levels, raising key questions about their consilience 
whilst underscoring the importance of metabolic functioning in disordered eating. 
 
6.2  Binge-eating as a transdiagnostic syndrome: What have we learned?  
  
At the behavioural level, women with AN-BP and BN bore a striking resemblance: 
they did not differ significantly in terms of psychiatric comorbidity, self-report 
measures of psychopathology, reactive inhibition performance or stress-induced 
eating behaviour. It should be noted that, although group comparisons were 
assessed via non-orthogonal treatment contrasts, comparing AN-BP and BN groups 
to controls, these contrasts, albeit qualitatively, yield insight into distinctions between 
clinical groups by way of comparison to a shared control. Indeed, differences 
between patient groups would offer limited insight into the mechanisms of psychiatric 
illness if values did not also differ from the normative population. Two notable 
behavioural distinctions were observed during proactive inhibition performance and 
the ad libitum meal. Women with BN showed reduced proactive inhibition relative to 
matched controls (Chapter 4); however, the absence of this effect in AN-BP provides 
some preliminary evidence of diagnostic specificity. Conversely, calorie intake in the 
free choice meal was significantly reduced in AN-BP relative to controls, whereas a 
nominally significant difference was found in BN (Chapter 3). Given the central role 
of caloric restriction in AN, this effect perhaps speaks more to overarching 
distinctions between AN and BN than it does to behavioural correlates of binge-
eating per se. A clearer picture of divergent mechanisms of binge-eating emerged 
from my biological assessments, particularly those assaying markers of peripheral 
and central nervous system metabolism.  
 
In Chapter 3, I described a series of results, implicating abnormal metabolic 
functioning in AN-BP, both in terms of diurnal cortisol secretion and gut hormone 
signalling under neutral and stressful conditions. Additional analysis via communality 
regression indicated that BMI explained substantially more variance in waking 
cortisol responses than psychopathology scores (e.g., self-reported anxiety, 
depression and eating disorder severity). Chapter 4 identified distinct, stress-induced 
alterations in inferior and superior frontal BOLD responses in AN-BP and BN during 
performance of a response inhibition task; these effects will be discussed further in 
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Sections 6.3 and 6.5. Moreover, Chapter 5 presented findings of altered neural 
chemistry in the inferior frontal cortex in AN-BP relative to controls, suggesting 
reduced glial and neuronal integrity. Whilst metabolic and endocrine dysfunction in 
acute AN has been meticulously documented (for review, see Misra & Klibanski, 
2014; Schorr & Miller, 2016), this work represents one of the first investigations of 
metabolic alterations in AN-BP and BN, offering an opportunity to identify metabolic 
correlates of binge-eating that are independent of (significantly low) body weight. 
However, this study failed to elucidate any shared metabolic alterations across AN-
BP and BN. This would suggest that basal metabolic functioning must be considered 
when attempting to identify putative ‘biomarkers’ of binge-eating, and perhaps more 
broadly, when conceptualising eating disorders. 
 
The physician Sir Richard Morton first insinuated that anorexia nervosa manifests as 
a consequence of both metabolic and neurocognitive factors in the 17th century. 
Findings of recent large-scale, genomics studies have reignited scientific inquiry in 
this area. For example, the largest genome-wide association study of anorexia 
nervosa (n = 16,992 AN cases, n = 55,525 controls) to date has identified eight 
genetic loci that confer risk for AN (H. J. Watson et al., 2019). Further investigation of 
the genetic architecture of AN revealed significant genetic correlations with not only 
psychiatric traits but also anthropometric traits, physical activity and metabolic 
markers. These findings align with those from whole-exome sequencing studies, 
which have identified rare and common variants in the Epoxide Hydrolase 2 
(EPHX2) gene in AN (Scott-Van Zeeland et al., 2014). EPHX2 has been functionally 
implicated in cholesterol metabolism as its protein product, the enzyme, soluble 
epoxide hydrolase, mediates lipid signalling in various tissues (Newman et al., 2005). 
Findings of altered proxy measures of soluble epoxide hydrolase activity lend further 
support to a potential role of lipid metabolism in the pathogenesis of AN (Shih et al., 
2016). However, the observations of Watson et al. (2019) are the first to implicate 
metabolic dysfunction as a causal mechanism of AN. Specifically, the authors noted 
a significant, bidirectional causal association between the genetic risk for AN and 
genetic risk for low BMI (H. J. Watson et al., 2019), which reflects what is observed 
at the phenotypic level (i.e., that low BMI and current diagnostic conceptualisations 
of AN are inextricably linked).  
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6.2.1 Characterising the metabolic mechanisms of binge-eating: Outstanding questions 
 
One key question for future experimental medicine, and perhaps genomics, studies 
will be: Do the metabolic alterations observed in AN-R and AN-BP differ from those 
amongst individuals who are constitutionally thin? One recent systematic review 
suggests that heterogeneity in the definition and assessment of ‘constitutional 
thinness,’ or the presence of underweight in the absence of medical comorbidity, 
complicates interpretation in the existing literature (Bailly et al., 2020). Nevertheless, 
findings of normative insulin-like growth factor 1, oestradiol, free triiodothyronine, 
mean cortisol and non-blunted leptin levels in some constitutionally lean individuals 
(Germain et al., 2014; Ling et al., 2016) could be suggestive of a unique metabolic 
profile in AN.  
 
A related question concerns the degree to which metabolic alterations in AN reflect 
significantly low body weight versus extreme caloric restriction. Historically, there has 
been little consensus surrounding BMI cut-offs for underweight (Thomas et al., 
2009), and mounting evidence suggests that significant caloric deprivation and 
weight loss elicit severe medical comorbidities even in the absence of significantly 
low body weight (reviewed by Moskowitz & Weiselberg, 2017). These observations 
led to the formalisation of ‘atypical anorexia nervosa’ as a subtype of DSM-5 
Otherwise Specified Feeding or Eating Disorders (OSFED), in which ‘all of the 
criteria for anorexia nervosa are met, except that despite significant weight loss, the 
individual’s weight is within or above the normal range [18.5 – 24.9 kg/m2]’ 
(American Psychiatric Association, 2013, p. 353). I aimed to account for the potential 
effects of dietary restriction on these measures by assessing binge-eating in AN-BP 
and BN, where both patient populations report dietary restriction (Stice et al., 2008), 
yet additional assessment in other restrictive-type eating disorders, such as atypical 
AN, is warranted. Indeed, findings of partial hormonal normalisation during weight 
restoration in AN may suggest a role for dietary restriction in altered metabolic 




6.3 On the role of inhibitory control in binge-eating: Reconciling psychiatric 
terminology and neural circuitry  
 
Given that binge-eating disorders are frequently associated with increased 
impulsivity (see Chapter 1, Section 1.4.2), a primary aim of this thesis was to 
determine if such disinhibition related to reduced inhibitory control at the neural level. 
I tested this by using a variant of the stop-signal task, which measures brain 
responses during proactive (anticipatory, goal-directed stopping) and reactive 
(outright stopping) inhibition (Zandbelt et al., 2011; Zandbelt & Vink, 2010). My 
decision to use this task reflected pragmatic factors, such as the availability of 
validated paradigms for neuroimaging studies of inhibitory control, as well as a 
desire to model the subjective ‘loss of control’ that defines binge-eating episodes. As 
patients often report that they feel they cannot stop eating during a binge-eating 
episode, use of a task that models one’s ability to cancel an ongoing action seemed 
conceptually appropriate. However, consensus on the defining features of binge-
eating has shifted across iterations of both the DSM-5 and ICD, where the choice of 
terminology has had little, if any, relation to an underlying cognitive or biological 
process of the associated illnesses.  
 
Whilst a perceived loss of control over eating has been considered a defining feature 
of binge-eating, I would argue that subtle changes to its definition have inadvertently 
swayed models of its neurocognitive underpinnings. For example, experiencing a 
loss of control over eating was not considered a defining feature of binge-eating in 
BN until the DSM-IV (Wolfe et al., 2009), and the definition of ‘loss of control’ has 
evolved over time. This definition has shifted from a ‘fear of not being able to stop 
voluntarily’ in the DSM-III to a sense of ‘lack of control over eating behaviour during 
the eating binges’ in the DSM-III-R, and finally, the DSM-5 has defined ‘loss of 
control’ as, ‘a sense of lack of control during the eating episode (i.e., a sense that 
one cannot stop eating or control what or how much one is eating)’ (Wolfe et al., 
2009). Despite these evolving definitions, the DSM has maintained that the amount 
of food consumed during the binge episode must be objectively large for the 
circumstances to support diagnoses of BN and BED. A substantial change within the 
proposed ICD-11 criteria for BN and BED would eliminate the size criterion for binge-
eating episodes, instead emphasising the experience of 'a loss of control over his or 
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her eating behaviour’ in which an individual, ‘feels unable to stop eating or limit the 
type or amount of food eaten’ (Claudino et al., 2019). As such, the perceived 
experience of loss of control has become an increasingly central attribute of binge-
eating disorders, and this has coincided with a premature acceptance that 
neurobiological models of other disorders characterised by abnormal consummatory 
behaviours (e.g., alcohol and substance use disorders) apply to disordered eating.  
 
As there is no reliable neural substrate of a perceived loss of control over behaviour, 
how can we identify the putative neural circuits of binge-eating? One approach would 
be to investigate dysfunction of well-defined neural circuits of related cognitive 
processes, such as response inhibition; however, this thesis found that women with 
AN-BP and BN had intact behavioural and neural responses during reactive 
inhibition under neutral conditions. Although women with BN had reduced proactive 
inhibition and a concurrent increase in superior frontal gyrus responses relative to 
controls, this inhibitory mode indexes goal-directed modulation of responding as 
opposed to one’s capacity for action cancellation. In contrast, reactive inhibition, or 
the ability to inhibit an ongoing response, arguably aligns more closely to 
contemporary conceptualisations of ‘loss of control’ in binge-eating. An important 
limitation to the work herein is the absence of food stimuli in the modified stop-signal 
task, where inhibitory control deficits in AN-BP and BN may be elucidated or 
exacerbated in the presence of disorder-specific stimuli (Wu, Hartmann, et al., 2013). 
Moreover, women with BED were not included in this thesis, and assessment of this 
population will lend further insight into associations between inhibitory control and 
binge-eating across the weight and diagnostic spectrum. Whilst this thesis included 
an adequate sample size with multiple, within-subject neuroimaging measurements, 
detection of subtle inhibitory control impairments might require significantly larger 
sample sizes (e.g., in the order of thousands; Marek et al., 2020). Indeed, the lack of 
concordance between neural and behavioural measures of inhibitory control in 
neuroimaging studies of binge-eating (Bartholdy et al., 2019; Lock et al., 2011; 
Marsh et al., 2009; Skunde et al., 2016) may have emerged as a consequence of 
low statistical power.   
 
Alternatively, the high degree of subjectivity in ‘loss of control’ associated with binge-
eating could simply be to heterogenous across individuals to map to a common 
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neural circuit. Although anecdotal, the women who took part in this study offered 
diverse explanations of what this ‘loss of control’ felt like, the particular role it played 
in their binges and at which point in the binge it was experienced. Some participants 
felt a loss of control due to perceived transgressions of dietary rules, dissociative 
experiences, or because their binge-eating episodes had become so intractable that 
they comprised a daily routine. Interestingly, others suggested that a loss of 
behavioural control initiated their binge episodes, but their eating would become 
increasingly goal-directed throughout the episode (e.g., purging the food became the 
goal, and this could be more easily accomplished with a high volume of food). As 
such, a subjective loss of control over eating could feasibly relate to a wide range of 
cognitive processes, including abnormal beliefs about food intake, aberrant 
interoceptive and/or satiety sensing and altered decision-making processes.  
 
6.3.1 Refining the cognitive neuroscience of disorder eating: Future directions 
 
Rather than searching for a one-to-one mapping between the brain and complex 
behaviours, a more powerful approach could be one that interrogates cognitive 
processes, such as aberrant learning and decision-making, which map to many 
different behavioural domains in illness and health (Montague et al., 2012). A 
growing body of research has begun to characterise how individual differences in 
learning and decision-making might relate to various forms of mental illness, 
including substance use disorders (Mollick & Kober, 2020), obsessive compulsive 
disorder (Palminteri et al., 2012) and internalising disorders like depression (Eshel & 
Roiser, 2010; Rupprechter et al., 2018). Although humans likely formulate various 
learning strategies (see Collins & Cockburn, 2020; Feher da Silva & Hare, 2020), 
these processes are commonly conceptualised as a dual systems of ‘model based’ 
or ‘model free’ learning. Model-based learning reflects a deliberative process, where 
decisions are selected after considering the possible consequences of myriad 
actions that would move the agent closer toward its goal. In contrast, model-free 
agents base decisions on their cumulative reward history, which results in efficient 
yet inflexible behaviours in changing environments. Although model-based learning 
improves across normative development (Decker et al., 2016), impairments in this 
goal-directed learning strategy have been related to various forms of mental illness 
(reviewed by Collins & Cockburn, 2020). 
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A compelling case can be made that health-harming eating behaviours reflect 
alterations in reinforcement learning, whereby an individual cannot transition 
between slower, goal-direct behaviours and automatic ones in a flexible manner 
(Marteau et al., 2012). Consistent with this, individuals with BED have demonstrated 
inefficient ‘switching’ between exploratory and exploitative choice behaviour in a 
changing environment (Reiter et al., 2017). Aberrant reward learning has been 
reported in adolescents (Cyr et al., 2016) and adults (Frank et al., 2011) with BN, 
where patients showed altered neural responses to unexpected reward receipt 
during spatial learning and unexpected reward receipt or omission during taste 
learning, respectively. However, assessment of model-based or model-free learning 
and decision-making processes have neither been examined in AN-BP nor assessed 
in relation to real-world eating behaviour. One follow-up project to this thesis aims to 
characterise how learning and decision-making under uncertainty explain variability 
in both restrictive and binge-eating behaviours in the natural environment. As this 
project will recruit a large sample (n=200) of adults with any DSM-5 eating disorder 
and controls (n=100), findings will offer critical insight into transdiagnostic cognitive 
processes in binge-eating. 
 
6.4 Delineating the role of stress in disordered eating   
 
Decades of research have shown that psychological stress can profoundly alter 
eating behaviour (see Chapter 1 Section 1.5); however, the mechanisms the 
underpin this association remain poorly understood. This thesis examined the impact 
of induced, psychological stress on metabolic signalling, functional brain responses 
and behaviour, yielding several important insights to potential pathways that might 
explain variability in individuals’ eating patterns under stress. Findings counsel 
against a prominent theoretical model, which proposes that stress-induced 
decrements in self-control precipitate binge-eating (Heatherton & Baumeister, 1991), 
instead sketching a more complex picture of the metabolic and neurocognitive 
factors that may alter eating behaviour under stress. These results also highlight 
several areas of ambiguity, notably the use circulating cortisol as a putative 
‘biomarker’ of subjective stress, that must be addressed before a clearer 
understanding of stress-induced eating patterns can be reached.  
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As I discussed in Chapter 4, acute stress did not significantly affect proactive or 
reactive inhibition performance; however, women with AN-BP and BN showed 
distinct, stress-induced alterations in prefrontal responses relative to controls. 
Moreover, acute stress failed to augment calorie consumption during the ad libitum 
meal. These findings provide, at best, equivocal support for the model proposed by 
Heatherton & Baumeister (1991). However, as women with AN-BP and BN 
demonstrated sensitivity to acute, psychological stress at the neural level, it would be 
useful to determine if related cognitive domains, such as delay discounting or 
decision-making, might be affected by negative mood states. Women with AN-BP 
had stress-induced reductions in right vmPFC activity during reactive inhibition, and 
vmPFC responses during outright stopping were negatively related to ad libitum 
intake across the full sample. This would indicate that recruitment of the vmPFC 
during response inhibition relates to increased dietary control (i.e., a lower likelihood 
of overconsumption), and more broadly, that vmPFC responses in AN-BP are 
sensitive to negative emotional states under certain task conditions. As the vmPFC 
plays a role in various cognitive processes, including value-based choice (Hare et 
al., 2009) and emotion regulation under stress (Hänsel & von Känel, 2008; Sinha et 
al., 2016), it will be critical to determine if psychological stress alters vmPFC activity 
in AN-BP across variable contexts. 
 
Perhaps one of the more intriguing findings reported in this thesis was the 
observation of stress-induced increases in acyl-ghrelin and PYY in AN-BP relative to 
healthy women. These data might suggest that psychological stress disrupts 
‘bottom-up’ satiety sensing in AN-BP, but not BN, and imprecision in homeostatic 
hunger-sensing could increase reliance on ‘top-down’ control of eating behaviour. In 
the case of AN-BP, this could leave the individual more likely to either binge-eat or 
restrict their energy intake; however, as ad libitum consumption was unaffected by 
stress, future research will be needed to determine the relevance of these hormonal 
changes to naturalistic eating behaviour. These data broadly align with previous 
reports of altered interoceptive sensing in women who have recovered from AN 
(Berner et al., 2018; Kerr et al., 2016), yet it will be important to determine if and how 
stress-induced alterations in gastrointestinal signalling relate to subjective 
experiences of hunger and satiety.   
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Another key finding of this thesis aligns with a growing body of work, which has 
urged caution when interpreting circulating cortisol as a putative ‘biomarker’ of 
prolonged psychological distress. Circulating cortisol levels were assessed on two 
timescales, reflecting diurnal HPA-axis activity and acute reactivity; however, these 
data primarily indicated that cortisol alterations related to significantly low body 
weight as opposed to psychopathology symptoms or acute stress. For example, 
women with AN-BP, but not BN, had an augmented salivary cortisol awakening 
response when compared to controls, and BMI explained an appreciable proportion 
of CAR variability. In contrast, self-report measures of eating disorder, depression 
and anxiety symptomatology were not significantly related to salivary CAR. The 
absence of any association with these symptoms could reflect a lack of temporal 
coupling between cortisol sampling and psychological assessment (Lazarides et al., 
2020). Indeed, neither cross-sectional nor longitudinal assessment of cortisol was 
related to prolonged, perceived stress in a large Danish cohort (Mikkelsen et al., 
2017). Others have found nonsignificant associations between socioeconomic 
disadvantage and both diurnal and hair cortisol concentrations in a population-
representative sample of US children (Malanchini et al., 2020). Moreover, recent 
work found that only momentary stress ratings are positively correlated with salivary 
cortisol in pregnant women (Lazarides et al., 2020). Integration of cortisol sampling 
with retrospective measures of psychiatric symptoms may therefore constitute a 
suboptimal analytic approach, and these limitations should be carefully considered in 
future work.  
 
Stress reactivity analyses, which assessed total plasma cortisol as opposed to ‘free’ 
cortisol in saliva, similarly lent little support to the hypothesis of stress-induced 
cortisol alterations in AN-BP and BN, or even in healthy women. In contrast to 
salivary CAR, both patient groups demonstrated increased basal plasma cortisol 
relative to controls regardless of the stress induction. Women with BN, but not AN-
BP, had nominally-significant reductions in plasma cortisol under stress, which 
counters the suggestion that acute, stress-induced increases in glucocorticoids 
represent a primary driver of binge-eating. Although robust increases in cortisol 
output are often regarded as markers of dysfunctional stress sensitivity, this 
interpretation has largely been informed by studies of men, and male participants 
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mount a stronger reactive cortisol response than women (Kajantie & Phillips, 2006; 
Kudielka et al., 2004). Women instead show a more robust sympathetic nervous 
system response to stress than men, as indexed by increased salivary alpha 
amylase (Ali et al., 2020). Moreover, recent work implicates an imbalance of HPA 
axis and sympathetic nervous system responses to acute stress, not the overall 
magnitude of the cortisol response, as the primary mechanism of stress-induced 
mood disturbances in otherwise healthy women (Ali et al., 2020). Although I did not 
collect measures of sympathetic nervous system activity, increased resting heart rate 
variability and concurrent dampened stress responses have been found in BN 
(Peschel et al., 2016). As such, the present findings in AN-BP and BN align with 
emerging knowledge of dysregulated physiological responses to stress in women 
that may not manifest as augmented cortisol secretion. A deeper understanding of 
the contribution of circulating glucocorticoids to binge-eating symptomatology will be 
predicted on further research in this area.   
 
6.4.1 Examining shared and unique morphometric correlates of disordered eating and stress-
related psychopathology 
 
One ongoing avenue of work aims to characterise shared and unique neural 
correlates of disordered eating symptoms and stress-related psychopathology, such 
as depression and anxiety symptoms. An estimated 71-94% of individuals with an 
eating disorder will have a comorbid psychiatric condition during their lifetime, with 
approximately half suffering with concomitant anxiety or depressive disorders (Udo & 
Grilo, 2019; Ulfvebrand et al., 2015). However, there is considerable debate 
surrounding the causes of such comorbidity, where some have argued that comorbid 
psychiatric illnesses reflect a shared latent factor (Caspi & Moffitt, 2018). 
Alternatively, proponents of network models of psychopathology suggest that the 
illnesses reflect a network of symptoms and the causal associations between them 
(e.g., insomnia causes fatigue in depression; van Bork et al., 2017), where ‘bridge 
symptoms’, or symptoms that are common to the multiple disorders, may partly 
explain psychiatric comorbidity (Cramer et al., 2010). Both latent factor (Kotov et al., 
2017) and network (Levinson et al., 2017) models have identified covariance 
between eating disorder, depressive and anxiety symptoms, yet it remains unknown 
if such covariance is preserved at the neurobiological level.  
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Attempts to characterise shared and unique neural correlates of eating disorders and 
other internalising symptoms can be achieved through the use of large, normative 
samples. Moreover, neuroimaging datasets, such as the Adolescent Brain and 
Cognitive Development (ABCD) study, provide not only sufficient statistical power for 
complex modelling of comorbidity, but also dimensional measures of 
psychopathology in a representative population sample. As such, my ongoing work 
has used a structural equation modelling framework to examine the degree to which 
latent factors of depressive, anxiety and eating disorder psychopathology predict 
morphometric similarity and regional volume of the developing brain of ~11,000 
children (M±SD = 9.91 ± 0.62 years; n = 5,185 female) in the ABCD Study. Briefly, 
when fitting a two-factor model of eating-disorder related psychopathology, I found 
that latent factor scores for disordered eating and depressive/anxious symptoms did 
not share common neural correlates. Moreover, disordered eating scores and 
adiposity (indexed as age-adjusted BMI Z-score) showed dissociable associations 
with the size of subcortical volumes, such as the nucleus accumbens. These 
preliminary findings have lent additional insight into the mechanisms by which stress-
related psychopathology symptoms relate to disordered eating in childhood, and 
future work will examine if and how these associations change over development.  
 
6.5 Reaching consilience in aetiological models of disordered eating   
 
Taken together, this thesis provides a potentially important perspective on the role of 
metabolic factors in binge-eating disorders, and it succeeded in providing piecemeal 
insight into the aetiology of AN-BP and BN. However, arguably the greatest utility in 
these observations will emerge once an understanding of how perturbations at one 
level relate to those at other levels has been reached. This notion of ‘consilience,’ a 
term coined by the philosopher William Whewell that refers to a point, “when an 
Induction, obtained from one class of facts, coincides with an Induction 
obtained from another different class” (Whewell, 1840) has long been the white 
whale of psychiatric research. One reason for this arises from the challenges of 
decomposing a complex, biological phenomenon, or ‘system’, like psychiatric illness. 
As Kendler (2008) has argued, explanatory models of mental illness must begin with 
decomposition, in which scientists determine how each level, be it molecular, 
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neurobiological, cognitive, environmental, etc., works, beginning with the simplest 
and moving toward the most complex mechanisms. The relative ease of 
decomposing the system will depend on whether systems demonstrate 
‘aggregativity’, whereby the relations between their constituent parts can be 
explained in a simple, additive manner (Wimsatt, 1997). In these systems, each level 
can be studied in isolation as its actions are neither context-dependent nor 
influenced by causal loops, in which actions at one level alter those at another 
(Kendler, 2008). Mental illness, however, reflects a non-aggregative system that is 
defined by recursive causal loops, in which the experience of the illness in and of 
itself affects the functioning of its constituent levels. Indeed, this thesis demonstrated 
that the experience of acute, psychological stress affects functioning at neural and 
metabolic levels amongst women with AN-BP and BN, and this dysfunction may, in 
turn, contribute to the maintenance of disordered eating. 
 
Given that binge-eating disorders represent non-aggregative systems, how can 
future research integrate observations across the multilevel mechanisms that 
subserve them? First, I suggest that a deeper understanding of the interacting 
metabolic and neural pathways that control food intake will be a necessary 
prerequisite to developing comprehensive models of disordered eating. Despite 
major advances in preclinical neuroscience research of eating behaviour in recent 
years (Han et al., 2018; Tellez et al., 2016), knowledge of the neural circuits that 
integrate peripheral hunger and satiety signals to orchestrate motivated behaviour 
remains rudimentary. Second, given that the primary targets of peripheral metabolic 
signals are small, subcortical nuclei (e.g., ARC, VTA), increased use of high-field 
fMRI will be central ‘stitching together’ knowledge of metabolic and neural 
mechanisms in human subjects studies. Third, intensive, prospective studies, such 
as the ABCD or IMAGEN studies, will enable well-powered, within-subject 
assessment of how multilevel mechanisms interact over time, and this may be 
particularly important for the aetiology of eating disorders, which tend to onset during 
the critical developmental period of adolescence. Such designs will also enable 
quantification of unique and common mechanisms of binge-eating amongst 
individuals who demonstrate diagnostic crossover during the course of their illness. 
A final and related avenue will involve leveraging biobanks, such as the UK Biobank 
and the NIH All of US initiative, which have sufficiently large sample sizes for ‘deep 
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phenotyping’ approaches. Deep phenotyping would offer a complementary approach 
to basic physiological research as the increased sample size and rich, within-subject 
data would permit use of complex statistical modelling of inter-level, mechanistic 
processes.  
 
6.6 Conclusion  
 
In this thesis, I sought to undertake a comprehensive assessment of metabolic, 
neurobiological, cognitive and behavioural functioning in women who are acutely ill 
with the eating disorders, AN-BP and BN. These are serious illnesses with low rates 
of remission and, in the case of AN-BP, unacceptably high rates of morbidity and 
mortality. Ultimately, progress in our understanding of the complex aetiology of 
eating disorders will be the key to developing novel therapeutics for those affected 
by them. By assessing how these disorders relate to dysfunction at different 
physiological and psychological levels, I advanced knowledge of the role of 
metabolic markers, acute psychological stress and the cognitive process of inhibitory 
control in the maintenance of AN-BP and BN. This work can be extended by several 
diverse avenues of research, as discussed in this Chapter, and each will provide 
complementary insight into the mechanisms of these illnesses, thus moving 
incrementally closer toward the end goal of translational medicine: relief from 
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1. Hormone assays  
All assays were completed by the Core Biochemistry Assay Laboratory (CBAL) 
within the Cambridge University Hospitals NHS Foundation Trust at Addenbrooke’s 
hospital.  
 
1. Salivary cortisol assay  
As described in the main text, participants collected saliva samples at home on two 
working days of their choice. Participants stored samples in their home refrigerator 
before delivery to the study team, at which point samples were stored at -80°C until 
assayed. Unbound salivary cortisol was measured in duplicate with a commercially 
available ELISA immunoassay kit (Salimetrics; Cat# 1-3102-5, intra-assay coefficient 
of variation (CV) = 3.35 – 3.65%, inter-assay CV = 9.3 – 9.7%).  
 
2. Plasma cortisol assay 
Blood samples for cortisol were acquired in 2.6mL serum tubes and allowed to clot at 
room temperature. Within 1 hour of collection, tubes were centrifuged at 3500g for 
10 minutes at 4°C to obtain plasma. Plasma samples were stored at -80°C until 
assayed. Total plasma cortisol was measured in triplicate with a commercially 
available radioimmunoassay (RIA) kit (Diasorin; Cat# 313261), using the Liaison XL 
system (intra-assay CV = 3.5 – 4.9%, inter-assay CV = 3.2 – 7.1%).  
 
3. Acyl ghrelin assay 
Blood samples for acyl-ghrelin were collected in 1.3mL tubes containing EDTA and 
20μL of 200mM AEBSF serine protease inhibitor. Tubes were placed on ice and then 
centrifuged for 10 minutes at 3500g and 4°C within 30 minutes of collection to isolate 
plasma. After plasma samples were pipetted into two, 250μL aliquots, 50μL of 1M 
HCL were added to each aliquot. Aliquots were then capped and inverted three 
times to mix. Plasma samples were stored at -80°C until assayed. Acyl ghrelin, one 
of three preproghrelin derived peptides, results when the ghrelin peptide is acylated 
by the enzyme, ghrelin O-acyl transferase (GOAT) (Yang et al., 2008). As high 
concentrations of GOAT are found in the human stomach, small intestine and 
pancreas (Yang et al., 2008), measurements of acyl ghrelin are thought to represent 
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a more specific orexigenic signal than measurements of total ghrelin, which include 
both acyl ghrelin and the degradation product, des-acyl ghrelin. Acyl ghrelin was 
measured in triplicate in a commercially available RIA kit (Millipore; Cat# EZGRA-
88K), where intra-assay and inter-assay CVs ranged from 0.88 – 7.53% and 14.5 – 
20.3%, respectively.    
 
4. PYY and GLP-1 assays 
Blood samples for PYY and GLP-1 were acquired in 2.6 mL tubes containing EDTA 
and clotted on ice. To obtain plasma, samples were centrifuged for 10 minutes at 
3500g and 4°C, and plasma samples were stored at -80°C until assayed. Both total 
PYY and total GLP-1 were measured with MesoScale Discovery 
electrochemiluminescence immunoassay kits K151MPD1 and K150JVC, 
respectively. Assays for both hormones had an intra-assay CV of less than 10% 
across range based on duplicate analysis of precision. Inter-assay CV ranged from 
6.1 – 9.9% for PYY and 6.0 – 8.5% for GLP-1. 
 
5. Estradiol, leutenising hormone and follicular stimulating hormone  
Plasma samples of estradiol, leutenising hormone (LH) and follicular stimulating 
hormone (FSH) were acquired upon waking on Day 2 of the study to determine the 
participant’s menstrual phase at the time of testing. We note that several participants 
were prescribed a hormonal contraceptive at the time of testing (n = 29), and some 
patient participants reported amenorrhea (n = 12). Samples were acquired in 2.5mL 
serum tubes and allowed to clot. Samples were then centrifuged within one hour of 
collection to obtain plasma, and plasma samples were stored at -80°C until assayed. 
Estradiol, LH and FSH were measured with commercially available kits (Diasorin; 
Cat# 310680, Cat# 312201 and Cat# 312251, respectively) on the Liaison XL 
immunoassay system. Coefficients of variation were acceptable for estradiol (intra-
assay CV = 2.4 – 2.6%, inter-assay CV = 1.9 – 2.9%), LH (intra-assay CV = 2.8 – 
3.5%, inter-assay CV = 3.1 – 9.0%) and FSH (intra-assay CV = 2.3 – 5.6%, inter-
assay CV = 3.3 – 4.8%). To determine participants’ menstrual phase, estradiol, LH 




6. Insulin and glucose assays  
Blood samples for insulin and glucose were collected in 2.6mL lithium-heparin tubes 
and clotted on ice. Samples were centrifuged within 1 hour of collection (10 minutes 
at 3500g and 4°C) to obtain plasma samples, which were stored at -80°C until 
assayed. Insulin was measured with a commercially available RIA kit (Diasorin; Cat# 
310360) on the Liaison XL immunoassay system (intra-assay CV = 2.2 – 5.0%, inter-
assay CV = 5.9 – 11.0%). Glucose was similarly measured with a commercial kit 
(Siemens; DF30) on the Dimensional EXL immunoassay system (intra-assay CV = 
0.5 – 1.0%, inter-assay CV = 2.5 – 3.6%).  
 
7. Leptin assay 
Blood samples for leptin were collected in 2.6mL serum tubes and clotted on ice. 
Within 1 hour of collection, samples were centrifuged for 10 minutes to isolate 
plasma. Plasma samples were stored at -80°C until assayed. Leptin was measured 
with an in-house kit on the AutoDELFIA automatic immunoassay system, and the 
intra-assay CV was less than 5% across the dynamic range of the assay (0.1 ng/mL 
– 95 ng/mL).  Inter-assay CV ranged from 3.9 – 7.1%. 
 
8. Potassium 
Potassium samples were acquired in 2.6mL  serum tubes, clotted on ice and 
centrifuged for 10 minutes at 3500g and 4°C within 1 hour of collection. Resulting 
plasma samples were stored at -80°C until assayed.  Potassium levels were 
measured using a commercially available RAI kit (Siemens) on the Dimensional EXL 
immunoassay system (intra-assay CV = 0.6 – 0.8%, inter-assay CV = 1.2 – 1.3%). 
 
2. Robustness checks 
2.1 Robustness check of salivary cortisol linear-mixed effects model 
After excluding values ±2 SD from the mean (5.6% of observations), our robustness 
check also identified a significant main effect of group on salivary CAR, where CAR 
was elevated in AN-BP (β=3.75, t(79)=2.73, p=.008) but not BN (β=0.10, t(79)=0.1, 
p=.93) relative to the control group. Moreover, salivary CAR was related to both 
linear (β=37.12, t(445)=11.72, p<.0001) and quadratic (β=-35.68, t(445)=-11.31, 
p<.0001) time terms, where the latter improved fit indices (χ2(1)=112.90, p<.001). A 
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significant group-by-timelinear interaction showed greater CAR in AN-BP relative to 
controls (β=36.40, t(441)=4.52, p<.0001) and improved model fit (χ2(4)=26.54, 
p<.0001). Finally, hormonal contraceptive use was related to reduced salivary 
cortisol (β=-3.18, t(79)=-2.91, p=.005). Visual inspection of the model residuals did 
not raise concerns about deviations from normality. 
 
2.2 Robustness check of acyl ghrelin linear-mixed effects model 
The exclusion of outlier values resulted in the loss of 4.2% of observations. We 
found a trend toward a main effect of condition, where ghrelin levels were increased 
following the stress induction relative to the neutral day (β=36.72, t(78)=2.55, 
p=.013). As in our original model, the main effects of group and time were 
nonsignificant; however, there was a trend toward increased acyl ghrelin in AN-BP 
relative to controls (β=183.07, t(78)=1.96, p=.053). A significant group-by-condition 
interaction indicated elevated ghrelin in AN-BP following acute stress (β=114.32, 
t(76)=3.40, p=.001), but the effect was not significant in BN (β=-19.60, t(76)=-0.65, 
p=.52). Model fit improved with the addition of the interaction term (χ2(1)=15.01, 
p=.0001), and inspection of the quantile-quantile plot indicated approximate 
normality of the model residuals. 
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Breakfast Menu Snack Menu 
• Scrambled egg, toast with butter, 
orange juice 
• Plain yogurt, pineapple, dried fruit & 
nut mix 
 
• Apple and blackberry porridge with 
whole milk and protein powder, 
orange juice 
 
• Low-fat cream cheese, deli ham, 
water crackers, orange juice 
• Homemade muesli with milk • Cottage cheese, water crackers, 
orange juice 
 
• Crunchy peanut butter, whole grain 
toast, orange juice  
• Soreen malt loaf (banana flavor) 
with butter, Nakd fruit and nut bar 
 
 • Popcorn (peanut butter almond 
flavor), raisins, milk with protein 
powder 
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Appendix Table 2. P-values for exploratory hormone correlation analyses – Neutral 
day  
 
 BMI BNvHC ANvHC PYY GLP1 Cortisol Ghrelin KCAL OBE NAFF 
BMI 0 3.70E-07 0 0.066 0.046 0.043 0.001 0.004 4.3846E-05 0.101 
BNvHC 8.3231E-06 0 1.00 0.238 0.845 0.008 0.726 0.432 0.579 0.006 
ANvHC 0 1.00 0 0.048 0.454 0.082 0.189 0.045 0.004 0.258 
PYY 0.166 0.40 0.135 0 0.089 0.341 0.080 0.735 0.541 0.314 
GLP1 0.135 0.90 0.601 0.182 0 0.578 0.080 0.281 0.242 0.887 
Cortisol 0.135 0.04 0.175 0.494 0.704 0 0.184 0.063 0.007 9.2754E-06 
Ghrelin 0.013 0.81 0.340 0.175 0.175 0.340 0 0.616 0.351 0.657 
KCAL 0.026 0.59 0.135 0.807 0.436 0.166 0.730 0 0.877 0.028 
OBE 0.000 0.70 0.026 0.696 0.403 0.036 0.494 0.907 0 0.026 
NAFF 0.199 0.03 0.415 0.470 0.907 0.000 0.758 0.106 0.105 0 
 
Note: False discovery rate corrected p-values are presented in the lower triangle (shaded 




Appendix Table 3. P-values for exploratory hormone correlation analyses – Stress 
day  
 
 BMI BNvHC ANvHC PYY GLP1 Cortisol Ghrelin KCAL OBE NAFF 





06 0 1.000 0.143 0.875 0.539 0.046 0.324 0.563 0.186 
ANvHC 0.000 1.000 0 5.2E-06 0.972 2.46E-07 4.44E-05 0.096 0.005 0.014 
PYY 0.000 0.240 4.70E-05 0 0.025 0.041 0.881 0.779 0.306 0.110 
GLP1 0.279 0.944 0.995 0.069 0 0.973 0.199 0.674 0.372 0.659 
Cortisol 0.000 0.693 3.69E-06 0.103 0.995 0 0.186 0.025 0.026 0.127 
Ghrelin 
5.24E-
08 0.108 0.000 0.944 0.288 0.279 0 0.823 0.078 0.088 
KCAL 0.025 0.442 0.188 0.899 0.798 0.069 0.926 0 0.048 0.017 
OBE 0.000 0.704 0.021 0.430 0.493 0.069 0.167 0.108 0 0.144 
NAFF 0.016 0.279 0.048 0.206 0.798 0.229 0.179 0.056 0.240 0 
 
Note: False discovery rate corrected p-values are presented in the lower triangle (shaded 
area). Uncorrected p-values are included in the upper triangle (whitespace).  
 
 
